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Globally, over 50% of the world’s urban population, or approximately 2.2 billion people, 
lack access to safely managed sanitation (1). Inequities in access increase in low-resource 
regions like Sub-Saharan Africa, where over 80% of urban residents lack access to safely 
managed sanitation (1). Because development of advanced wastewater infrastructure may 
be decades away for rapidly growing cities of developing nations, there is increasing 
interest in decentralized sanitation technologies that serve urban clusters. Though various 
methods for improved on-site urban sanitation have been piloted, the impacts of such 
strategies on reducing exposure to enteric (gut) pathogens and subsequent effects on 
enteric infections have not been characterized. Here we present results from the Maputo 
Sanitation (MapSan) trial, the largest controlled health impact study to date of 
decentralized urban sanitation in the developing world (2). In this study, we examined the 
expansion of improved on-site sanitation serving household clusters (compounds) in low-
income, densely populated urban neighborhoods of Maputo, Mozambique, where the 
burden of sanitation-related disease is high. We measured objective health outcomes in 
children <6 years old before and after the implementation of new sanitation systems 
which included pour-flush toilets to septic tanks with soak-away pits to discharge 
aqueous effluent. In parallel, we measured the same outcomes in children enrolled in 
control compounds that did not receive the new latrines. We used a difference-in-
difference (DID) analytical approach, coupled with our controlled before-and-after study 
design, to estimate the effects of the intervention on three metrics of child health: enteric 
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infection, environmental enteric dysfunction (EED), and reported diarrhea. We collected 
stool from enrolled children at three time-points during the study: pre-intervention 
(n=757), 12-months post intervention (n=803), and 24-months post-intervention (n=923). 
We tested stools for enteric pathogens using a qualitative multiplex molecular method 
detecting 15 enteric bacteria, protozoa, and viruses identified as important causative 
agents of diarrhea and four biomarkers of EED using enzyme-linked immunosorbent 
assays.  
Enteric infection was common at baseline with over 80% of children in both intervention 
and control arms positive for one or more pathogen. The sanitation improvements had no 
effect on enteric infections when we analyzed results from the 12-month and 24-month 
time-points separately or combined into a single “follow-up” phase. We also found no 
effect on caregiver-reported diarrhea over the course of the study. Sanitation increased 
the concentration of EED biomarker neopterin, an indicator of immune system activation 
and inflammation, by 0.17 log10 nmol/L (95% CI: 0.07 - 0.27) at the 12-month time-point 
and 0.10 log10 nmol/L (95% CI: -0.01, 0.21) at 24-months. Results from sub-group 
analyses of children with data collected at multiple time-points and children born into the 
study post-intervention were largely similar to the main analyses. We observed a 
reduction in risk of Shigella infection by almost 50% (adjusted risk ratio: 0.53, 95% CI: 
0.29-0.95) in children born into intervention compounds by the 24-month time-point.  
There are many potential reasons the intervention had a limited effect on child health in 
this setting. It may not have interrupted all transmission pathways of import or limited 
fecal contamination of the living environment to the extent necessary to observe real 
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changes in exposure. In these densely populated, low-income urban areas, sources of 
contamination are ubiquitous and our intervention sites may have been impacted by poor 
water, sanitation, and hygiene (WASH) conditions in surrounding areas. Delivery of 
comprehensive WASH interventions at a community level may be necessary to realize 








Clean water and safe sanitation have been recognized as basic human rights that are 
necessary to the achievement of all other human rights. Unfortunately, these international 
normative goals are only partly realized, and over 2 billion people live without access to 
basic sanitation services and 785 million lack access to basic water services (1). This 
burden is not equally distributed and falls largely on the disenfranchised, poor, and most 
vulnerable among us. In Sub-Saharan Africa, only 44% of urban residents have access to 
basic sanitation (improved sanitation infrastructure), leaving approximately 228 million 
people without basic services and an additional 98 million without access to safely 
managed sanitation (improved sanitation infrastructure plus safe disposal and treatment 
of waste) (1). While these numbers represent progress in increasing access generally, 
progress is not equitable and in many places often favors the richest. In Mozambique, 
where cities are quickly expanding, the proportion of the urban population without access 
to basic services decreased from 68% in 2000 to 48% in 2017, however, gains among the 
richest quintile of the population far outpaced progress among the poorest, increasing the 
gap in access between them by 30 percentage points (1). Population growth and 
increasing migration to cities will put additional pressure on already fragile urban 
sanitation systems in many places (3–5). In fact, due to population growth in Sub-
Saharan Africa, the total population using unimproved facilities increased by almost 140 
million between 2000 and 2017, the only developing region to experience an increase in 
use of unimproved sanitation without a corresponding decrease in open defecation (1).  
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The primary goal of safe sanitation systems is to sequester human waste away from 
human contact. Use of failing or inadequate sanitation infrastructure can lead to fecal 
contamination of the environment increasing the risk of human exposure to enteric (fecal) 
pathogens (6–11). Enteric pathogens are transmitted via several fecal-oral pathways 
historically defined by the F-diagram (Figure 1) (11). Consumption of contaminated food 
and water and interaction with fecally contaminated environments have been implicated 
as dominant transmission pathways for bacterial and protozoan enteric pathogens (12,13). 
While enteric viruses can be transmitted via similar environmentally-mediated routes, it 
is posited that person-to-person transmission is also important (14). Exposure to enteric 
pathogens via unsafe water, sanitation, and hygiene conditions (WASH) can result in in 
enteric infections and acute and chronic diarrheal disease, and has been associated with 
environmental enteric dysfunction (a disorder affecting the function and structure of the 
gut), malnutrition (poor growth), cognitive deficiencies, and other long term health and 
well-being outcomes (6,15–23). In 2016, unsafe water and sanitation contributed to 72% 









FIGURE 1: The F-diagram describes major environmentally-mediated routes of 
transmission of enteric pathogens. Adapted from Wagner and Lanois 1958 (11). 
 
 
Urban slums - or low-income, unplanned neighborhoods in urban or peri-urban areas - 
represent high risk settings for enteric pathogens transmission, particularly among 
vulnerable populations like children, as they are characterized, in part, by high population 
density and crowding, poverty, limited access to adequate water and sanitation services, 
and high infection burdens (3,5,24,25). Developing effective WASH interventions to 
interrupt transmission of enteric pathogens is a necessary, albeit complex, step to protect 
public health in these settings. Traditional centralized sewerage systems, often used in 
urban settings, have demonstrated health benefits both historically and in several recent 
evaluations of sewerage expansion projects in Brazil and Iran (26–28). While these types 
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to cost and logistical constraints (26,29). Sanitation solutions for urban slums will require 
technologies and service models that can deliver benefits at lower cost. 
On-site systems such as septic tanks with soakaway pits or small-bore sewers may fill the 
growing need for safe sanitation in rapidly expanding urban areas in low and middle 
income countries (LMIC) (26,30). To date, there is limited evidence of the health impact 
such systems may have in these settings. A recent meta-analysis found that sanitation 
interventions reduce the risk of diarrhea by 25%, though the estimate was reduced to 16% 
when limited to non-sewerage interventions (31). Recent large-scale, rigorous trials of 
on-site sanitation and combined WASH interventions in low-resource areas have found 
mixed evidence of impact on human health (32–36), but all were performed in rural areas 
and their findings may not be generalizable to urban settings. Two trials in India found no 
effect on health outcomes such as self-reported diarrhea, growth, protozoan infection or 
soil-transmitted helminth (STH) infection, likely due to poor uptake and sustained use of 
the intervention (34,35). In contrast, a study of a community-led total sanitation (CLTS) 
intervention in rural Mali observed better growth outcomes in children in the intervention 
study arm but no effect on diarrhea (36). The Water, Sanitation, and Hygiene Benefits 
(WASH-B) trial and the Sanitation Hygiene Infant Nutrition Efficacy (SHINE) trial, both 
cluster-randomized trials studying the effects of WASH and nutrition interventions on 
child health in LMICs, found modest effects of nutritional interventions, but not WASH, 
on child growth (32,33,37). The WASH-B Bangladesh site found reductions in diarrhea 
due to the intervention (from 5.7% to 3.5% prevalence) (33), but WASH-B Kenya site 
and SHINE trial in Zimbabwe did not (32,37). Recently, many of these trials have 
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released findings on their secondary outcome measures such as enteric infections and the 
results are similarly mixed. In Bangladesh, the on-site sanitation intervention reduced the 
prevalence of Giardia (25% reduction) and T. trichiura (29% reduction) (38,39), and in 
Kenya the combined WASH intervention, but not the individual sanitation intervention, 
reduced the prevalence of Ascaris but not Giardia or T. trichiura, the latter of which was 
detected in too few samples to precisely estimate (40). In the Zimbabwe trial, the 
combined WASH intervention decreased the number of parasites detected but did not 
reduce the prevalence of any single pathogen. The combination of a WASH and nutrition 
interventions resulted in an absolute reduction in Giardia prevalence by 10% (41). 
Evidence from these trials is mixed for several potential reasons: (1) a lack of 
acceptability, sustainability, and use of the intervention, (2) failure of the intervention(s) 
to adequately limit exposure to fecal contamination (possibly due to inadequate coverage 
levels), (3) selection of inappropriate study outcomes due to flaws in hypothesized causal 
pathways, (4) the abbreviated length of follow-up periods, and (5) inter-site differences in 
behaviors, exposures, and circulating enteric pathogens (42).  
Health impact of enteric infection 
Diarrheal disease, a commonly used metric of health in WASH intervention trials, is 
largely caused by enteric pathogens, including bacteria, viruses, and protozoa, shed in 
human and animal feces. Until recently, the main etiologic agents of childhood diarrhea 
in LMICs were poorly characterized. The Global Enteric Multicenter Study (GEMS), a 
large-scale study of the etiology of moderate to severe diarrhea (MSD) in seven sites 
located in LMICs in Africa and Asia, found that the majority of MSD in children less 
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than five years of age was caused by just four of the 17 enteric pathogens measured: 
rotavirus, Cryptosporidium spp., enterotoxigenic Escherichia coli (ETEC), and Shigella 
spp (43). The contribution of these pathogens and others to the burden of MSD varied 
with age and site location. For example, rotavirus had the highest attributable fraction of 
MSD in infants aged  <12 months but its relative importance diminished with age across 
most sites (43). Conversely, the proportion of MSD attributed to Shigella tended to 
increase with age. Some pathogens were regionally important, suggesting specificity of 
diarrheal etiology to setting: in the Mozambique site, adenovirus was a frequent etiologic 
agent of MSD whereas Aeromonas was important in the Bangladesh and Pakistan sites 
(43,44). Another large scale multicenter study, the Etiology, Risk Factors and 
Interactions of Enteric Infections and Malnutrition and the Consequences for Child 
Health and Development (MAL-ED) study, identified causative agents of any diarrhea, 
mild, moderate, or severe, (measured as caregiver reported diarrhea) in children less two 
years of age across 8 sites in LMICs in South America, Africa, and South Asia (45). 
Results from the MAL-ED study found that norovirus GII, rotavirus, astrovirus, 
Campylobacter, Shigella, and Cryptosporidium were the most frequent causative agents 
of diarrhea across study sites (46). Again, the importance of specific pathogens varied 
with age and geography as well as other factors such as deployment of the rotavirus 
vaccine in a given region.  
Enteric pathogens can be shed in high numbers by both symptomatic and asymptomatic 
individuals (43). In GEMS, one or more enteric pathogen was detected in 83% of 
children with MSD and 72% of matched control children (children without diarrhea) 
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(43). In the MAL-ED study, one or more pathogen was detected in 77% of diarrheal 
stools and 65% of non-diarrheal surveillance stools (46). Although the immediate and 
longer-term health and productivity effects for asymptomatic individuals are unclear (47), 
persistent asymptomatic infections are associated with environmental enteric dysfunction 
(21,23,48). Environmental enteric dysfunction (EED) is a subclinical and poorly defined 
condition affecting the function and structure of the gut. At present, no formal case 
definition for EED exists (49), though EED is often characterized by the flattening or 
blunting of the intestinal villi, malabsorption, increased intestinal permeability, and 
aberrations in immune system activation (18,22,50–53). EED, originally described as 
tropical enteropathy, was first identified in the mid-twentieth century in local populations 
and expatriate populations living in tropical regions where sanitary conditions tended to 
be poor (54). Upon repatriation or migration to an industrialized nation, the 
pathophysiologies associated with EED, such as reduced villus height, typically resolved 
within weeks to years (55–57).  These initial studies of EED were the first to suggest that 
environmental exposures may drive the onset of or recovery from EED. While the precise 
etiology of EED is unknown, it is postulated that it develops in response to repeated 
exposure to fecal contamination and enteric pathogens - common exposures in low-
resource settings where sanitary conditions can be poor (21,22,58).  
When first identified, EED was often compared with the condition known as tropical 
sprue: a disorder which exhibits many of the same pathophysiological changes as EED 
including flattening of the intestinal villi, nutrient malabsorption, and immune activation 
leading to diarrhea, weight loss, fatigue, fatty stool, and signs of nutrient deficiencies. 
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Patients with tropical sprue often recover after receiving courses of folic acid 
supplementation and antibiotics. Unlike tropical sprue, EED tends to be subclinical with 
affected persons displaying no overt symptoms, and typical treatments for tropical sprue 
tend to have no effect on the course and persistence of EED. The effects of EED, like gut 
inflammation, malabsorption, and intestinal permeability are believed to contribute to 
malnutrition which together with the other manifestations of EED can lead to increased 
susceptibility to future infections, completing the cycle of infection, EED, and 
malnutrition (23)pred. The onset and persistence of EED, especially at a young age, has 
been empirically linked to poor growth outcomes (22,58–60), though the precise 
mechanism through which EED contributes to stunting is unclear (22). Enteric infection 
and EED have also been linked to other serious or long-term health and well-being 
effects including reduced immunogenicity of oral vaccines (52,61,62) and cognitive 
deficits (63–65).  
The lack of a precise case definition makes measurement of EED difficult. While the 
optimal method for assessing EED is measurement of villus height and morphology and 
crypt depth in a biopsied section of the intestinal mucosa or via endoscopy, this method is 
highly invasive - especially in children with no overt symptoms - and can present 
technical and logistical difficulties. Numerous biomarkers that can be assessed in stool, 
urine, and serum represent less invasive alternatives to traditional microscopic evaluation 
of biopsied specimens. Several pathophysiological parameters have been proposed as 
defining characteristics of EED: intestinal (local) inflammation, systemic inflammation, 
intestinal permeability and malabsorption, microbial translocation, and intestinal damage 
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and repair, though there is overlap among these domains and the biomarkers used to 
measure them (22,50,51). A brief overview of biomarkers frequently used to assess EED 




Table 1: Biomarkers of the five domains of EED and specimen type required for 
measurement (22).  
EED Domain Biomarkers Specimen 
type 




Systemic inflammation total IgG and IgM, α-1-acid glycoprotein, 
c-reactive protein, ferritin, soluble CD14, 









Microbial translocation Elevated endotoxin core antibody, anti-
lipopolysaccharide IgG and IgA 
serum 
 
Intestinal damage & repair Citrulline, regenerating proteins, 
Glucagon-like peptide 2, intestinal fatty 
acid binding protein 
serum 
1 “EED score” is a weighted combination of results from assays of myeloperoxidase, neopterin, and alpha-




Measurement of fecal biomarkers of EED represents one of the least invasive methods of 
assessing EED and several biomarkers have been proposed and used for this purpose 
including alpha-1-anti-trypsin (AAT), myeloperoxidase (MPO), neopterin (NEO), and 
calprotectin (CAL). NEO and MPO are both enzymes released during an inflammatory 
response in the gut. CAL is released during intestinal cell damage and is considered a 
marker of inflammation, however, there is some evidence that high CAL concentrations 
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are correlated with breastfeeding in otherwise healthy infants (66). AAT is also released 
in response to inflammation, but because AAT is synthesized in blood it is largely 
considered a marker of intestinal permeability (22). A composite metric of three of these 
biomarkers (AAT, NEO, and MPO), known as “EED score,” was previously developed 
by Kosek et al. and may better explain linear growth deficits in young children than 
measurement of any single biomarker (59). 
While many biomarkers have been proposed to measure different domains of EED, there 
is little consensus in the literature regarding which domains and biomarkers best define 
EED and most strongly associate with potential downstream outcomes like stunting. A 
systematic review of recent EED literature found either no evidence or conflicting 
evidence of the connections between most EED domains and stunting (22). The strongest 
evidence supported the pathway between intestinal inflammation and stunting. The lack 
of evidence, or conflicting evidence, for associations between the other domains and 
stunting could be due to a true lack of relationship or to issues with the biomarkers (and 
methodology) selected to represent those domains. 
Health Impact Evaluations 
Health impact evaluations (HIE) of WASH interventions, like WASH-B, SHINE and 
others described previously, serve several purposes. Theoretically, a HIE that aims to 
have good external validity could demonstrate the expected effect of an intervention on 
the health and well-being of a population generally. Practically, the generalizability of 
results from HIEs are limited by several factors related to the study population, setting, 
and specific intervention (67). Conclusions from HIEs can also aid in the refinement and 
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revision of hypotheses and causal pathways – leading to more robust future studies. 
Further, and arguably most importantly, when properly executed HIE can estimate the 
magnitude of health gains to be expected following implementation of a specific 
intervention in a specific setting. This context-specific information facilitates 
comparisons of different WASH solutions for particular locations and helps inform local 
health and WASH-related policy decisions made by government officials, non-profits, 
and other WASH practitioners (68). 
The Maputo Sanitation (MapSan) trial is a three-year independent HIE of an on-site, 
privately shared sanitation intervention implemented in low-income, unplanned 
neighborhoods of Maputo, Mozambique. The interventions we evaluated for this trial 
were built by the non-governmental organization Water and Sanitation for the Urban 
Poor (WSUP) which has been building similar latrines in Maputo for over a decade. 
These sanitation improvements were designed and delivered at the compound level. 
Compounds, in this context, are clusters of two or more households that share sanitation 
and outdoor living space and are typically surrounded by a physical barrier (wall or 
fence) to delineate the compound boundaries. While the intervention is officially 
considered shared sanitation, as it was meant to be used by two or more related or 
unrelated households, it not considered public sanitation and was only accessible by 
members of the compound (“privately shared”). The basic intervention infrastructure 
consisted of pour-flush latrines (ceramic squat plates or pedestals) to septic tanks with 
soakaway pits to discharge liquid effluent (Appendix A, Figure A1). Septic tanks were 
designed to contain approximately two years of waste and included access ports to 
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facilitate formal emptying services. WSUP constructed different latrine designs 
depending on the population of the compound but the basic sanitation technology 
remained the same in both. Communal sanitation blocks (CSBs) were built in compounds 
with more than 20 members and included multiple latrine stalls (one for every 20 
compound members), covered vent pipes for fly control, secure doors with padlocks, a 
municipal water supply connected to an elevated water storage tank (to allow for semi-
continuous water access), a rainwater harvesting system and storage basin with floor 
level taps, a sink that could be connected to the water supply (connection not performed 
by WSUP), and a laundry facility (Appendix A, Figure A2). Shared latrines (SLs) were 
constructed in compounds with 20 or fewer members and included a single latrine stall, a 
covered vent pipe, and a secure door with a padlock (Appendix A, Figure A3).  
MapSan is the first large-scale HIE of a decentralized urban sanitation intervention, the 
first to study a shared sanitation intervention, and the first to use enteric infection, an 
objective metric of health, as the primary outcome (2). My work aims to characterize the 
baseline health status of the study population prior to the introduction of the intervention, 
understand the main environmental and sanitary risk factors for infection (Chapter 2), and 
evaluate the impact of the intervention on two metrics of child health: enteric infection 
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Enteric infections are common where public health infrastructure is lacking. This study 
assesses risk factors for a range of enteric infections among children living in low-
income, unplanned communities of urban Maputo, Mozambique.  
Methods & Findings 
We conducted a cross-sectional survey in 17 neighborhoods of Maputo to assess the 
prevalence of reported diarrheal illness and laboratory-confirmed enteric infections in 
children. We collected stool from children aged 1–48 months, independent of reported 
symptoms, for molecular detection of 15 common enteric pathogens by multiplex RT-
PCR. We also collected survey and observational data related to water, sanitation, and 
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hygiene (WASH) characteristics; other environmental factors; and social, economic, and 
demographic covariates.  
We analyzed stool from 759 children living in 425 household clusters (compounds) 
representing a range of environmental conditions. We detected ≥1 enteric pathogens in 
stool from most children (86%, 95% confidence interval (CI): 84-89%) though diarrheal 
symptoms were only reported for 16% (95% CI: 13-19%) of children with enteric 
infections and 13% (95% CI: 11-15%) of all children. Prevalence of any enteric infection 
was positively associated with age and ranged from 71% (95% CI: 64-77%) in children 
1-11 months to 96% (95% CI: 93-98%) in children 24-48 months. We found poor 
sanitary conditions, such as presence of feces or soiled diapers around the compound, to 
be associated with higher risk of protozoan infections. Certain latrine features, including 
drop-hole covers and latrine walls, and presence of a water tap on the compound grounds 
were associated with a lower risk of bacterial and protozoan infections. Any 
breastfeeding was also associated with reduced risk of infection.  
Conclusions 
We found a high prevalence of enteric infections, primarily among children without 
diarrhea, and weak associations between bacterial and protozoan infections and 
environmental risk factors including WASH. Findings suggest that environmental health 
interventions to limit infections would need to be transformative given the high 







Diarrheal illness is estimated to cause approximately 1.7 million deaths annually and 
result in over 74 million disability-adjusted life years lost (16), primarily among children 
in low-and middle-income countries where fecal contamination of the living environment 
is common. Diarrheal diseases are mostly caused by enteric pathogens, including 
bacteria, viruses, and protozoa, shed in human and animal feces. These pathogens can be 
shed in high numbers by both symptomatic and asymptomatic individuals (43). Although 
the immediate and longer term health and productivity effects for asymptomatic 
individuals are unclear (47), persistent asymptomatic infections are associated with 
environmental enteric dysfunction (21,48,69) and other conditions, including 
undernutrition, poor linear growth, reduced immunogenicity of oral vaccines and 
cognitive deficits. 
Enteric pathogens are transmitted via several fecal-oral pathways historically defined by 
the F-diagram (11). Consumption of contaminated food and water and interaction with 
fecally contaminated environments have been implicated as dominant transmission 
pathways for bacterial and protozoan enteric pathogens (12,13). While enteric viruses can 
be transmitted via similar routes, it is posited that person-to-person transmission is also 
important (14). Improvements in WASH conditions can reduce risk of diarrheal disease 
by interrupting transmission pathways. A recent meta-analysis observed reductions in 
diarrheal disease risk by an average of 67%, 25%, and 30% for water, sanitation, and 
hygiene interventions, respectively (31). Sanitation interventions may be more likely to 
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interrupt transmission of protozoa, bacteria, and helminths which are primarily spread via 
indirect, environmentally mediated pathways than viruses which are often spread via 
person-to-person transmission (9).  
Densely populated, urban, unplanned communities with inadequate sanitary infrastructure 
represent high-risk settings for exposure to enteric pathogens, though the great majority 
of sanitation-related exposure and health outcome research has been focused on rural 
communities where sanitation coverage is lowest and open defecation is common. In the 
context of the Maputo Sanitation (MapSan) trial (2)(ClinicalTrials.gov Identifier: 
NCT02362932), we conducted a baseline, cross-sectional survey of compounds (defined 
as multi-household clusters with shared outdoor space) served by shared latrines. The aim 
of our study was to estimate prevalence of selected enteric pathogens in stool samples of 







Study design & health outcomes 
This cross-sectional study measures enteric infections and key socio-demographic and 
WASH-related risk factors among children in low-income neighborhoods of Maputo.  
We defined four outcomes, based on analysis of stool for 15 common enteric pathogens, 
for our risk factor assessment: (1) detection of any enteric infection, (2) detection of any 
17 
 
bacterial infections, (3) detection of any protozoan infections, and (4) detection of any 
viral infections. We also measured caregiver-reported diarrhea with 7-day recall  as a 
secondary outcome (70). We defined diarrhea as ≥3 loose or liquid stools in a 24-hour 
period or any stool with blood (71). 
Study setting 
The study sites are located in densely populated, low-income, unplanned neighborhoods 
of Maputo, Mozambique. Poor sanitary conditions, inadequate infrastructure, 
environmental conditions including seasonal flooding, and increasingly high population 
density in these areas has led to a high burden of enteric disease and child mortality 
(30,72). In 2015, an estimated 53% of the urban population in Mozambique (∼4.5 million 
people) lacked access to basic ‘improved’ sanitation facilities, as defined by the 
UNICEF/WHO Joint Monitoring Program (73). In Maputo, approximately 89% of 
households use onsite waste disposal (10% have access to sewerage; an estimated 1% 
practice open defecation), and only 26% of fecal waste is safely managed (74). An 
estimated 8% of urban sanitation in Mozambique is shared, often among the poorest 
households in informal neighborhoods (1). All households in the MapSan trial used 
shared sanitation facilities that were in poor condition at the time of enrollment. 
Enrollment 
Field teams enrolled children and collected baseline data concurrently between February 
2015 and February 2016. We enrolled all children who met the following eligibility 
criteria: (1) the child’s parent or guardian provided written informed consent, (2) the 
child was 1 - 48 months of age at the time of enrollment, and (3) the child resided in 
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compounds meeting certain inclusion criteria. Compounds were eligible for enrollment if 
they were located within a predefined geographic area, were in close proximity to a legal 
piped water supply, had a minimum number of households (2), and residents shared 
sanitation in poor condition and had stated demand for improved sanitation. The larger 
MapSan trial involved additional criteria to select compounds for intervention and details 
are presented in Chapter 3. Our enrollment period overlapped with the September 2015 
rollout of the rotavirus A vaccination program in Mozambique. Children six weeks or 
younger at the time of rollout and children born after rollout began were eligible for 
immunization; some children enrolled in our study after September 2015 may have 
received the vaccination.  
Data collection 
Following enrollment, field teams collected data on socio-demographics and WASH-
related risk factors using questionnaires and direct observation. Questionnaires are 
available in Appendix C (Table C1, Table C2).  Enumerators administered three levels of 
surveys in each compound with an enrolled child: compound-level, household-level, and 
child-level. For compound-level surveys, the head of compound or the head of 
compound’s spouse was the target respondent. For household- and child-level surveys, 
the child’s mother was the target respondent, though another parent or guardian was 
eligible to complete the questionnaire. All questionnaires were communicated in either 
Portuguese or the local language, Changana, as requested by the respondent.  
Surveys included socioeconomic and demographic questions such as child age and sex, 
household assets, caregiver’s education level, and breastfeeding practices.  We calculated 
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household wealth using an asset-based wealth index developed for Mozambique (75). At 
each level, surveys included direct observations and questions about risk factors of 
enteric infection, including characteristics of household and compound level water and 
sanitation, sanitary condition of living spaces, presence of animals within the compound 
grounds, environmental conditions including flooding patterns, and measures of 
population density and crowding. We created a composite ‘latrine improvement score’ 
ranging from 0-4 with one point awarded for the presence of each of the following latrine 
features: permanent superstructure, tile or masonry slab, drop-hole cover, and ventilation 
pipe. Similarly, we created a “compound sanitary score” ranging from 0-3 with higher 
scores indicating poorer sanitary conditions. One point was awarded for each of the 
following potential risk factors: (1) compound floods during rainy season, (2) leaking or 
standing wastewater observed by latrine, and (3) feces or soiled diapers observed around 
compound grounds.  Compound-specific population density was defined as the number of 
people who live in a compound divided by the area of that compound. We measured the 
area of the compound using high resolution, orthorectified and geolocated satellite 
imagery. Enumerators equipped with GPS enabled tablets would work with compound 
residents to identify landmarks and define the shape of a compound on the satellite 
imagery. We calculated compound area from the shapes and divided the number of 
compound residents by the calculated compound area to obtain our measure of 
compound-specific population density. We used rainfall data from the National Oceanic 
and Atmospheric Administration’s National Centers for Environmental Information 
(https://www.ncdc.noaa.gov/cdo-web/datatools/findstation) to calculate cumulative 
rainfall during the 30 days before data collection.  
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Sample collection and laboratory analysis 
We provided stool collection supplies, including diapers, plastic potties (for older 
children no longer wearing diapers), and pre-labeled sterile sample bags to the caregiver 
of each enrolled child. Samples were collected, irrespective of reported symptoms, the 
following day. If a specimen was not immediately available, caregivers alerted the field 
team by phone when available. Following collection, samples were stored on cold packs, 
and transported to the medical parasitology laboratory at the Mozambican Ministry of 
Health (MISAU/INS) within six hours of collection for storage at -80°C. If a child 
produced a liquid stool, lab technicians stored a piece of the soaked diaper material 
(“diaper samples”) at -80°C upon receipt. Stool samples were shipped on dry ice with 
temperature probes to the Georgia Institute of Technology where they were stored at -
80°C until analysis.   
We used the Luminex MagPix xTAG Gastrointestinal Pathogen Panel (GPP, Luminex 
Corp, Austin, TX) to analyze stool samples for the presence of 15 enteric pathogens:  
Campylobacter; Clostridium difficile, Toxin A/B; Enterotoxigenic Escherichia coli 
(ETEC) LT/ST; Shiga-like toxin producing E. coli (STEC) stx1/stx2; E. coli O157, a 
serotype of STEC; Salmonella; Shigella; Vibrio cholerae; Yersinia enterocolitica; 
adenovirus 40/41; norovirus GI/GII; rotavirus A; Giardia; Cryptosporidium; and 
Entamoeba histolytica. The GPP is a stool-based multiplex RT-PCR assay that has been 
extensively tested for direct detection of enteric infections in a range of countries (76–
84). Per GPP protocol, we pretreated bulk stool samples with 1 mL of ASL stool lysis 
buffer (Qiagen, Hilden, Germany) and performed nucleic acid extraction for DNA and 
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RNA using the QIAcube HT platform and the QIAamp 96 Virus QIAcube HT Kit 
(Qiagen, Hilden, Germany). We eluted diaper samples in 2.5 mL of ASL stool lysis 
buffer. A sterile 10-mL syringe was used to facilitate elution via agitation by taking in 
and expelling the buffer 5 times. We used 1 mL of the final eluate in the pretreatment 
step and then proceeded with extraction as previously described. Extracts were stored at 
4°C and analyzed by GPP within 24 hours of extraction. 
Data analysis 
Sample size for the present study is based on enrollment in the larger MapSan trial. 
Sample size calculations for the larger MapSan trial have been described previously (2). 
To minimize potential bias, we specified the statistical model and variables of interest 
before beginning the analyses. Details for individual variables used in these analyses - 
including definitions, coding schemes and proportions of missing values - are available in 
Appendix B (Table B1). 
We calculated unadjusted and adjusted risk ratios (RRs) and 95% confidence intervals for 
outcome variables and potential risk factors using generalized estimating equations 
(GEEs) to fit Poisson regression models with robust standard errors (85). We used GEEs 
to account for clustering at the compound level. Outcome variables, including any 
infection and infection with bacterial, protozoan, or viral pathogens, were defined to 
identify differences in exposure risks from pathogen groups with different dominant 
routes of transmission (e.g. person to person versus environment to person). All 
multivariable models were adjusted for a set of five variables determined a priori as 
contextually important covariates. These variables included child age and sex, 
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breastfeeding practices, caregiver’s education level, and an index of household wealth. 
We also calculated RRs and aRRs for enteric infections using child age (stratified by age 
group:  1-11, 12-23, and 24-48 months), sex, breastfeeding practices, and caregiver’s 
education as the predictors of interest. We ran separate multivariable models for each 
combination of risk factor and outcome and assessed multicollinearity of multivariable 
models using the variance inflation factor. We assessed crude and adjusted associations 
between specific enteric pathogens and diarrheal symptoms as described for the main risk 
factor analysis.  
Our primary analysis focused on complete observations. The proportion of incomplete 
observations per variable are denoted in supporting information (S1 Table). In parallel 
with the complete case analysis, we ran all univariable and multivariable models on 
completed data following multiple imputation (MI) of missing values (86–89). Details of 
the MI process are presented in Appendix B (Supporting Information B1). Briefly, we 
performed MI using chained equations (also known as fully conditional specification) to 
handle missing data (88,90). MI models were congenial with previously discussed 
analysis models and included a fixed effect to account for clustering at the compound 
level. Auxiliary variables were included in the MI model if they were a priori defined as 
related to either an outcome or predictor, if they were correlated with observed values of 
an outcome or predictor (r≥0.2), or if they were correlated with missingness of any 
outcome or predictor variable (r≥0.2) (89).  All statistical analyses were performed with 





The head of the compound provided verbal assent for study activities before enrollment 
of any children within the compound. As children were ≤4 years old at the time of 
visitation, field enumerators obtained written informed consent from each child’s parent 
or guardian before enrollment. The study protocol was approved by the Comité Nacional 
de Bioética para a Saúde (CNBS), Ministério da Saúde (333/CNBS/14), the Ethics 
Committee of the London School of Tropical Medicine and Hygiene (reference # 8345), 
and the Institutional Review Board of the Georgia Institute of Technology (protocol # 









Field workers enrolled 519 of the 601 compounds approached regarding participation in 
the MapSan study. Eighty-two (15.8%) compounds were ineligible for enrollment 
because they did not have a child <48 months old at the time of visitation. From those 
519 compounds, workers enrolled 993 children in 815 households. Field teams 
administered child-level surveys for 980 of the 993 (99%) enrolled children and collected 
stool samples from 759 (76%) (Appendix B, Table B1).   
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Sociodemographic characteristics and prevalence of risk factors among study children 
The average age of enrolled children was 23 months (Table 1).  Approximately 27% 
(258/944) were <12 months old, while an equal percentage (28%, 266/945) were 12-23 
months old, and the remainder (45%, 421/944) were 24-48 months old. Breastfeeding 
was very common among children 1-11 months old (87%, 224/258), though 31% 
(82/266) of children 12-24 months were also breastfed. A little over half of child 
caregivers had completed primary school (527/980). About 17% (163/975) of households 
met an a priori definition of crowding (>3 people per room of living space).  
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Table 2: Baseline measures of demographic, socioeconomic, environmental, and WASH-
related exposure variables presented as # participants (%). 
 Total n # (%) 
Latrine wall present 974 305 (31) 
Drop-hole cover 974 557 (57) 
Vent pipe 975 138 (14) 
Pedestal or slab 971 361 (37) 
Latrine improve index (range 0-4), unitless, mean (SD) 953 1.41 (1.24) 
Households per latrine drop-hole 950  
<=2  171 (18) 
3-5  576 (61) 
>5  203 (21) 
Child feces disposal in latrine 980 289 (29) 
Standing water observed 974 71 (7.3) 
Waste water observed 974 606 (62) 
Feces observed 974 455 (47) 
Compound has tendency to flood 974 601 (62) 
Compound sanitary score index, unitless, mean (SD) 974 1.71 (1.06) 
Drinking water tap on compound grounds 976 757 (78) 
Any animal present 993 645 (65) 
Dog present 993 76 (7.7) 
Ducks or chickens present 993 131 (13) 
Cat present 993 550 (55) 
Household floor is covered 975 917 (94) 
>3 Persons per room (household crowding) 975 163 (17) 
Child Age (days), mean (SD) 967 662 (390) 
Child sex, female 967 500 (52) 
Any breastfed 980 316 (32) 
Caregiver completed primary education 980 527 (54) 
Wealth index (unitless), mean (SD) 976 43.7 (10.2) 
Definitions of variables present in Appendix B, Table B1. 
 
Almost all study children lived in a household that had access to a latrine in the 
compound (98%, 956/973) and most had access to latrines (61%, 576/950) shared by 3-5 
households (median = 4). About half of children had latrines with drop-hole covers (57%, 
557/974), 37% (361/971) had a masonry or ceramic slab or pedestal, while only 31% 
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(305/974) had a formal superstructure (made of bricks or cement blocks), and 14% 
(138/975) had a vent pipe. Sanitary conditions of compounds were poor: 62% (606/974) 
of study children lived in compounds with wastewater leaking from in or around a latrine 
and 47% (455/974) lived in compounds where feces or soiled diapers were visible around 
the grounds. Disposal of child feces into a latrine was common for children 24-48 months 
old (57%, 238/421). Feces of children between the ages of 1 – 23 months, most of whom 
wore diapers, was less frequently disposed of in a latrine (6.4%, 34/528).  Most children 
lived in study compounds with animals (65%, 645/993), with cats (55%, 550/993) most 
commonly observed. All study households used piped water as their primary drinking 
water source and 78% (757/976) of children lived in households with access to a drinking 
water tap on the compound grounds.  
Prevalence of enteric infections in study children 
One or more pathogens were identified in stool samples from 655 (~86%) of the 759 
children from whom a sample was collected; most (59%, 445/759) had coinfections 
(Table 2). Stool samples from 66 (8.7%) children yielded four or more enteric pathogens. 
The prevalence of coinfection (≥2 infections) increased with age from 33% (69/208) in 
the youngest age group to 73% (214/293) in the oldest. Most children (76%, 579/759) 
had a bacterial infection, about half (53%, 402/759) had a protozoan infection, and only 
14% (107/759) of children had a viral infection. Giardia, Shigella, ETEC, Salmonella, 
and norovirus were the most frequently detected pathogens among all children, though 
prevalence varied with age. Prevalence of any infection, and of bacterial and protozoan 
infections by themselves, increased with age and were largely driven by the most 
27 
 
common bacterial and protozoan infections: Shigella and Giardia. Prevalence of Shigella 
infection increased from 9% (19/208) in children 1-11 months old to 65% (189/293) of 
children aged 24-48 months. Giardia showed a similar pattern with prevalence increasing 
from 14% (29/208) among 1-11 month-olds to 75% (219/293) prevalence in 24-48 
month-olds. Prevalence of viral infections, largely driven by norovirus GI/GII, was 
highest among the youngest children (17%, 36/208) and lowest among the oldest children 
(11%, 33/293). Prevalence of rotavirus was low among all age groups (1-2%). Prevalence 
of enteric infections was similar among boys and girls with the exception of viral 
infections which tended to be more frequent in girls (17%, 64/370) than boys (11%, 
41/370). Only 13% (126/980) of children were reported to have had diarrhea in the 
previous week. Reported diarrhea was higher among boys (16%, 74/464) than girls (10%, 
50/498) and peaked in children aged 12-23 months (20%, 52/266). Norovirus was the 
only infection associated with higher risk of reported diarrhea (adjusted RR (aRR): 1.76, 
95% CI: 1.03 – 3.02 adjusted for child age and sex, caregiver education, breastfeeding 
practices, and household wealth (Appendix B, Table B2), aRR 1.75, 95% CI: 1.00-3.1 




Table 3. Prevalence and 95% confidence intervals of enteric infections in children <4 years of age measured at baseline.   






Any Infection (≥1 
infections) 
0.86 (0.84-0.89) 0.88 (0.84-0.91) 0.85 (0.81-0.89) 0.71 (0.64-0.77) 0.87 (0.82-0.91) 0.96 (0.93-0.98) 
Any Viral Infection 0.14 (0.12-0.17) 0.17 (0.14-0.22) 0.11 (0.08-0.15) 0.17 (0.12-0.23) 0.15 (0.11-0.20) 0.11 (0.08-0.15) 
Any Bacterial 
Infection 
0.76 (0.73-0.79) 0.78 (0.74-0.82) 0.74 (0.69-0.78) 0.65 (0.58-0.72) 0.74 (0.68-0.80) 0.84 (0.79-0.88) 
Any Protozoan 
Infection 
0.53 (0.49-0.57) 0.52 (0.47-0.57) 0.54 (0.49-0.60) 0.18 (0.13-0.24) 0.53 (0.47-0.60) 0.76 (0.71-0.81) 
Number of 
coinfections 
      
≥2 infections 0.59 (0.55-0.62) 0.62 (0.56-0.67) 0.55 (0.50-0.60) 0.33 (0.27-0.40) 0.60 (0.53-0.66) 0.73 (0.68-0.78) 
≥3 infections 0.27 (0.24-0.31) 0.29 (0.24-0.34) 0.25 (0.21-0.30) 0.13 (0.09-0.19) 0.33 (0.27-0.39) 0.32 (0.27-0.38) 
≥4 infections 0.09 (0.07-0.11) 0.10 (0.07-0.14) 0.08 (0.05-0.11) 0.04 (0.02-0.08) 0.14 (0.10-0.19) 0.08 (0.05-0.12) 
Bacteria       
Shigella 0.44 (0.40-0.48) 0.44 (0.39-0.49) 0.43 (0.38-0.48) 0.09 (0.06-0.14) 0.44 (0.38-0.51) 0.65 (0.59-0.70) 
ETEC LT/ST 0.30 (0.27-0.34) 0.32 (0.27-0.37) 0.28 (0.24-0.33) 0.23 (0.18-0.29) 0.37 (0.31-0.44) 0.30 (0.25-0.35) 
Salmonella 0.21 (0.18-0.24) 0.22 (0.18-0.26) 0.19 (0.15-0.24) 0.29 (0.23-0.36) 0.20 (0.16-0.26) 0.16 (0.12-0.20) 
Campylobacter 0.08 (0.06-0.10) 0.08 (0.06-0.12) 0.08 (0.05-0.11) 0.10 (0.06-0.15) 0.09 (0.06-0.13) 0.05 (0.03-0.09) 
Clostridium difficile, 
Toxin A/B 
0.05 (0.03-0.06) 0.05 (0.03-0.08) 0.05 (0.03-0.07) 0.11 (0.07-0.16) 0.04 (0.02-0.08) 0.01 (0.00-0.02) 
Escherichia 
coli O157 
0.04 (0.03-0.06) 0.05 (0.03-0.08) 0.03 (0.01-0.05) 0.03 (0.01-0.06) 0.04 (0.02-0.08) 0.05 (0.03-0.08) 
STEC stx1/stx2 0.02 (0.01-0.03) 0.02 (0.01-0.05) 0.01 (0.00-0.03) 0.01 (0.00-0.04) 0.03 (0.01-0.06) 0.01 (0.00-0.03) 
Yersinia 
enterocolitica 
0.00 (0.00-0.01) 0.00 (0.00-0.01) 0.00 (0.00-0.01) 0.00 (0.00-0.02) 0.00 (0.00-0.02) 0.00 (0.00-0.01) 
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Table 3 (continued). 
Vibrio cholerae 0.00 (0.00-0.00) 0.00 (0.00-0.01) 0.00 (0.00-0.01) 0.00 (0.00-0.02) 0.00 (0.00-0.02) 0.00 (0.00-0.01) 
Protozoa       
Giardia 0.51 (0.48-0.55) 0.51 (0.46-0.56) 0.52 (0.47-0.58) 0.14 (0.10-0.19) 0.53 (0.46-0.60) 0.75 (0.69-0.80) 
Cryptosporidium 0.03 (0.02-0.05) 0.03 (0.01-0.05) 0.04 (0.02-0.06) 0.05 (0.02-0.09) 0.04 (0.02-0.08) 0.02 (0.01-0.04) 
Entamoeba 
histolytica 
0.01 (0.00-0.01) 0.00 (0.00-0.01) 0.01 (0.00-0.02) 0.00 (0.00-0.03) 0.00 (0.00-0.02) 0.01 (0.00-0.03) 
Virus       
Norovirus GI/GII 0.10 (0.08-0.13) 0.13 (0.09-0.17) 0.08 (0.06-0.12) 0.13 (0.09-0.18) 0.11 (0.07-0.16) 0.08 (0.05-0.12) 
Adenovirus 40/41 0.03 (0.02-0.04) 0.05 (0.03-0.07) 0.01 (0.00-0.03) 0.03 (0.01-0.07) 0.03 (0.01-0.06) 0.03 (0.01-0.05) 

















Risk of any enteric infection in unadjusted and adjusted models 
Risk factors for enteric infection were assessed using generalized estimating equations in 
unadjusted models and models adjusted for age and sex of child, socioeconomic status, 
caregiver’s education, and any breastfeeding. Among complete cases (Table 4), presence 
of a latrine superstructure was associated with 7% reduced risk of any enteric infection in 
the unadjusted model (risk ratio (RR): 0.93, 95% CI: 0.86-1.00), though the association 
was attenuated in adjusted models (RR: 0.95, 95% CI: 0.89-1.02). Presence of visible 
feces or used diapers in the compound was a risk factor in both unadjusted and adjusted 
models (aRR: 1.07, 95% CI: 1.01-1.14). Compound-specific population density was also 
associated with higher risk of ≥1 enteric infection; children living in the most densely 
populated quintile of compounds had a 10% higher risk (aRR: 1.10, 95% CI: 1.00-1.21) 
of any enteric infection compared with children in the least densely populated 
compounds. Among a priori covariates adjusted for in models, any breastfeeding was 
associated with a 13% reduced risk of any infection in adjusted models. Child age was 
positively associated with enteric infection; children in the oldest age group were 1.21 
times more likely to have an enteric infection than children in the youngest age category. 
Risk factors for the any infection were also assessed by multiple imputation (Appendix B, 




Table 4. Crude and adjusted risk ratios and 95% confidence intervals for associations of WASH-related risk factors and four measures 
of enteric infection: any enteric infection, any bacterial infection, any protozoan infection, and any viral infection. Multivariable 
models are adjusted for child age and sex, caregiver education, household wealth, and breastfeeding practices.  
 Any enteric infection Any bacterial infection Any parasitic infection Any viral infection n 









































































































        728; 
685 
HH<=2 Reference Reference Reference Reference Reference Reference Reference Reference  






















































































































































































































































































































        740; 
695 






































































rainfall last 30 
days, terciles 
        759; 
714 



































Child age         726; 
698 
1-11 months Reference Reference Reference Reference Reference Reference Reference Reference  



















Table 4 (continued). 


















































































Risk of bacterial infection in unadjusted and adjusted models 
Risk factors for any bacterial infection were assessed as previously described. Among 
complete cases (Table 4), presence of a drop-hole cover in the latrine was associated with 
reduced risk of any bacterial infection (aRR: 0.90, 95% CI: 0.83-0.99). Among a priori 
covariates, any breastfeeding was associated with 19% reduced risk of bacterial infection 
in the unadjusted model but was not associated with bacterial infection risk in the 
adjusted model. Despite increasing prevalence of any bacterial infection with age, we 
found no association between age and bacterial infection in adjusted models. Results 
from multiple imputation models were consistent with models limited to complete cases 
(Appendix B, Table B3).   
Risk of protozoan infection in unadjusted and adjusted models 
Among complete cases (Table 4), presence of a latrine superstructure was associated with 
20% reduced risk of any protozoan infection in the unadjusted model but was only 
marginally associated with reduced risk in the adjusted model (aRR: 0.86, 95% CI: 0.74-
1.01). In adjusted models, presence of visible feces or used diapers was associated with 
higher risk of protozoan infection (aRR: 1.16, 95% CI: 1.01-1.32). Household crowding, 
as well as presence of a drinking water tap on the compound grounds, were associated 
with reduced risk of protozoan infection in adjusted models only (aRR: 0.85, 95% CI: 
0.73-0.98 and aRR: 0.82, 0.68-0.99).  
Among a priori covariates included in all models, any breastfeeding was associated with 
reduced risk of protozoan infection in both unadjusted and adjusted models (aRR: 0.49, 
95% CI: 0.36-0.66). Caregiver completion of primary school was associated with 17% 
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reduced risk of protozoan infection in the unadjusted model but was only marginally 
associated in the adjusted model (aRR: 0.89, 95% CI: 0.79-1.01). Age was a risk factor 
for protozoan infection; children in the 12-23 month and 24-48 month age groups had a 
2.41 (1.64 – 3.57) and 3.20 (2.14 – 4.80) times higher risk of protozoan infection, 
respectively, than children aged 0-11 months (Table 3). 
Among multiple imputation models, most results were in agreement with those in models 
limited to only complete cases (Appendix B, Table B3). The presence of visible feces or 
used diapers around the compound grounds was not associated with increased risk of 
protozoan infection in unadjusted or adjusted multiple imputation models.  
Risk of viral infection in unadjusted and adjusted models 
Viral infections were not associated with any of the risk factors assessed in adjusted 
complete case analysis (Table 4). Household crowding (presence of >3 persons per room) 
was only marginally associated with risk of any viral infection in adjusted models (aRR: 
1.55, 95% CI: 0.95-2.43). Among a priori covariates, sex was a predictor of viral 
infection, with girls at higher risk of infection than boys (aRR: 1.65, 95% CI: 1.17-2.31). 
Children in the oldest age group (24-48 months) had 52% reduced risk of any viral 
infection compared with the youngest age group (1-11 months).  
Results from multiple imputation models were consistent with results from models 
limited to only complete cases (Appendix B, Table B3). Among risk factors in multiple 
imputation models, household crowding was a risk factor in the unadjusted model (RR: 
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1.55, 95% CI: 1.04-2.32), but not in the adjusted model. Sex remained a risk factor for 







We observed a high prevalence of enteric infection, including coinfections, among study 
children yet most children lacked diarrheal symptoms. The prevalence of enteric 
infection, but not reported diarrhea, increased with age though pathogen-specific age-
related patterns varied. We found some independent WASH or environmental risk factors 
to be associated with enteric infection, though magnitudes of specific associations were 
often small. In this setting where burden of disease was high and sanitary conditions were 
poor, pathogen acquisition, symptomology, and the duration of carriage (colonization), 
may be driven by multiple interdependent risk and protective factors, including acquired 
immunity. 
These results are consistent with findings from other studies of enteric infection in 
resource-constrained but predominantly rural settings in Africa and elsewhere. The 
Global Enteric Multicenter Study (GEMS) site in the rural district of Manhiça, 
Mozambique identified one or more enteric pathogens in 85% of stools from children 
with moderate-to-severe diarrhea (MSD) and 76% of stools from control children 
(without diarrhea in the 7 days preceding enrollment) (44). Similar trends were observed 
in the Etiology, Risk Factors, and Interactions of Enteric Infections and Malnutrition and 
the Consequences for Child Health and Development Project (MAL-ED) study sites 
where 77% diarrheal and 65% of non-diarrheal stool samples were positive for ≥1 enteric 
pathogen (46). Studies using the GPP for enteric pathogen detection in similar settings in 
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Ghana and Côte d’Ivoire have also found high prevalence of enteric infection among both 
symptomatic and asymptomatic children (76,78). 
Compared with enteric infection, the prevalence of caregiver-reported diarrhea was low. 
We observed a decrease in caregiver-reported diarrhea in children aged 24-48 months 
compared with the younger age strata, similar to the pattern observed for viral infections.  
Decreases in reported diarrhea follows a trend observed in historic data of hospital 
admissions for acute diarrheal episodes among young children in Mozambique (44). 
Though we could not formally calculate attributable fractions for etiologic agents of 
reported diarrhea with these data, we note that norovirus GI/GII was the only enteric 
pathogen associated with reported diarrhea. This is consistent with findings from the 
MAL-ED study sites where norovirus GII had one of the highest attributable fractions of 
diarrhea in children <2 years old (46). In contrast with reported diarrhea and viral 
infection, prevalence of bacterial and protozoan infections tended to increase with age, 
though patterns varied by pathogen. The high prevalence observed here, especially in 
older children, could be due to the poor clearance and accumulation of persistent enteric 
infections over time (91) or could be a result of a high rate of reinfection due to frequent 
pathogen exposure (92). As children age and become increasingly mobile they interact 
with their environment more, potentially leading to high exposures to fecal contamination 
and increased enteric infection (93).   
While the overall prevalence of enteric pathogens was similarly high among our study 
and sites in GEMS and MAL-ED, there were differences in the frequency of detection of 
specific enteric pathogens. Giardia (51%), Shigella (44%), ETEC (30%), Salmonella 
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(21%) and norovirus GI/GII (10%) were the most frequently detected pathogens in this 
cohort of children.  Giardia, rotavirus, Cryptosporidium, E. histolytica, and 
enteroaggregative E. coli (EAEC) were the most common pathogens detected among 
cases and controls at the GEMS-Manhiça site, just 80 kilometers north of our study sites 
(44). Across all MAL-ED sites, the most frequently detected pathogens in diarrheal and 
non-diarrheal stools were Campylobacter, Giardia, EAEC, and norovirus GII (46). 
Notably, even though our data collection occurred largely before the rollout of the 
rotavirus vaccine in Mozambique in September 2015, we detected almost no rotavirus in 
our study population. This is in stark contrast to findings from the GEMS-Manhiça site 
where rotavirus was deemed one of the principal causative agents of MSD and was 
detected in up to 18% of controls (44). To further interrogate this difference, we tested 
the 8 rotavirus GPP-positive specimens and 84 randomly selected rotavirus GPP-negative 
specimens for the presence of rotavirus using the Premier Rotaclone  (Meridian 
Bioscience, Cincinnati, OH, USA) in-vitro diagnostic fecal antigen enzyme-linked 
immunosorbent assay (ELISA) (94). Using the ELISA results as the reference, we 
calculated the GPP to have 100% sensitivity and 100% specificity for detection of 
rotavirus A antigen in our fecal specimens. The variations in detection frequencies of 
enteric pathogens across these studies could be due to differences in detection methods or 
may suggest that pathogen profiles vary across even limited geographical distances. 
Molecular reanalysis of the GEMS specimens yielded higher detection frequencies of 
many bacterial pathogens than the original culture-based methods (95). However, the 
GEMS reanalysis did not substantially change detection of Cryptosporidium or rotavirus, 
highlighting potential geographic differences.  
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Results from this risk factor analysis are consistent with previous studies identifying the 
build quality or physical characteristics of latrines as factors for increased risk of 
infection exposure (96); we found presence of a superstructure or a drop-hole cover to be 
associated with decreased infection risk. We did not identify any association between 
enteric infection prevalence and the presence of a cleanable slab, however, consistent 
with previous work from Tanzania (97). Associations between the physical 
characteristics of a latrine and enteric infections were observed only for risk of bacterial 
and protozoan infections. Household crowding was also associated with a reduced risk of 
protozoan infection, further evidence that transmission of enteric bacterial and protozoan 
pathogens is likely to be largely environmentally mediated (9,12,13). We did not identify 
any WASH or environmental variables associated with risk of viral enteric infection.  
This is consistent with our prior assumption that person-to-person transmission is likely 
the predominant pathway for viral infection in this setting (2) as has been observed 
elsewhere under similar conditions (13).  
Consistent with previous work, any breastfeeding appeared protective for enteric 
infection risk in our analysis (98–103). Adjusted estimates of association show that this 
observation is primarily driven by protection from Giardia infection (RR = 0.50, 95% CI 
0.37 – 0.67); a similar correlation was also observed in the MAL-ED study (101). Any 
breastfeeding limits enteric pathogen transmission by eliminating exposure via direct 
consumption of contaminated food or water.  
Maputo, like many cities of sub-Sahara Africa, is rapidly urbanizing (104).  Urbanization 
may result in higher risk of direct (person-to-person) or indirect (environmentally-
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mediated) transmission of enteric infection, especially in low-income, unplanned 
neighborhoods where WASH infrastructure is lacking (105,106). Recent studies of 
population density and enteric infection risk have found mixed results, though most were 
based in rural areas or less dense urban settings (107–109). In our study, we observed an 
association between higher compound-level population density and higher risk of enteric 
infections.  
There are important limitations to this study that qualify our results. First, our a priori 
selection of specific pathogen targets and our methods for stool sample analysis present 
key constraints to interpretation. The GPP tests for 15 of the most common enteric 
pathogens including bacteria, viruses, and protozoa, but this is a sub-set of all enteric 
infections and therefore an incomplete accounting of current infections. For example, the 
GPP does not detect EAEC, a pathogen commonly detected in young children in both 
MAL-ED and the GEMS-Manhiça site (44,46) and associated with malnutrition (102). 
Metagenomics or other primer-independent approaches may have yielded information on 
additional targets of public health significance. Although detection of pathogens in stool 
samples was observed to be closely associated with age – suggesting persistent infections 
or frequent reinfection – we cannot make conclusions about either duration of infections 
or shedding or about the potential for rapid clearance and reinfection based on a single 
stool specimen. Detection of an enteric pathogen in stool can represent symptomatic or 
asymptomatic infection, pathogen carriage due to colonization of the gut, or simply 
passage due to recent exposure. Further, certain pathogens may be shed for weeks after 
clinical symptoms of infection have abated, and the onset or absence of symptoms 
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following infection can depend on factors related to the environment, host, or pathogen 
strain of interest (91). The GPP was designed to aid in diagnosis of enteric infections and 
the relatively high limits of detection (2.2x102 – 3.75x106 CFU or copies/mL stool) 
largely exceed the known infectious doses for target pathogens. This suggests that enteric 
pathogen detections via the GPP may primarily represent active infection (symptomatic 
or asymptomatic) or long or short term colonization of the intestinal tract. Although 
detection of enteric pathogens in feces is an unambiguous indication of past exposure and 
a clear indication that fecal waste from such individuals represents downstream exposure 
risks, absence of a particular pathogen in stool by the methods we used does not indicate 
absence of previous exposure to that pathogen. Because the detection limit of the assay 
we used is relatively high, a negative assay may not necessarily mean that the pathogen is 
absent in stool. Cross-sectional, end-point RT-PCR analysis of stool samples alone 
cannot reveal information on time since exposure, etiology of symptomatic infections, 
intensity of infections, health implications of infections, or infectivity of pathogens shed 
in stool. Enteric infections are on the causal pathway between exposures and all 
downstream health impacts of WASH, including diarrheal disease and environmental 
enteric dysfunction, but they should be considered an intermediate outcome of uncertain 
clinical significance.  
Second, the study population and the study setting, though diverse across some variables, 
was characterized by a limited range of WASH conditions. All participating households 
had access to shared sanitation without safe excreta management – a key criterion used in 
determining eligibility for the MapSan trial – and so exposures were likely to be high 
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across our study sites. This lack of heterogeneity of WASH conditions may have limited 
our ability to observe variation in risk attributable to specific exposures.  
Third, certain inclusion criteria may limit the generalizability of our findings. Because 
our study only included children living in households sharing sanitation in densely 
populated urban neighborhoods, our results may not represent risks for children in rural 
areas or in households using private sanitation.    
Fourth, our analysis is constrained by missing data for variables, including the outcome. 
A secondary analysis used multiple imputation to handle missing values, and these 
methods are accompanied by different assumptions and limitations. We note, however, 
that results from the complete case models and estimates from multiple imputation were 
largely consistent. Finally, our modeling strategy did not include adjustment for multiple 
comparisons. While it is possible that some of our findings are spurious and due to type I 
error (110,111), all variables in this analysis have strong foundations in the literature or 
plausibility as risk factors for enteric infection. 
Overall, we found high prevalence of enteric infection and comparatively low prevalence 
of reported diarrhea among children <4 years old living in informal neighborhoods of 
Maputo, Mozambique. Most infections were observed in reportedly asymptomatic 
children. Prevalence of bacterial and protozoan infection increased with child age and is 
likely due to variations in exposure profiles as children become more mobile. Certain 
sanitation facility characteristics were associated with decreased risks of enteric infection, 
though the magnitude of these associations was small. The importance of effective 
sanitation increases where prevalence of enteric infections is high: fecal wastes in such 
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settings present elevated exposure risks, potentially driving burdens of infection and 
disease higher. Strategies to interrupt this cycle of infection and exposure risk should 
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Exposure to fecal contamination due to inadequate sanitation can result in infection with 
enteric pathogens and short- and long-term health and well-being effects. Exposure to 
enteric pathogens may be frequent in low-income urban settings with high population 
density and low coverage of safe sanitation. We aimed to evaluate whether an on-site, 
privately shared sanitation intervention could reduce the burden of enteric infection and 
diarrheal disease in young children living in Maputo, Mozambique.  
Methods & findings 
The Maputo Sanitation trial is an independent controlled before-and-after study of the 
impact on an on-site sanitation intervention on child health in urban Mozambique. We 
enrolled and collected baseline (pre-intervention) data from children <4 years old in 
intervention and control sites between February 2015 and February 2016 and returned to 
collect 12-month and 24-month follow-up data between March 2016-April 2017 and 
April 2017-May 2018, respectively. Water and Sanitation for the Urban Poor (WSUP) 
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selected sites for intervention and designed and constructed the intervention latrines, 
pour-flush toilets to septic tanks with soakaway pits. The MapSan team, independent 
from WSUP, used a modified version of WSUP’s site selection criteria to identify and 
enroll control sites. Enrollment was progressive and all eligible children were enrolled at 
each visit regardless of availability at baseline. In our main analysis of all enrolled 
children, the intervention had no impact on our pre-defined primary outcome, infection 
with one or more bacterial or protozoan infection as detected in stool by the Luminex 
Gastrointestinal Pathogen Panel (GPP) at either the 12- or 24-month time-point or when 
time-points were combined into a single follow-up phase. The intervention also had no 
measurable effect on the risk of infection with any individual pathogen target detected by 
the GPP. In a sub-group analysis of children born into intervention sites (post-
intervention) by the 24-month follow-up time-point, the intervention reduced the risk of 
Shigella infection by 47% (aRR 0.53, 95% CI 0.29-0.95) but did not affect the risk of 
infection with any other individual pathogen. A second longitudinal sub-group analysis of 
children available at baseline and at least one follow-up phase also demonstrated no 
effect of the intervention on any enteric infection outcome. The intervention had no effect 
on reported diarrhea in the main analysis of all children or in either of the two sub-group 
analyses. 
Conclusions 
The intervention had a limited effect on the risk of on enteric infection and caregiver-
reported diarrhea. In this and similar settings where infection burden is high and fecal 
contamination of the environment is pervasive, exposure is likely to be complex and 
48 
 
driven by multiple transmission pathways. To achieve rapid health gains, interventions 









Currently, 2.2 billion people in urban areas lack access to safely managed sanitation 
systems and this problem will only worsen as migration to urban areas accelerates over 
coming decades (3). Rapid urbanization will likely result in the expansion of informal 
urban settlements, or slums, in many areas, stressing existing inadequate sanitation 
systems and increasing the number of people without access to basic or safely managed 
sanitation (3,4). Exposure to fecal contamination due to lack of access to adequate 
sanitation has been associated with enteric infection, diarrheal disease, environmental 
enteric dysfunction (EED), linear growth deficits, impaired cognitive development, and 
other long term health and well-being effects (6,15–21,101,112). Children living in 
densely populated slum areas where fecal contamination is pervasive, infection burdens 
are high, and sanitation infrastructure is limited, may be at increased risk enteric infection 
and other down-stream sanitation-related health effects (24,25,105,113,114). 
While development or expansion of centralized sanitation systems in urban areas has 
been demonstrated to have important health benefits and is an aspirational solution 
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(26,31,115–117), such systems may not be a practical fix in the short-term due to cost, 
logistical constraints, and the urgency of the need for sanitation solutions in many places 
(26,29). On-site systems which use soak-way pits for liquid effluent discharge may fill 
the growing need for safe sanitation in rapidly expanding urban areas in LMICs but, to 
date, there has been little evidence of the health impact such systems may provide in 
these settings. Several large-scale, rigorous evaluations of on-site sanitation interventions 
and combined water, sanitation, and hygiene interventions have been completed recently, 
however, all were performed in rural areas and their findings may have limited 
generalizability to urban areas (32–37). Further, results from these trials have 
demonstrated mixed effects on health. A recent meta-analysis estimated non-sewerage 
interventions reduced risk of self-reported diarrhea by 16%, however, it did not include 
results from the most recent studies (32,33,37) and did not estimate effects on objective 
health outcomes (31). Self-reported diarrheal disease is subjective and, when coupled 
with unblinded interventions, presents significant risk of bias as an outcome measure in 
health impact trials (118–120). 
The Maputo Sanitation (MapSan) is the largest controlled trial of decentralized urban 
sanitation performed to date, the first to evaluate shared sanitation, and the first to use 
enteric infection, an objective measure of exposure to sanitation-related pathogens, as the 
primary study outcome (2). Our study is located in densely populated, low-income 
neighborhoods of Maputo, Mozambique where sanitary conditions are poor and disease 
burden is high (Chapter 2). As of 2017, an estimated 48% of urban residents in 
Mozambique lacked access to even basic sanitation infrastructure (1). In Maputo, the 
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capital city, only 10% of residents have access to sewerage, 89% rely on on-site disposal, 
and 1% practice open defecation (121). An estimated 9% of urban residents share 
sanitation with multiple households (1), often in the poorest neighborhoods where space 
and resources are limited. We aimed to investigate whether an on-site, privately shared 
sanitation intervention could reduce enteric infection and reported diarrhea in young 








Study design and intervention 
The MapSan Trial is a prospective, non-randomized controlled before-and-after (CBA) 
study to measure the impact of an on-site, privately shared sanitation intervention on 
several important metrics of child health. We conducted the study in 17 densely 
populated, low-income, and unplanned neighborhoods in Maputo, the largest city and 
capital of Mozambique. The trial consisted of three phases of data collection: an 
enrollment and baseline phase, a 12-month follow-up phase, and 24-month follow-up 
phase. Each phase took approximately one year to complete. We enrolled and visited 
intervention and control sites concurrently to limit any differential influence of 
seasonality on data collection and outcome measurement (Figure 3). We revisited 
intervention sites approximately 12-months (median 397 days) and 24-months (median 
792 days) after the intervention latrines were opened for us and revisited control sites at a 
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similar rate (Figure 3). Each site consisted of a single compound: a group of related or 
unrelated households with shared outdoor living space, sanitation facilities, and 
sometimes food preparation and cooking areas. Compound sanitation facilities are shared 
among member households but they are not considered public latrines.   
The sanitation interventions, pour-flush latrines to septic tanks, were designed and 
constructed by the non-governmental organization Water and Sanitation for the Urban 
Poor (WSUP) between 2015 and 2017. WSUP built a total of 450 new latrines in 11 
neighborhoods of the Nlhamankulu district of Maputo, Mozambique. Two types of 
latrines were constructed and delivered at the compound level: communal sanitation 
blocks (CSBs) and shared latrines (SLs). The primary difference between CSBs and SLs 
is size. CSBs include multiple stalls with toilets and serve compounds of 21 or more 
people with one stall allocated per 20 beneficiaries. CSBs also include rainwater 
harvesting systems, elevated water storage tanks, a laundry facility, a shared water 
connection, and a well-drained area for bathing (Appendix A, Figure A2). Shared latrines 
are single-stall infrastructure serving fewer than 21 people (Appendix A, figure A3). All 
interventions, regardless of size, are pour-flush latrines to septic tanks with soakaway 
pits. The septic tanks for both CSBs and SLs were designed to require emptying after two 
years of use (Appendix A, Figure A1).  
Participants 
Children between 29 days and 48 months old were eligible for baseline enrollment in the 
MapSan study if we received written informed consent by a parent or guardian and if 
they lived in a selected intervention or control compound. As this study was an 
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independent impact evaluation of a pre-planned intervention, our study team was not 
involved with intervention site selection. WSUP, the implementation organization, 
worked with neighborhood-level government representatives to select sites for 
intervention based on factors related to demographics, engineering constraints, and 
WASH conditions. Specifically, sites were evaluated using the following criteria: (1) 
compound residents must share sanitation in poor condition as determined by a WSUP 
engineer, (2) compounds must be located in the pre-defined implementation 
neighborhoods, (3) a minimum number of beneficiaries (12 – 21 depending on latrine 
type) must reside in the compound, (4) compound residents must have stated demand for 
improved sanitation and must be willing to contribute to construction costs, (5) sites must 
have space for construction of a new facility, (6) sites must be accessible for both 
transportation of construction materials and tank-emptying activities, (7) compounds 
must have nearby access to a legal piped water supply, and (8) the groundwater level 
must be deep enough to support construction of the septic tank. Handover of the original 
tranche of 300 compounds began in February 2015 and continued through February 
2016. A second tranche of compounds (150) began in November 2016 and continued 
through June 2017. Our study team selected control sites using WSUP criteria 1, 3, 4, and 
7. We modified criterion 3 to select control compounds to have similar numbers of 
residents as intervention compounds so that the population distribution of intervention 
and control compounds would be comparable. Criterion 4 was presented as a hypothetical 
during control selection. Prospective intervention sites which did not meet engineering 
and construction constraints (criteria 5, 6, and 8) were eligible for recruitment as controls. 
Control sites outside of WSUP’s pre-defined implementation area were also eligible for 
53 
 
recruitment so long as they met criteria 1, 3, 4, and 7. Additionally, control compounds 
were required to have at least one child less than four years old in residence.  
Concurrent with latrine construction and handover, our field teams completed baseline 
enrollment and data collection between February 2015 and February 2016. We aimed to 
visit intervention compounds two weeks prior to the opening and handover of the new 
latrines. Interventions and control compounds were enrolled at approximately the same 
rate during all three study phases to avoid potential biases due to seasonality.  Follow-up 
visits at years one and two were scheduled to be 12 months (±2 weeks) and 24 months 
(±2 weeks) from the date intervention compound members began using their latrines. 
Within two weeks of each 12-month or 24-month follow-up visit of an intervention 
compound, a control compound was revisited, thus maintaining similarity in the rates of 
visits between study arms across phases. Enrollment was progressive meaning all 
eligible, consented children were enrolled in the study during each visit (baseline, 12-
month, and 24-month). Children who moved into the compound after baseline 
measurement and fewer than six months before the 12-month or 24-month visit were not 
eligible for enrollment during that phase given their limited exposure to their new 
compound. Children born into a study compound after baseline measurement were 
eligible for enrollment regardless of the length of their exposure to the compound so long 
as they met the age criterion (>29 days). During enrollments at 12- and 24-month visits, 
the upper age limit was increased to 60 months as our target age demographic was 
children less than five years.  
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The nature of the intervention infrastructure made it impossible to blind participants and 
field enumerators to intervention status. However, the MapSan study team and the WSUP 
implementation team were independent and included different individuals.  
Procedures 
At each phase – baseline, 12-month, and 24-month - field teams completed consent 
procedures, administered surveys, and collected biological specimens from enrolled 
children. We obtained verbal assent from the head of the compound or his or her spouse 
prior to starting study related activities at each site. The parents or guardians of each 
eligible child provided written, informed consent prior to child enrollment in the study. 
Field enumerators sought verbal assent for continuation in the study at the first visit of 
each subsequent phase. Enumerators planned to visit households with enrolled children 
twice during each phase, though more visits were sometimes necessary to complete 
specimen collection. On the first visit of each phase, enumerators completed consent 
procedures and administered child-, household-, and compound-level surveys (Appendix 
C, Tables C1-C5) at households with eligible children and delivered stool specimen 
collection supplies. The next day, field enumerators returned to collect specimens and 
complete any remaining surveys. The child’s mother was the target respondent for child 
and household surveys, though the father or another guardian was also eligible. For 
compound-level surveys, the head of compound or his or her spouse was the preferred 
respondent. All study-related communication was in Portuguese or the local language, 
Changana, depending on the preference of the respondent. 
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Surveys included questionnaires and direct observation and were tailored to collect data 
on key socio-demographic factors, environmental conditions in the household and 
compound, and WASH practices and behaviors. We used an asset-based wealth index 
developed for Mozambique to calculate relative household wealth (75). Other survey 
variables have been described previously (Chapter 2, Appendix B, Table B2). 
Enumerators used the mwater smartphone application for collection of survey data 
(www.mwater.co). 
Field enumerators attempted to collect stool specimens from each enrolled child at each 
phase independent of reported symptomology. Enumerators provided each caregiver with 
stool collection supplies, including diapers, a plastic potty if the child was no longer 
wearing diapers, and a pre-labeled sterile sample bag. Enumerators returned the next day 
to collect the specimens. If a specimen was unavailable during the scheduled pickup, 
caregivers called the field team, using phone credit provided by the study, as soon as one 
was available or if fresh collection supplies were needed. If field enumerators were 
unable to collect a bulk stool sample after multiple attempts, a registered nurse used an 
anatomically designed rectal swab (Copan Diagnostics Inc, Murrieta, CA, USA) to 
collect fecal material. Parents or guardians were required to complete a separate written 
consent procedure prior to collection of rectal swabs. Bulk stool specimens and rectal 
swabs were stored in coolers with cold packs and delivered to the medical parasitology 
laboratory at the Mozambican Ministry of Health (MISAU/INS) within six hours of 
collection. Upon receipt, laboratory technicians aliquoted bulk stools into several sterile 
tubes and storage them, and any rectal swabs, at -80°C. If a child produced a liquid stool, 
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lab technicians stored a piece of the soaked diaper material (“diaper samples”) at -80°C. 
Stool samples were shipped frozen on dry ice with temperature probes to the Georgia 
Institute of Technology in Atlanta, Georgia, USA where they were stored at -80°C until 
analysis. 
A member of the Mozambican National Deworming Campaign (NDC) worked in 
coordination with our study team to provide single dose albendazole (400 mg, 200 mg for 
children aged 6 – 12 months) to all eligible members of intervention and control study 
compounds following completion of each study phase. Eligibility was defined by the 
NDC guidelines and included compound members older than six months who were not 
pregnant at the time of distribution.   
We analyzed stool specimens (bulk, diaper, and rectal swabs) for the presence of 15 
enteric pathogens:  Campylobacter; Clostridium difficile, Toxin A/B; Enterotoxigenic 
Escherichia coli (ETEC) LT/ST; Shiga-like toxin producing E. coli (STEC) stx1/stx2; E. 
coli O157, a serotype of STEC; Salmonella; Shigella; Vibrio cholerae; Yersinia 
enterocolitica; adenovirus 40/41; norovirus GI/GII; rotavirus A; Giardia; 
Cryptosporidium; and Entamoeba histolytica using the Luminex MagPix xTAG 
Gastrointestinal Pathogen Panel (Luminex Corp, Austin, TX). The Gastrointestinal 
Pathogen Panel (GPP) is a multiplex end-point reverse transcriptase polymerase chain 
reaction (RT-PCR) assay developed to aid diagnosis of enteric pathogen infection in 
clinical settings (122).The GPP has been rigorously and extensively tested for direct 
detection of enteric pathogens in stool in a range of settings and countries including some 
similar to the present study (76–84,123). The analysis of bulk stool, diaper specimens, 
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and rectal swabs have been previously described (Chapter 2). Briefly, we adhered to 
pretreatment, lysis, and analysis procedures described in the GPP protocol with additional 
elution steps included in the pretreatment procedure for diaper and rectal swab samples. 
We added MS2, a non-pathogenic RNA virus, to each sample prior to nucleic acid 
extraction as an extraction and RT-PCR inhibition control. We included at least one 
sample process control (containing only lysis buffer and MS2) and negative extraction 
control (containing only lysis buffer) with each set of extractions. During the PCR step, 
we included at least one no-template control, containing molecular grade water and all 
PCR reagents, with each run. To assess elution and extraction of nucleic acid from diaper 
and swab samples, we measured the concentration of double-stranded DNA (dsDNA) 
present in extracts using the Qubit® High Sensitivity dsDNA kit (Invitrogen™, Carlsbad, 
CA, USA) and Qubit® 4 Fluorimeter (Invitrogen™, Carlsbad, CA, USA). Following 
extraction we stored all extracts at 4°C and analyzed them by GPP within 24 hours. For 
long-term storage, we archived samples at -80°C. We extracted and analyzed 
approximately 10% of samples in duplicate. If duplicate analyses yielded different 
results, we combined the results from all analyses. If we could not detect a MS2 signal in 
a given sample, we either re-extracted or diluted the extract 1:10 in molecular grade 
water and re-assayed by GPP.  
Outcomes 
We pre-specified the primary outcome of the study as infection with one or more of the 
12 bacterial or protozoan enteric pathogens detected by the GPP and a secondary 
outcome as caregiver reported diarrhea with a 7-day recall (64). We excluded viral 
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enteric pathogens from the primary outcome definition because we hypothesized that 
their dominant transmission pathway in this setting may be person-to-person, a pathway 
unlikely to be interrupted by the intervention. Other pre-specified outcomes - the results 
of which will be described elsewhere - include soil-transmitted helminth infection, 
concentrations of biomarkers of environmental enteric dysfunction (Chapter 4), and 
measures of growth and nutrition (height-for-age, weight-for-age, and height-for-weight 
z-scores and associated metrics of stunting, underweight, and wasting). In addition to the 
pre-specified primary outcome, we will also evaluate the effect of the intervention on 
specific pathogen types (bacterial, protozoan, viral) and on individual pathogen targets.  
We defined caregiver reported diarrhea as the passage of the three or more loose or liquid 
stools in a 24-hour period or any stool with blood (70,71). Field enumerators assessed 
caregiver reported diarrhea in the preceding seven days as part of the child-level surveys. 
We measured reported diarrhea in all available, enrolled children at each phase. 
Statistical analysis 
Our initial sample size calculations were based on the planned construction of 190 
intervention latrines. We estimated a necessary enrollment of 380 children per study arm 
assuming 80% power, a primary outcome risk ratio of 0.84 which assumed high 
prevalence of endemic infection in controls (70%), a small clustering effect (intraclass 
correlation coefficient (ICC) = 0.1) due to the low number of participants per cluster, and 
approximately 10% loss to follow-up (2,124). Even though the number of planned 
intervention latrines increased just prior to the start of the study, ultimately, due to much 
higher than anticipated loss to follow-up (~38% between baseline and 12-month), sample 
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size for this study was constrained by the number of intervention latrines constructed and 
the number of eligible children in those compounds.    
The primary analyses included all enrolled children living in control compounds or in 
intervention compounds which received an intervention latrine during the baseline phase 
of the study (February 2015 – February 2016). Children living in compounds which 
received an intervention latrine after February 2016 are excluded from the current 
analyses but will be included in a future sub-group analysis. The primary analyses 
examined the effect of the intervention at the 12-month and 24-month phases separately.  
We also performed an exploratory effect analysis which combines all data collected after 
baseline into a single follow-up phase. This combined follow-up analysis assumes that 
the effect of the intervention was uniform over the study period. 
Additional sub-group analyses examined here include a comparison of (1) children with 
baseline data and data from at least one phase of follow-up and (2) children who were 
born into a study site post-intervention (and aged <1 year at 12-month visit or less than 2 
years at 24-month visit) or were < 1- 2 years at baseline (to obtain comparable age 
distributions for comparison).  
We used chi-squared tests and two sample t tests to test for differences in baseline 
demographic, socio-economic, and environmental and WASH characteristics between the 
two study arms. We used a difference in difference (DID) approach to assess the impact 
of the intervention on infection and reported diarrhea outcomes at the 12- and 24-month 
phases. In regression analyses, the DID estimator is created as an interaction term of 
dummy variables representing the study arm and study phase. For binary outcome 
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measures, such as the primary outcome measure (defined as ≥1 bacterial or protozoan 
infection as detected by the GPP) or reported diarrhea, we used generalized estimating 
equations (GEE) to fit modified Poisson regression models and account for compound 
level clustering effects. For the count of the number of infections detected by GPP, we 
used GEE to fit a negative-binomial regression model since the distribution of count data 
was zero-inflated (125). We clustered on compound because it was the highest level of 
nested data (which included household level, child level, and repeated measures data) and 
the level of the intervention allocation (126). The primary outcome assessment is based 
on multivariable models which adjust for covariates determined a priori as potentially 
predictive of the primary outcome, including child age, sex, and breastfeeding status, 
caregiver’s education, and household wealth. Additional covariates we considered for 
inclusion in multivariable models included measures of  population and crowding (e.g. 
number of compound members, number of households, number of household members, 
compound-level population density), compound level amenities (e.g. functioning 
electricity), environmental conditions (e.g. propensity of compound to flood, cumulative 
rainfall during month prior to measurement, standing water, presence of animals), and  
baseline WASH conditions (presence of a pedestal or slab, drophole cover, vent pipe, or 
sturdy latrine walls, number of water taps and latrines in the compound). We excluded 
from consideration any variable with limited variation (<5%) in the study population at 
baseline. To select covariates for the multivariable model, we first assessed whether they 
were associated with the treatment assignment (study arm) and the primary outcome (or 
diarrhea) at baseline (>10% relative difference in prevalence or value). Covariates 
associated with the exposure (study arm designation) and outcome at baseline were 
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entered into univariable DID models to evaluate whether their inclusion resulted in a 
meaningful change in effect in the outcome (±10% change in DID estimator). No 
additional covariates met these criteria and our final multivariable models adjust for only 
the a priori covariates listed previously. We also present the results from the unadjusted, 
univariable models. The results of effect estimation are evaluated with traditional 
statistical hypothesis testing using a significance level of α=0.05. We did not adjust for 
multiple comparisons because the main analyses of the primary outcome and reported 
diarrhea were pre-specified and all others, including analysis of pathogen groups, 
individual pathogens, and all sub-group analyses were exploratory (127).  We analyzed 
data from participants according to their exposure status (as treated analysis). Statistical 
methods for sub-group analyses were similar to those for the primary analysis. We 
performed all statistical analyses with Stata version 14.1 (StataCorp, College Station, 
TX). 
Ethics 
The study protocol was approved by the Comité Nacional de Bioética para a Saúde 
(CNBS), Ministério da Saúde (333/CNBS/14), the Ethics Committee of the London 
School of Tropical Medicine and Hygiene (reference # 8345), and the Institutional 
Review Board of the Georgia Institute of Technology (protocol # H15160). The trial has 








We enrolled 993 children in 497 compounds during the baseline phase (February 2015 – 
February 2016) (Figure 2). Children in intervention and control compounds were enrolled 
at approximately the same rate during baseline (Figure 3). Of these 993 children, 456 
(45.9%) resided in 207 intervention compounds and 537 (54.1%) resided in 290 control 
compounds (Figure 2). We collected stool specimens from 362/456 (79%) children 
enrolled in intervention sites and 395/537 (74%) children enrolled in control sites at 
baseline. We also collected data on caregiver-reported diarrhea from 99% of children in 
intervention (450/456) and control (530/537) sites.  
The 12-month follow-up phase lasted from March 2016 – April 2017, during which time 
we visited 458 children in 196 intervention compounds and 482 children in 242 control 
compounds. We collected stool material from 403/458 (88%) intervention children and 
400/482 (83%) control children and data on caregiver-reported diarrhea from 432/458 
(94%) intervention children and 435/482 (90%) control children. Sixty-six percent 
(303/456) of children enrolled into intervention compounds and 59% (317/537) of 
children enrolled into control compounds at baseline were available for follow-up at the 
12-month visit. An additional 155 children were enrolled into the intervention arm and 














































 500 visited & 459 stools collected 
 369 households 
 195 compounds 
458 visited & 403 stools collected 
 348 households 
 196 compounds 
Lost to follow-up (n=133) 
 2 died 
 131 traveling or moved 
 
456 children enrolled & 362 stools 
collected in intervention sites 
 364 households 
 207 compounds  
482 visited & 400 stools collected 
 373 households 
 242 compounds 
537 children enrolled & 395 
stools collected in control sites 
 447 households 
 290 compounds 
505 visited & 464 stools collected 
 354 households 
 211 compounds 
Baseline 
24-month Follow-up
Lost to follow-up (n=153) 
 2 died 
 6 refused 
 145 traveling or moved 
Lost to follow-up (n=220) 
 2 died 
 3 refused 
 215 traveling or moved 
12-month Follow-Up 
Newly eligible (n=165) 
 85 born-in 
 52 moved in 
 28 absent† 
Newly eligible (n=145) 
 75 born in 
 29 moved in 
 41 absent† 
 30 enrolled at baseline but 
absent at 12-month 
Newly eligible (n=155) 
 92 born-in 
 50 moved in 
 13 absent†
Newly eligible (n=159) 
 85 born in 
 27 moved in 
 47 absent† 
 31 enrolled at baseline 
but absent at 12-month
Lost to follow-up (n=167) 
 1 died 
 136 traveling or moved 




Figure 2: Trial profile. †absent at baseline and missing 12-month/24-month survey - 
born-in/moved-in status unknown at enrollment. ‡ Children removed from analysis 




Figure 3: Schematic of study timeline and enrollment and visitation profile for intervention and control children during baseline, 12-
month, and 24-month phases.  
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Of the 155 newly enrolled intervention children, 92 (59%) were born after the baseline 
visit, 50 (32%) moved in after baseline, and 13 (8.4%) were absent for reasons not 
captured by the study team. In control compounds, 85/165 (52%) newly enrolled children 
were born in after baseline, 52 (32%) moved in, and 28 (17%) were absent. The median 
number of days between baseline enrollment and the 12-month follow-up visit was 397.   
At the 24-month visit (April 2017 – September 2018), we visited 500 children in 
intervention compounds and 505 children in control compounds. We collected stool 
material from 92% of intervention (464/505) and control (459/500) children and reported 
diarrhea data from 81% (407/500) of intervention children and 78% (392/505) of control 
children. Children available for data collection at 24-month included 145 children newly 
enrolled in the intervention arm (75 born in, 29 moved in, 41 absent at baseline and 12-
month visits for unspecified reasons), 159 newly enrolled in the control arm (85 born in, 
27 moved in, 47 absent), and 61 children (30 intervention, 31 control) who were enrolled 
at baseline but absent during the 12-month visit. A total of 300 children (133 
intervention, 167 control) available during the 12-month visit were unavailable during the 
24-month visit. Of the children originally enrolled during baseline, 233/456 (51.1%) of 
intervention children and 217/537 (40.4%) of control children were available during all 
three phases of data collection, and 73% (333/456) and 65% (348/537) of intervention 
and control children enrolled at baseline, respectively, were available during at least one 
follow-up phase. 
Enrollment and follow-up visitation of intervention and control compounds occurred at a 
similar rate in each phase (Figure 3). Concurrent enrollment should have limited any 
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differential effect of seasonality or weather-related secular trends on the outcome in 
intervention and control arms, as these variables would have affected both arms equally 
in the aggregate.  
Baseline population characteristics and balance 
The average age at baseline enrollment was 23 months (SD = 13) and 51% of enrollees 
were female (Table 5). 32% of children were still breastfeeding at the time of enrollment, 
including 9% who were exclusively breastfeeding, and 66% wore diapers. A little over 
half of all caregivers had completed primary school. Measures of all child-level variables 
were similar among intervention and control children at baseline. All households with an 
enrolled child used a private municipal water tap as their primary drinking water source 
at baseline, though it was more common for the tap to be inside compound boundaries in 
intervention compounds. Households in intervention compounds scored slightly lower on 
the asset-based wealth index than control households, though the magnitude of difference 
was small. Control households more frequently had covered floors (concrete, wood, or 
other) and walls constructed with sturdy materials like bricks, concrete, or wattle and 
daub. Controls household also had almost one fewer person in residence than intervention 
compounds though the frequency of household crowding (>3 persons/room) was similar 
among arms. Differences in household construction and number of residents contributed 
to the difference observed in household wealth between intervention and control. (Table 
5). On average, intervention compounds had higher populations at baseline than control: 
the mean population of intervention compounds was 19 compared with 15 in controls. In 
addition to having larger resident populations, intervention sites also had more 
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households, more water taps, and higher population density (measured in persons/m2) 
(Table 5). Both intervention and control sites had an average of one latrine at baseline. 
Drophole covers and sturdy latrine walls were less common in control compounds than 




Table 5: Baseline characteristics measured in questionnaires and by direct observation at 
the child, household, and compound level by study arm 
 Control Intervention  
 n  n  p-value 
Child level variables      















































Household level variables   





Household wealth score, 1 (poorer) - 
100 (wealthier)† 
439 45 (10) 357 44 (11) 0.0306












Table 5 (continued). 














Latrine used by household  






















































































Data are n (%) or mean (SD) and collected by questionnaire unless otherwise noted. †Assessed using 
Simple Poverty Scorecard for Mozambique, ‡Data collected by direct observation, *Calculated as # of 
people living in the compound divided by the area of the compound in square meters. Area measurement 





Balance of baseline population characteristics of children who remained in the study 
through the 12-month and 24-month visits and children who were lost to follow-up are 
presented in Tables D1 and D2 (Appendix D). Some characteristics of children lost to 
follow-up differed from those of children who remained in the study, though differences 
tended to be consistent in both study arms with few exceptions. Children lost to follow-
up by the 12-month visit in the intervention arm were more likely to reside in compounds 
without chickens, more likely to have a caregiver who had not completed primary school, 
and lived in compounds with fewer water taps than intervention children who remained 
in the study. These differences were not observed in control children (Table D1). In 
comparison, control children were more frequently lost to follow-up from households and 
compounds with smaller populations and less crowding (Table D1). – a trend observed in 
both intervention and control children in an analysis of children lost to follow-up by the 
24-month phase (Table D2). While rates of enrollment of new participants were similar 
between study arms at the 12-month and 24-month visits, some variation observed in the 
characteristics of newly enrolled children compared with children enrolled at baseline 
was not consistent in both arms (Tables D3 and D4). Compared with differences among 
new and original enrollees of control compounds, new enrollees in intervention sites at 
the 24-month visit had slightly higher wealth scores, came from smaller households 
(population), and were less likely to be a part of compounds with animals than original 
intervention enrollees (Table D4).  
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Estimation of intervention effect on all enrolled children (main analysis) 
Our main analysis estimated the effect of the sanitation intervention on enteric infection 
and caregiver reported diarrhea among all enrolled children regardless of phase of 
enrollment or loss to follow-up prior to study completion. Effect estimates for all 
analyses are presented as adjusted risk ratios with 95% confidence intervals. Unadjusted 
risk ratios are also presented for comparison. Confidence intervals of risk ratios which 
include the null value (1.0) indicate the intervention latrine had no effect on the specified 
outcome by traditional methods of statistical hypothesis testing. 
Enteric infection was common at baseline, and the observed prevalence of our primary 
outcome (84%, 95% CI: 81 – 87%), any bacterial or protozoan infection, exceeded the 
figure we used in our sample size calculations (70%) (2,128). The prevalence of most 
enteric pathogens was similar among intervention and control children at baseline (Table 
6). However, the prevalence of the primary outcome was higher among controls (87%) 
than intervention (81%) children at baseline as was the prevalence of any bacterial 
infection (79% vs 73%), which is a component of the primary outcome. Coinfection 
(concurrent infection with two or more measured pathogens) was common (58%) at 
baseline and detected at a similar frequency in intervention and control children. We 
detected an average of 1.79 (SD=1.23) pathogens in intervention children and 1.85 
(SD=1.17) in control children at baseline. The most frequently detected pathogens at 
baseline, among both intervention and control, included Giardia, Shigella, ETEC, 
Salmonella, and norovirus GI/GII. Bacterial infections were the most common type of 
infection, followed by protozoan, and viral. We did not detect V. cholerae in any of the 
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specimens assayed and detected very low prevalence of Yersinia pestis, rotavirus A, 
Entamoeba histolytica, Cryptosporidium, and E. coli O157. The prevalence of caregiver 
reported diarrhea was 13% in both intervention and control arms at baseline.  
In both study arms, the prevalence of most enteric infections at follow-up phases was 
similar to or higher than baseline prevalence with few exceptions. The mean number of 
infections per child and prevalence of coinfection increased with each phase in controls. 
In intervention children, the mean number of infections and prevalence of coinfection 
increased between baseline and the 12-month phase but leveled off by the 24-month 
phase (Table 6). Giardia, Shigella, ETEC, Salmonella, and Norovirus GI/GII remained 
the most prevalent infections detected in both arms during follow-up phases. The 
frequency of caregiver-reported diarrhea did not vary substantially across phases in 
intervention children. In control children, the prevalence of reported diarrhea decreased 
between baseline and 12-month but returned to baseline levels by the 24-months phase.  
Cumulative rainfall in the 30-days prior to sample collection was considered as a 
potential covariate in the main analysis models to capture the potential effects of 
seasonality. During model building, we found rainfall to have no meaningful impact on 
effect estimates and it was dropped from the models in the main analysis and both sub-




Table 6: Prevalence (%) of enteric infections and caregiver reported diarrhea in intervention and control children at each study phase 
 Baseline 12-month 24-month Combined Follow-up 
















Primary outcome 87 (83-90) 81 (77-85) 87 (83-90) 88 (84-91) 91 (87-93) 88 (84-90) 89 (86-91) 88 (85-90) 
Bacterial 79 (74-83) 73 (69-78) 76 (71-80) 76 (72-80) 80 (76-84) 74 (70-78) 78 (75-81) 75 (72-78) 
Shigella  46 (41-51) 42 (37-47) 51 (46-56) 52 (47-57) 59 (54-63) 53 (48-57) 55 (52-58) 52 (49-56) 
ETEC 30 (25-35) 30 (25-35) 34 (30-39) 35 (31-40) 27 (23-32) 27 (23-32) 31 (27-34) 31 (28-34) 
Salmonella 
enterica 
23 (19-27) 18 (14-23) 17 (13-21) 16 (13-20) 16 (13-20) 14 (11-18) 16 (14-19) 15 (13-18) 
Campylobacter 10 (7.3-14) 5.8 (3.6-
8.7) 
8.0 (5.5-11) 7.9 (5.5-11) 11 (7.9-14) 7.2 (5.0-
9.9) 
9.4 (7.5-12) 7.5 (5.9-
9.5) 






























E. coli O157 3.3 (1.8-
5.6) 
















Protozoan 52 (47-57) 54 (48-59) 58 (53-63) 62 (57-67) 66 (62-70) 63 (59-68) 62 (59-66) 63 (60-66) 
Giardia 51 (46-56) 51 (46-56) 56 (51-61) 60 (55-65) 64 (59-68) 62 (57-66) 60 (57-64) 61 (58-64) 
Cryptosporidium 2.0 (0.9-4) 4.4 (2.5-
7.1) 

























Table 6 (continued). 
Viral 14 (10-17) 14 (11-18) 14 (10-17) 10 (7.6-14) 13 (9.8-16) 13 (10-17) 13 (11-16) 12 (9.9-14) 
norovirus GI/GII 9.9 (7.1-13) 11 (7.8-14) 12 (9-16) 8.4 (5.9-12) 10 (7.5-13) 12 (9.0-15) 11 (9.0-13) 10 (8.3-12) 
























Coinfection 60 (55-65) 57 (51-62) 63 (58-68) 65 (60-70) 70 (66-74) 64 (59-68) 67 (64-70) 64 (61-68) 
Number of 
infections‡ 
1.85 (1.17) 1.79 (1.23) 1.92 (1.16) 1.97 (1.16) 2.05 (1.16) 1.91 (1.13) 1.99 (1.16) 1.94 (1.15) 
















Data presented as prevalence (%) and 95% CI unless noted. n= # of unique children. V. cholerae not detected at any phase.  † Not detected , ‡ mean (SD) 
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The intervention had no effect on the prevalence of the primary outcome in adjusted or 
unadjusted analyses at the 12-month follow-up phase (aRR 1.08, 95% CI: 0.99-1.18). The 
intervention also had no measurable effect at 12-months on risk of infection with any of 
the three pathogen types (bacterial, protozoan, viral) or on any individual pathogen tested 
by the GPP (Table 7). While the results of the analysis of protozoan pathogens were 
driven by a single, highly prevalent pathogen, Giardia, numerous bacterial pathogens 
contributed to results of the bacterial analysis, with all targets but V. cholerae detected, 
and four bacterial pathogens detected in >5% of samples. The intervention did not affect 
the risk of coinfection. The results of the 12-month bacterial and protozoan analyses were 
similar in magnitude and direction to one another. Conversely, the measure of effect for 
viral targets, though not significant, went in the opposite direction (RR, aRR <1) of the 
bacterial and protozoan measures (RR, aRR>1). The results of adjusted analyses were 
largely consistent with unadjusted results at 12-month.   
At 24-months, the intervention had no effect on the primary outcome, or any of the 
individual pathogens or pathogen types. For most pathogen outcomes, estimates of 
intervention effect at 24-months decreased in magnitude and were subsequently closer to 
the null value (RR, aRR = 1) than at the 12-month analysis. In some instances, the 
direction of the effect estimate varied between the 12-month and 24-month phases (Table 
7).   
Results from the combined follow-up analysis (including observations from both the 12-
month and 24-month phases) were largely consistent with results from the individual 12-
and 24-month analyses. We did not observe the intervention to have a measurable effect 
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on the risk of the primary outcome, any pathogen group, or any individual pathogen 
target (Table 7). Results from adjusted and unadjusted analyses were similar. We could 
not calculate effect estimates at any phase for Y. pestis, E. histolytica, or rotavirus due to 
sparse data. 
The intervention had no measurable effect on the risk of reported diarrhea after 12-
months or 24-months of intervention exposure when phase results were analyzed 
separately or combined into a single follow-up phase. The adjusted and unadjusted 
analyses yielded similar results. As observed with the pathogen results, the magnitude of 
the effect estimate was smaller at 24-months than at 12-months and changed direction. 
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Table 7: Effect of intervention on enteric infection and reported diarrhea in all enrolled children at 12-months, and 24-months and 
with follow-up data combined.  
 12-month 24-month Follow-up combined 












Primary outcome 1.08          
(0.99-1.17) 
1.08          
(0.99-1.18) 
1.03          
(0.95-1.11) 
1.02          
(0.94-1.11) 
1.05          
(0.98-1.13) 
1.05          
(0.97-1.13) 
Bacterial 1.08          
(0.96-1.21) 
1.09          
(0.97-1.23) 
1.00          
(0.89-1.11) 
0.99          
(0.87-1.12) 
1.03          
(0.94-1.14) 
1.04          
(0.94-1.16) 
Shigella 1.12          
(0.91-1.39) 
1.14          
(0.94-1.39) 
0.97          
(0.79-1.19) 
0.96          
(0.79-1.16) 
1.04          
(0.86-1.26) 
1.04          
(0.88-1.24) 
ETEC 1.02          
(0.74-1.41) 
1.05          
(0.75-1.46) 
0.98          
(0.69-1.39) 
0.87          
(0.60-1.26) 
1.00          
(0.74-1.36) 
0.96          
(0.71-1.32) 
Salmonella 1.18          
(0.77-1.81) 
1.22          
(0.79-1.89) 
1.11          
(0.72-1.71) 
1.18          
(0.74-1.88) 
1.15          
(0.80-1.65) 
1.22          
(0.84-1.77) 
Campylobacter 1.70          
(0.84-3.45) 
1.52          
(0.72-3.21) 
1.18          
(0.58-2.38) 
1.23          
(0.56-2.70) 
1.38          
(0.73-2.60) 
1.34          
(0.68-2.65) 
C. difficile 1.64          
(0.60-4.50) 
1.76          
(0.64-4.88) 
1.24          
(0.44-3.54) 
1.49          
(0.49-4.57) 
1.43          
(0.62-3.33) 
1.63          
(0.69-3.85) 
STEC 0.25          
(0.05-1.11) 
0.25          
(0.06-1.13) 
0.33          
(0.08-1.35) 
0.28          
(0.07-1.13) 
0.30          
(0.08-1.10) 
0.28          
(0.08-1.00) 
E. coli O157 0.62          
(0.23-1.65) 
0.60          
(0.23-1.54) 
0.39          
(0.13-1.17) 
0.62          
(0.19-2.05) 
0.47          
(0.19-1.18) 
0.60          
(0.24-1.49) 
Yersinia -† - - - - - 
Protozoan 1.06          
(0.88-1.27) 
1.03          
(0.87-1.23) 
0.92          
(0.77-1.10) 
0.93          
(0.78-1.12) 
0.98          
(0.83-1.15) 
0.98          
(0.84-1.15) 
Giardia 1.08          
(0.90-1.30) 
1.06          
(0.89-1.26) 
0.95          
(0.80-1.14) 
0.97          
(0.82-1.16) 
1.01          
(0.85-1.19) 




Table 7 (continued). 
Cryptosporidium 0.75          
(0.19-2.86) 
0.87          
(0.22-3.35) 
0.47          
(0.11-1.95) 
0.47          
(0.10-2.15) 
0.54          
(0.17-1.75) 
0.59          
(0.18-1.96) 
E. histolytica - - - - - - 
Viral 0.71          
(0.41-1.22) 
0.68          
(0.39-1.15) 
0.97          
(0.55-1.70) 
1.07          
(0.57-1.98) 
0.84          
(0.52-1.35) 
0.86          
(0.53-1.39) 
Norovirus GI/GII 0.62          
(0.33-1.16) 
0.57          
(0.30-1.06) 
1.02          
(0.53-1.96) 
1.05          
(0.52-2.14) 
0.81          
(0.46-1.42) 
0.78          
(0.44-1.39) 
Adenovirus 40/41 1.79          
(0.42-7.63) 
1.58          
(0.38-6.57) 
1.19          
(0.24-6.02) 
1.38          
(0.22-8.83) 
1.49          
(0.42-5.34) 
1.54          
(0.42-5.64) 
Rotavirus A - - - - - - 
Coinfection 1.10          
(0.94-1.28) 
1.09          
(0.94-1.28) 
0.96          
(0.83-1.12) 
0.97          
(0.83-1.14) 
1.02          
(0.89-1.17) 
1.03          
(0.90-1.19) 
Number of infections 1.06          
(0.93-1.20) 
1.06          
(0.94-1.19) 
0.94          
(0.83-1.07) 
0.95          
(0.84-1.08) 
0.99          
(0.89-1.11) 
1.01          
(0.90-1.12) 
Reported diarrhea 1.43          
(0.81-2.53) 
n=1287 (1847) 
1.36          
(0.77-2.39) 
n=1253 (1812) 
0.93          
(0.56-1.56) 
n=1358  (1779) 
0.93          
(0.55-1.57) 
n=1318 (1773) 
1.15          
(0.73-1.82) 
n=1516 (2646) 
1.13          
(0.71-1.8) 
n=1471 (2594) 
Results presented as risk ratios (95% CI) unless specified, n= # unique children included in analysis (# unique stools included in analysis or # of unique data 
points in the case of reported diarrhea), V. cholerae not detected in any samples and excluded from analysis, †Could not be calculated due to sparse data 
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Sub-group analysis: impact of intervention on children available at 2 (or more) phases 
We performed a sub-group analysis to evaluate the impact of the intervention on children 
who were enrolled during the baseline phase, remained in the study through the 12-month 
or 24-month phase, and provided a stool specimen (or reported diarrhea data) at baseline 
and at least one follow-up phase. The sample sizes for these analyses were 61-75% 
smaller than the comparable main analyses given the additional inclusion restrictions and 
high rate of loss to follow-up observed in our study population. 
The results of these sub-group analyses were consistent with results from the main 
analyses: we found no evidence of an effect of the intervention on the prevalence of the 
primary outcome after 12-months of exposure or after 24-months of exposure (Table 8). 
We also found no effect of the intervention on the primary outcome when we combined 
observations from the 12-month and 24-month phases. Results for pathogen groups and 
individual pathogens were largely similar to results from the main analysis and 
demonstrated no measurable intervention effects. Effect estimates for Campylobacter, C. 
difficile, STEC, E. coli O157, Cryptosporidium, and adenovirus 40/41 could not be 
precisely estimated due to low prevalence coupled with the reduced samples size 
included in the sub-group analysis. Similar to results from the main analysis, we observed 
the magnitude of RR and aRRs were often smaller in the 24-month analysis than the 12-
month analysis. We also found no impact of the intervention on the occurrence of 





Table 8: Effect of intervention on enteric infection and reported diarrhea in children with stools or reported diarrhea data collected at 2 
or more phases (including baseline) at 12-months, and 24-months and combined follow-up data.  
 12-month 24-month Follow-up combined 












Primary outcome 1.08          
(0.97-1.19) 
1.07          
(0.96-1.19) 
1.02          
(0.92-1.12) 
1.03          
(0.92-1.15) 
1.05          
(0.97-1.15) 
1.08          
(0.98-1.19) 
Bacterial 1.04          
(0.90-1.20) 
1.06          
(0.91-1.23) 
0.99          
(0.86-1.13) 
1.00          
(0.85-1.16) 
1.01          
(0.90-1.14) 
1.06          
(0.93-1.21) 
Shigella 1.09          
(0.86-1.38) 
1.15          
(0.90-1.46) 
0.94          
(0.72-1.23) 
1.12          
(0.83-1.50) 
1.03          
(0.84-1.28) 
1.15          
(0.92-1.45) 
ETEC 0.98          
(0.65-1.47) 
1.02          
(0.66-1.57) 
0.91          
(0.55-1.49) 
0.94          
(0.55-1.61) 
0.94          
(0.64-1.38) 
1.04          
(0.70-1.56) 
Salmonella 1.59          
(0.88-2.90) 
1.55          
(0.83-2.91) 
1.16          
(0.54-2.48) 
1.21          
(0.51-2.86) 
1.35          
(0.80-2.25) 
1.45          
(0.84-2.51) 
Campylobacter‡ 1.37          
(0.52-3.60) 
1.20          
(0.41-3.52) 
1.34          
(0.50-3.57) 
1.72          
(0.61-4.88) 
1.40          
(0.61-3.20) 
1.37          
(0.55-3.43) 
C. difficile‡ 1.88          
(0.32-11.1) 
2.28          
(0.28-18.4) 
0.28          
(0.03-2.95) 
0.19          
(0.02-2.24) 
1.00          
(0.23-4.44) 
1.18          
(0.23-6.04) 
STEC‡ 0.27          
(0.03-2.11) 
0.35          
(0.04-2.83) 
0.85          
(0.08-8.83) 
2.29          
(0.15-35.0) 
0.44          
(0.09-2.22) 
0.43          
(0.07-2.8) 
E. coli O157‡ 0.84          
(0.28-2.53) 
1.95          
(0.46-8.30) 
0.69          
(0.14-3.4) 
0.80          
(0.14-4.51) 
0.59          
(0.20-1.72) 
1.37          
(0.39-4.79) 
Yersinia † - - - - - - 
Protozoan 1.18          
(0.94-1.48) 
1.17          
(0.94-1.47) 
0.94          
(0.74-1.2) 
1.02          
(0.79-1.31) 
1.1            
(0.90-1.34) 
1.13          
(0.92-1.39) 
Giardia 1.16          
(0.92-1.46) 
1.15          
(0.92-1.45) 
0.94          
(0.74-1.19) 
1.04          
(0.81-1.33) 
1.09          
(0.89-1.34) 




Table 8 (continued). 
Cryptosporidium1 1.75          
(0.26-11.6) 
3.50          
(0.33-37.28) 
0.57          
(0.06-5.38) 
0.24          
(0.02-2.81) 
0.99          
(0.20-4.83) 
1.29          
(0.26-6.40) 
E. histolytica † - - - - - - 
Viral 0.79          
(0.39-1.63) 
0.82          
(0.39-1.76) 
0.89          
(0.39-2.02) 
0.69          
(0.27-1.74) 
0.76          
(0.41-1.41) 
0.75          
(0.39-1.46) 
Norovirus GI/GII 0.61          
(0.27-1.39) 
0.68          
(0.28-1.62) 
0.68          
(0.27-1.74) 
0.41          
(0.14-1.22) 
0.60          
(0.29-1.22) 
0.55          
(0.25-1.22) 
Adenovirus 40/411 3.56          
(0.46-27.3) 
2.23          
(0.27-18.5) 
6.11          
(0.48-78.2) 
5.15          
(0.38-69.3) 
3.71          
(0.62-22.2) 
3.18          
(0.56-18.1) 
Rotavirus A † - - - - - - 
Coinfection 1.15          
(0.94-1.40) 
1.15          
(0.94-1.39) 
0.98          
(0.80-1.19) 
1.03          
(0.84-1.27) 
1.07          
(0.90-1.26) 
1.13          
(0.95-1.35) 
Number of infections 1.13          
(0.97-1.31) 
1.15          
(0.99-1.34) 
0.97          
(0.82-1.14) 
1.01          
(0.84-1.21) 
1.05          
(0.91-1.2) 
1.14          
(0.99-1.31) 
Reported diarrhea 1.71          
(0.78-3.78) n= 
560 (1120) 
1.78          
(0.82-3.90) 
 n=559 (1118) 
0.76          
(0.35-1.65) 
n=421 (842) 
0.73          
(0.33-1.58)  
n=415 (830) 
1.18          
(0.64-2.18)  
n=643 (1624) 
1.21          
(0.63-2.34)  
n=562 (1460) 
Results presented as risk ratios (95% CI) unless specified. n= # of unique children (# of unique samples assayed), V. cholerae not detected in any samples and 
excluded from analysis. ‡Effect estimate(s) imprecise due to low prevalence,  † Could not be calculated due to sparse data 
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Sub-group analysis: impact of the intervention on children born into the study 
To assess the effect of the intervention on children who had spent their entire lives 
exposed to the intervention, we performed a sub-group analysis which compared the 
prevalence of infection and reported diarrhea in children born into study compounds after 
the baseline visit (controls) or after the intervention latrine was opened for use with 
children of a similar age at baseline. For example, children born into the study population 
after the baseline visit and less than one year old at the time of the 12-month visit were 
compared with children who were less than one year of age at baseline; children born into 
the study and less than two years old by the 24-month visit were compared with children 
less than two years old at baseline. Because the analysis inclusion criteria drastically 
reduced the available sample size, we could not precisely model effect estimates for 
individual pathogen targets in the 12-month analysis. Effect estimates for pathogens with 
low prevalence (Campylobacter, C. difficile, STEC, E. coli O157, Cryptosporidium, and 
adenovirus 40/41) remained imprecise in the 24-month and combined analyses.  
The 12-month analysis included 103 (55 intervention, 48 control) children born into the 
study after baseline and 211 (100 intervention, 111 control) children of a comparable age 
at baseline (<1 year old). The intervention did not have a measurable effect on any of the 
infection outcomes in children born into the study before the 12-month visit (Table 9). 
The confidence intervals of our effect estimates were wide due to the small sample size 
and may have masked our ability to detect an effect.  
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Table 9: Effect of intervention on enteric infection and reported diarrhea in children born after baseline (compared to children of 
similar age at baseline) at 12-months, and 24-months and combined follow-up data.  
 12-month 24-month Follow-up combined 
 RR, n=314          
(314) 
aRR, n=308         
(308) 
RR, n=647          
(647) 
aRR, n=619         
(619) 
RR, n=691          
(750) 
aRR, n=673         
(722) 
Primary outcome 1.16          
(0.84-1.62) 
1.29          
(0.94-1.79) 
1.06          
(0.88-1.28) 
1.06          
(0.88-1.29) 
1.09          
(0.90-1.3) 
1.09          
(0.91-1.31) 
Bacterial 1.26          
(0.87-1.82) 
1.38          
(0.96-2) 
0.97          
(0.76-1.23) 
0.98          
(0.77-1.27) 
1.05          
(0.85-1.31) 
1.08          
(0.86-1.35) 
Shigella 1.22          
(0.32-4.69) 
1.38          
(0.36-5.3) 
0.49          
(0.28-0.86) 
0.53          
(0.29-0.95) 
0.62          
(0.37-1.03) 
0.69          
(0.41-1.16) 
ETEC 0.95          
(0.39-2.27) 
1.03          
(0.42-2.51) 
0.92          
(0.51-1.67) 
0.86          
(0.48-1.55) 
0.93          
(0.54-1.61) 
0.89          
(0.52-1.51) 
Salmonella 1.47          
(0.74-2.92) 
1.64          
(0.81-3.35) 
1.50          
(0.81-2.76) 
1.67          
(0.90-3.10) 
1.43          
(0.86-2.37) 
1.52          
(0.91-2.53) 
Campylobacter ‡ 2.14          
(0.46-10) 
3.13          
(0.67-14.5) 
1.94          
(0.69-5.46)  
1.97          
(0.69-5.66)  
1.88          
(0.73-4.80)  
1.88          
(0.72-4.91) 
C. difficile‡ 1.36          
(0.42-4.42) 
1.42          
(0.44-4.52) 
1.30          
(0.36-4.78)  
1.43          
(0.39-5.23)  
1.47          
(0.57-3.77)  
1.45          
(0.56-3.73)  
STEC ‡ -† -† 0.11          
(0.01-1.79) 
0.10          
(0.01-1.66)  
0.20          
(0.02-2.18) 
0.19          
(0.02-2.17)  
E. coli O157‡ 7.37          
(0.42-130) 
-† 0.44          
(0.05-3.61)  
0.49          
(0.06-3.9) 
0.43          
(0.05-3.51) 
0.44          
(0.06-3.51) 
Yersinia† - - - - - - 
Protozoan 0.41          
(0.12-1.43) 
0.57          
(0.16-2.03) 
0.85          
(0.56-1.30) 
0.88          
(0.59-1.32) 
0.82          
(0.54-1.24) 
0.86          
(0.57-1.29) 
Giardia 0.50          
(0.14-1.82) 
0.72          
(0.19-2.71) 
0.85          
(0.56-1.30) 
0.97          
(0.64-1.46) 
0.91          
(0.59-1.39) 




Table 9 (continued). 
Cryptosporidium‡ 0.12          
(0.01-2.5) 
0.24          
(0.01-5.26) 
0.44          
(0.08-2.53) 1 
0.45          
(0.08-2.53) 1 
0.40          
(0.08-1.95)  
0.40          
(0.08-1.99) 1 
E. histolytica† - - - - - - 
Viral 0.42          
(0.15-1.17) 
0.45          
(0.16-1.22) 
0.89          
(0.40-1.94) 
0.91          
(0.41-2.03) 
0.72          
(0.38-1.38) 
0.72          
(0.38-1.38) 
Norovirus GI/GII‡ 0.59          
(0.19-1.9) 
0.57          
(0.18-1.81) 
1.34          
(0.53-3.41) 
1.30          
(0.51-3.31) 
1.07          
(0.49-2.35) 
1.03          
(0.47-2.25) 
Adenovirus 40/41‡ 0.56          
(0.06-5.03) 
0.84          
(0.08-8.75) 
-† -† 0.20          
(0.03-1.32)  
0.17          
(0.02-1.18)  
Rotavirus A† - - - - - - 
Coinfection 0.83          
(0.46-1.51) 
1.04          
(0.59-1.84) 
0.86          
(0.61-1.22) 
0.88          
(0.62-1.25) 
0.89          
(0.65-1.22) 
0.91          
(0.66-1.25) 
Number of infections 0.90          
(0.61-1.32) 
1.04          
(0.71-1.5) 
0.91          (0.7-
1.17) 
0.93          
(0.72-1.19) 
0.91          
(0.73-1.14) 
0.93          
(0.75-1.16) 
Reported diarrhea 0.33                 
(-0.74-1.41) 
n=382 (382) 
1.51          
(0.53-4.3)  
n=377 (377) 
1.20          
(0.57-2.55)  
n=733 (733) 
1.33          
(0.60-2.96)  
n=716 (716) 
1.26          
(0.65-2.43)  
n=798 (852) 
1.37          
(0.69-2.72) 
n=781 (835) 
Results presented as risk ratios (95% CI) unless specified, n=# of unique children (# of unique stools or reported diarrhea data points), V. cholerae not detected in 
any samples and excluded from analysis, ‡Effect estimate(s) imprecise due to low prevalence,  † Could not be calculated due to sparse data
85 
 
The sample size for the 24-month sub-group analysis was larger than the sample size in 
the 12-month analysis and included 215 (108 intervention, 107 control) children who had 
been born into the study after the intervention was open for use (or after the baseline visit 
in case of controls) but before the 24-months visit and 432 (201 intervention, 231 control) 
children in the baseline comparison group (<2 years old at 24-month visit). The 
intervention had no effect on the primary outcome in children <2 years old who had been 
born into a compound with an intervention latrine but did reduce the risk of Shigella 
infection by almost 50% (aRR 0.53, 95% CI: 0.29-0.95) (Table 9). The intervention had 
no other measurable effects on infection outcomes in the 24-month sub-group analysis. 
We also observed no effect of the intervention on infection outcomes in the 12- and 24-
month combined analysis. The intervention had no effect on caregiver reported diarrhea 







We found little evidence that the intervention, hygienic privately shared pour-flush 
latrines to septic tanks, reduced the risk of enteric infection or caregiver reported diarrhea 
in children less than 6 years old (<4 at baseline + 24-month of follow-up) living in the 
low-income, unplanned neighborhoods of Maputo, Mozambique. Evidence of the effect 
of sanitation on health is mixed and may be influenced by study setting, study design, 
intervention infrastructure, and choice of outcome measure among other factors. Findings 
from previous studies of urban sanitation improvements have largely demonstrated health 
gains (26,115–117). A non-randomized before-and-after study (without a concurrent 
control group) of health benefits related to the expansion of the sewerage network in 
Salvador, Brazil demonstrated reductions in reported-diarrhea (21% reduction) and in the 
prevalence of objective health outcomes like Giardia, T. trichiura, and Ascaris, which 
were all reduced by 50 – 72% (115,117). These results aren’t anomalous within the urban 
sanitation literature: two meta-analyses have found that connections to sewerage can 
result in diarrhea reductions of 25-60% depending on starting conditions (26,31). There 
are many reasons our findings are inconsistent with much of the urban sanitation 
literature to date, with the most important being the type of sanitation technology 
evaluated: MapSan is the first health impact evaluation of an on-site sanitation system in 
an urban setting. Evidence from recent large-scale, rigorous health impact trails of on-site 
sanitation interventions in rural areas is mixed with most trials demonstrating modest 
effects or no effects on primary health outcomes (32–37). Recent sanitation trials have 
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focused on using linear growth (32,33,37)– a more distal measure than enteric infection 
on the causal chain from exposure to outcome – or reported diarrhea as the primary 
health outcome (32–36). Only two studies found the sanitation intervention to have a 
measurable effect on a reported diarrhea (33) or linear growth (36). A subset of these 
studies have also published results of enteric infection as secondary outcomes and the 
evidence demonstrates no clear trend across study sites. A trial of combined and 
independent effects of WASH interventions (including on-site sanitation) in rural 
Bangladesh, the same trial that found reductions in diarrhea due to the intervention, found 
that the sanitation intervention reduced prevalence of Giardia and soil-transmitted 
helminth (STH) T. trichiura by 25% and 29%, respectively (38,39) but its sister study in 
Kenya only found reductions in Ascaris (and no other pathogens) when sanitation was a 
component of broader combined WASH intervention (40). A similar study performed in 
Zimbabwe found a combined WASH and nutrition intervention reduced the prevalence of 
Giardia by 10 percentage points, but the effect was absent in the WASH-only 
intervention arm (41). Two large scale sanitation trials in India found no effect on 
infection with Giardia, Cryptosporidium, E. histolytica, or on several STH (34,35). The 
mixed nature of the evidence suggests that measurable health benefits cannot be assumed, 
at least in the short term, following sanitation improvements and that the health effect of 
sanitation interventions is likely highly context specific and dependent on baseline levels 
of fecal contamination, sanitation coverage, the burden and types of endemic enteric 
infection, pathways of transmission, setting specific WASH behaviors and practices, and 
choice of sanitation technology (42). 
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While we found no effect of the intervention on our pre-specified primary outcome, the 
intervention substantially reduced the risk of Shigella infection in children born into the 
study by the 24-month follow-up visit. Studying children born into intervention sites after 
the intervention was implemented allowed us to isolate the effect of the intervention on a 
naïve gut during the critical first two years of life. While exploratory, this result may 
suggest that the intervention delays exposure and the accumulation of enteric infection 
during early childhood. It is important to note that this, and other sub-group analyses of 
individual pathogens, were exploratory in nature and as such we did not correct for 
multiple comparisons. Therefore, it is possible that the effect observed on Shigella is 
specious and due to type I error.   
We were unable to estimate the effect of the intervention on several enteric pathogens 
due to their low prevalence. Of note, rotavirus A was detected too infrequently (<1% of 
samples) to be included in individual pathogen analyses. This result is surprising given 
that rotavirus has been implicated as one of the main etiologic agents of diarrheal disease 
in young children in LMICs (43), even in settings as geographically close to our study as 
the nearby rural province of Manhiça, Mozambique (44). It is unlikely that our low 
detection frequencies were a result of the rotavirus vaccine, as it was not added to the 
national immunization schedule of Mozambique until September 2015, approximately 
half way through our baseline phase. Therefore, we would only expect a subset of study 
population, specifically those born around or after September 2015, to be affected. It is 
also unlikely that our results are due to measurement error as we verified a subset (8 
positive for rotavius, 84 negative rotavirus as determined by GPP) using an in-vitro 
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diagnostic ELISA assay (Premier Rotaclone, Meridian Bioscience, Cincinnati, OH, 
USA). The observed variation in prevalence may suggest substantial variability in 
endemicity even across short distances.  
There are several reasons we may not have detected an effect of the intervention on 
enteric infection or self-reported diarrhea. The trial was originally powered to detect an 
effect based on a prospective longitudinal cohort design. One advantage of such designs 
is increased statistical efficiency that results from taking multiple measurements on the 
same participants over time. While we exceeded the original enrollment numbers detailed 
in our sample size calculations (345 per arm) because of progressive enrollment 
throughout the study, due to the greater than expected losses to follow-up we were not 
able to follow all children enrolled at baseline through time as expected. The potential 
reduction in statistical efficiency resulting from losses to follow-up and the subsequent 
necessity to treat measurements as repeated cross-sectional may have masked our ability 
to detect small effects. We simulated the original analysis, albeit with a smaller sample 
size than originally expected, by running a sub-group analysis that analyzed only children 
with data and stool collected at two or more time-points (including baseline). Results 
from this sub-group analysis demonstrated no intervention effect on any health outcome.  
We do not expect that our null effect finding was driven by a lack of use because the 
original pre-intervention latrine was removed, and we expect there to be minimal 
behavior change required to shift from using latrines in poor condition to the intervention 
latrines. Forthcoming research on the intervention fidelity and use will formally address 
this question. It is possible that in this setting, where fecal contamination was pervasive 
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and infection burden was high, that even considerable reductions in contamination and 
exposure due to the intervention would not have been sufficient to realize measurable 
health gains (118). Further, the intervention may not have addressed all important 
compound-level pathways of enteric pathogen transmission in this setting (7). The 
intervention did not specifically address of child feces disposal practices – which can be 
an important source of contamination, exposure, and health risk (113,129–132)- and it is 
unlikely the intervention infrastructure would have changed these behaviors and 
practices. The intervention would not have limited exposures occurring via consumption 
of contaminated food, which has been demonstrated as a dominant transmission route for 
enteric pathogens in some settings (7). Finally, the intervention did not address potential 
exposure to zoonotic pathogens present in animal feces. The frequent interaction of 
children with animal feces has been documented in similar settings and could be an 
important, unmitigated source of exposure to enteric pathogens in both intervention and 
control arms where animals were frequently observed (133,134).  
We hypothesized that the majority of exposures young children experienced in this 
setting occurred at the compound level (135,136) as that is where young children spent 
the majority of their time and compounds were typically sounded with walls – limiting 
exploratory behavior outside of the compound. However, exposures occurring outside of 
the compound could have influenced health outcomes. The transience of the study 
population meant that familial trips back and forth to provinces outside of Maputo, where 
exposures were varied and unmeasured, were common. Additionally, as allocation of the 
intervention was done at the compound level and intervention sites were interspersed 
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throughout the 11 study neighborhoods, it’s possible that sources of contamination 
originating outside of an intervention compound’s boundaries, such as a neighbor’s 
overflowing pit latrine, could have impacted study compounds and nullified any health 
gain triggered by the intervention. Communities may need to reach a certain level of 
sanitation coverage before real health gains are achieved (137). Future spatial analyses of 
this data will examine the role of sanitation coverage and “spill-over” contamination from 
the surrounding environment. 
 Strengths and limitations 
There are several important limitations of this study. First, as the intervention was pre-
planned by an independent non-governmental organization, WSUP, we could not 
randomize its allocation and therefore could not use a randomized controlled trial, the 
gold standard study design for drawing causal inferences, to evaluate the intervention 
effect. Because of this, the differences we observed between arms at baseline cannot be 
attributed to randomness and must be evaluated as potential confounders. While none of 
the variables that were imbalanced between intervention and control at baseline met our 
criteria for inclusion as covariates in multivariable models, our study has a higher risk of 
being affected by residual confounding bias (innate, unmeasured differences between the 
intervention and control groups) than in a randomized design. To address this, we use a 
difference-in-difference regression analysis which accounts for baseline values of our 
outcome measures. Adjusting for baseline outcome measurements is often the most 
effective method of controlling for potential confounding caused by baseline imbalance 
between the study arms (68,138). One of the key assumptions to ensure the validity of 
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DID analysis is the parallel trend assumption which asserts that any trend in outcome 
measures between intervention and control arms should be constant in the absence of the 
intervention or treatment. While this assumption cannot be proven, we can assess its 
plausibility using “placebo tests” whereby we rerun analyses using a variable expected to 
be unaffected by the intervention as the outcome metric (139). Any such analysis should 
show no effect of the intervention on the chosen outcome. For example, using the sex of 
enrolled children as the study outcome demonstrates that the intervention has no effect on 
the proportion of children recorded as female. Similarly, the intervention does not affect 
the proportion of respondents who report being the mother of an enrolled child when 
tested as a placebo outcome. We find similar results when using several different 
variables as placebo study outcomes, strengthening the plausibility of the parallel trend 
assumption and the validity of the DID approach in general. Because we did not collect 
multiple pre-intervention data points, we are unable to further assess the parallel trend 
assumption by comparing pre-intervention trends in study outcome metrics.  
Second, while it was not possible to mask participants as to their intervention status, our 
use of an objectively measured health metric, enteric infection, as our primary study 
outcome eliminated the risk of courtesy and recall bias in our main outcome measure 
(118,140). Both types of respondent bias posed threats to the validity of our reported 
diarrhea outcome measure. To reduce the risk of courtesy bias, our team of field 
enumerators was different from WSUP’s implementation team, and respondents were not 
informed explicitly that the MapSan study team was evaluating the health effect of the 
WSUP sanitation intervention. To limit the effect of recall bias, we used a 7-day recall 
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period, which has been demonstrated as superior, for this reason, to 14-day measures 
(70).  
Third, because of the higher than expected turnover rates in our study population, we 
modified our original analysis plan and treated our data as repeated cross-sectional 
measurements. We performed the originally planned prospective cohort analysis as a sub-
group analysis. This change may have affected the statistical efficiency of our analysis 
(141). The population movement into and out of the cohort also could have introduced 
bias into our effect estimates if it differentially affected the control and intervention arms 
in a meaningful way. Comparisons of characteristics of children who were present for 
multiple phases of data collection with children lost to follow-up and children enrolled 
after baseline demonstrated some degree of differential (non) response bias between 
study arms. Our two time-point sub-group analysis, which also served as a simulation of 
pre-specified analysis plan, provided the basis for a sensitivity analysis to estimate the 
impact of population churn on our effect estimates. Results from the main analysis and 
the sub-group analysis were similar making it less likely that population churn affected 
the study results. An additional exploratory analysis that uses inverse probability 
weighting techniques to adjust for imbalances caused by changes to the study population 
may be advisable to further interrogate the impact these changes could have on our effect 
estimates (141).  
Fourth, while molecular detection of enteric pathogens in stool is evidence that a child 
was, at some point, exposed to that pathogen, it does not necessarily indicate active 
infection, complicating the use of pathogen detection as a health indicator. Pathogen 
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detection could represent previous symptomatic or asymptomatic infection, pathogen 
carriage or colonization, or simply passage of the pathogen through the gastrointestinal 
tract following exposure. However, the GPP was designed specifically to aid in diagnosis 
of enteric infection and its relatively high limits of detection exceed estimated infectious 
doses of most pathogens, increasing the likelihood that pathogen detections in this study 
represent past or present active infections. Because of the high limits of detection, it is 
important to note that absence of detection does not indicate absence of exposure. While 
enteric infection is a more proximate outcome to fecal contamination exposure than many 
other commonly measured health outcomes in WASH impact trials, such as growth, its 
clinical significance is less clear. Recent studies, including this one, have observed high 
levels of asymptomatic infection, or infection which is not accompanied by typical 
symptoms of diarrheal disease (43,46,128). Further, our repeated cross-sectional 
qualitative measures of enteric infection do not provide information on the duration or 
intensity of infection, making it unclear whether repeated detection of a pathogen 
represented clearance and re-infection or persistent infection or carriage. Giardia, one of 
the most common pathogens we detected at baseline and follow-up phases, can cause 
persistent infection lasting months (101,142). The GPP detects 15 enteric pathogens, 
including many implicated as the main causes of childhood diarrhea in LMICs in recent 
studies (43,46), however, it does not detect all enteric pathogens of potential importance 
and our results cannot be considered a comprehensive accounting of infection burden. 
Further, while several studies have shown good specificity of the GPP for detection of 
most targets included in the assay (76,78,79,82,84,143), there have been a few recent 
studies that demonstrate higher than expected false positive detection rate for the 
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Salmonella molecular targets (80,144). In response to these studies, Luminex, the 
manufacturer of the GPP, has recently amended the criterion (median fluorescence 
intensity thresholds) for determining Salmonella detections. The results presented here 
use the original version of the criterion and a future reanalysis of results that uses the 
updated criterion or excludes Salmonella from the primary outcome definition would be 
prudent. 
Fifth, we had limited ability to comprehensively evaluate the impact of seasonality or 
weather-related trends, which have demonstrated associations with diarrheal disease risk 
in the literature (145,146), on our effect estimates. Mozambique typically experiences a 
rainy season lasting from November and March during which time flooding can be 
common, especially in the low-income, densely populated urban neighborhoods where 
drainage infrastructure is poor. However, rainfall during the 2015/2016 rainy season, 
which occurred during baseline data collection, was far below average leading to 
widespread drought (147,148). Because of this, we were unable to fully evaluate whether 
the effect of the intervention may be modified by the rainfall or flooding typical of a 
rainy season in Mozambique. We did assess cumulative 30-day rainfall as a potential 
confounder in multivariable models but excluded it as it did not meet our criteria for 
inclusion in final adjusted models.     
Finally, results from this study may not be generalizable outside of the study setting. The 
effectiveness (or lack thereof) of the intervention could be impacted by the specific 
assortment of pathogens circulating in the community or region, the WASH-specific 
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behaviors, practices and customs of the local population, the pre-existing or planned level 
of sanitation coverage, and the local population density (2).  
While our results demonstrate that access to hygienic, privately shared onsite sanitation 
systems do not reduce enteric infection in young children in this setting, future analyses 
of soil-transmitted helminth infections, environmental enteric dysfunction (Chapter 4) 
and malnutrition will explore further potential health impacts of the intervention. 
Additionally, results from our analysis of children born into intervention sites, which 
demonstrated a substantial reduction in the risk of Shigella infection, suggest that any 
health impact of the intervention may require greater than two years post-implementation 
to be realized, or may require protection from birth to delay key infections.  
The need for effective sanitation solutions may be most urgent in densely populated, low-
income, unplanned communities like our study setting where almost ubiquitous fecal 
contamination drives extraordinarily high infection burdens. Unsurprisingly, pathogen 
transmission in these settings may be very complex and is likely driven by multiple 
interrelated pathways. While decades of sanitation and health research have demonstrated 
meaningful health gains following improvements in sanitation, the results of this study, 
and many of the recent large-scale, rigorous trials of sanitation interventions, suggest that 
that relationship between sanitation and health is complicated, difficult to measure, and 
may not be generalizable across diverse settings and populations. Further, in settings 
similar to our study sites, where sanitary conditions are poor and infection burden is high, 
more comprehensive WASH interventions that achieve higher coverage levels may be 




ASSESSMENT OF THE IMPACT OF AN ON-SITE SHARED SANITATION 
INTERVENTION ON MARKERS OF ENVIRONMENTAL ENTERIC 









The relationship between fecal contamination exposure and long-term health and well-
being effects like stunting and cognitive deficiencies may be mediated, in part, by 
environmental enteric dysfunction (EED). EED is a subclinical disorder affecting the 
structure and function of the gut and believed to result from frequent and persistent 
enteric infection. We aimed to understand if access to new hygienic shared latrine 
infrastructure affected the concentration of biomarkers of intestinal inflammation and 
permeability in the stool of young children living in Maputo, Mozambique.  
Methods & findings 
The MapSan trial is an independent health impact evaluation of a privately shared on-site 
sanitation intervention (pour-flush latrines to septic tanks) in low-income, unplanned 
urban neighborhoods of Mozambique. We enrolled children <4 years old in intervention 
and control sites during the baseline (pre-intervention) phase and followed-up with them 
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12- and 24-months post-intervention. Enrollment was progressive and at each phase we 
enrolled all eligible children (children <5 years old at each post–baseline visit) and 
collected survey data and stool specimens for EED analysis. We measured the 
concentration of four biomarkers of EED in stool: alpha-1-antitrypsin, neopterin, 
myeloperoxidase, and calprotectin. Our main analyses included all enrolled children and 
sub-group analyses assessed intervention effects in children with longitudinal data 
(multiple data-points available including baseline) and children who were born into study 
sites post-intervention. We analyzed the 12- and 24-month phases separately and 
combined into a single follow-up phase. In our main analyses, the intervention increased 
the concentration of neopterin by 0.17 log10 nmol/L (95% CI: 0.07 - 0.27) by the 12-
month follow-up and had a borderline effect on MPO concentration (0.09 log10 ng/mL, 
95% CI: 0.00 - 0.18). We observed similar results in our longitudinal analysis of children 
available at both the baseline and 12-month phases. Concentrations of calprotectin (0.18 
log10 ng/mL, 95% CI: 0.02-0.35) and neopterin (0.17 nmol/L, 95% CI: 0.01, 0.33) 
increased in children born into intervention sites by the 24-month follow-up visit. The 
intervention did not a have statistically meaningful effect on the concentration of alpha-1-
antitrypsin, the only marker of intestinal permeability measured, but in contrast to the 
trend observed for markers of intestinal inflammation, the concentration of alpha-1-
antitrypsin tended to decrease following intervention handover and use. 
Conclusions 
The intervention had an inconsistent effect on the concentration of EED biomarkers after 
12- and 24-months of exposure. The etiology and pathophysiologic mechanisms 
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underlying EED have not been fully described, complicating its measurement. The lack 
of a formal case definition and of representative healthy reference concentrations for 
common EED biomarkers makes interpretation of effect estimates, especially 
interpretation of their potential clinical significance, complex. Our results highlight the 
urgency of filling these evidence gaps so we may begin designing and implementing 








Exposure to unsafe water and sanitation is a leading cause of diarrheal deaths in children 
less than five years old (16). While considerable progress has been made in reducing 
childhood death due to diarrhea since 2000 (16), measurement of diarrheal deaths, illness, 
or even disability-adjusted life years likely greatly underestimates the burden of disease 
attributable to poor water and sanitation conditions.  
Repeated exposure to enteric pathogens via contact with fecal contamination is 
hypothesized to contribute to development of environmental enteric dysfunction (EED), a 
sub-clinical disorder affecting the structure and function of the small intestine 
(15,21,22,50,58,149,150). While children and adults with EED may not exhibit overt 
symptoms, EED has been associated with several downstream health effects such as 
linear growth (59,151,152), impaired cognitive development (153,154), poor oral vaccine 
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response (155,156), and increased susceptibility to future infection (20). There is 
currently no formal case definition for EED and histopathology of the intestinal wall 
remains the gold standard for informal diagnosis (49). Given the highly invasive nature of 
biopsying the gut, non-invasive biomarkers of several of the underlying pathophysiologic 
mechanisms or domains of EED have been proposed. These include markers of intestinal 
inflammation, permeability, damage and repair, microbial translocation, and systemic 
inflammation (22). However, not all domains have been linked to health outcomes, like 
stunting, and there is some discordance between the theoretical relationship between 
domains and the evidence in the literature. EED is an important target for WASH 
intervention evaluations given potential downstream health effects and its association 
with exposure to fecal contamination and enteric pathogens. However, unresolved 
questions about its case definition and measurement can complicate interpretation of 
results.  
Few trials have measured the impact of WASH interventions on EED and no trials have 
specifically measured the impact of sanitation alone.  Two small trials estimating the 
effects of a handwashing intervention and a community-based WASH intervention on 
found no effect (157,158). A recent large -scale cluster-randomized controlled trial in 
rural Bangladesh found modest effects of an intensive combined WASH intervention on 
markers of inflammation and permeability in very young children (< 3 months old) but 
limited effects in children aged 14 and 28 months (159). To date, no rigorous health 
impact evaluations have investigated the impact of sanitation on EED in urban areas.  
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As part of the MapSan trial, a controlled before-and-after health impact evaluation of an 
onsite, privately shared sanitation intervention in urban Mozambique (2), we aimed to 
evaluate the effect of the intervention, pour-flush latrines to septic tanks shared by 2 or 








Study design and intervention 
The MapSan Trial was an independent health impact evaluation of an onsite, privately 
shared sanitation intervention in low-income, densely populated, unplanned 
neighborhoods in Nlhamankulu district of Maputo, Mozambique. We used a controlled 
before-and-after (CBA) study design to measure the effect of a non-randomized, cluster-
allocated sanitation intervention on child health. Prospective CBA studies like MapSan 
typically involve collecting data from participants in two study arms, an intervention 
group and a control group, at multiple time points before and after implementation of the 
intervention. This design enables us to estimate the effect of the intervention on outcomes 
while accounting for any secular trends in the study population over the study period 
which may affect outcome measures but be unrelated to the intervention (138). In 
MapSan, the intervention group was provided with pour-flush latrines to septic tanks and 
the control group continued using their original poor condition sanitation facilities. Data 
collection consisted of three phases – baseline (pre-intervention), 12-month follow-up, 
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and 24-month follow-up - each taking approximately one year to complete (Figures 2 & 
3). During baseline, we completed enrollment and data collection activities in 
intervention and control sites in parallel to reduce any impact seasonality may have on 
our outcome measures. All sites were revisited approximately 12 and 24 months after 
baseline (Figure 3).  
Water and Sanitation for the Urban Poor (WSUP) oversaw site selection and construction 
of intervention latrines independently of the MapSan study team. Due to the logistical 
and technical constraints of building latrine infrastructure in densely populated 
communities, intervention site selection was not random. WSUP performed site selection 
and implementation at the compound level. Compounds are groups of related or unrelated 
households which typically share outdoor living space and sanitation facilities. While 
compound-level sanitation facilities are shared by multiple households, they are not 
considered public latrines. 
WSUP constructed one of two types of latrine infrastructure depending on compound 
population - communal sanitation blocks (CSBs) and shared latrines (SLs). CSBs serve 
larger compounds and include one toilet stall for each 20 beneficiaries living in the 
compound. CSBs also include other amenities such as a shared water connection, an 
elevated tank to store water from the intermittently piped water supply, a laundry facility, 
a rainwater harvesting system, and a well-drained area for bathing (Appendix A, Figure 
A2). Shared latrines serve fewer than 20 people and are single-stall infrastructure 
(Appendix A, Figure A3). All interventions, regardless of size, utilize the same type of 
sanitation technology: pour-flush latrines to septic tanks with soak-away pits (Appendix 
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A, Figure A1). Soak-away pits facilitate the infiltration of liquid waste into the ground. 
The septic tanks for both CSBs and SL infrastructure were sized to contain approximately 
two years of waste after which time emptying would be necessary.  
Participants 
Details of intervention and control site selection and participant eligibility and 
recruitment have been described previously (Chapter 3). Briefly, children aged 29 days to 
48 months old were eligible for enrollment at baseline if they lived in a selected 
intervention or control compound and if their parents or guardians completed written 
informed consent. Intervention site selection was performed by WSUP which consulted 
with local government officials to identify potential sites for intervention. Final site 
selection was based on factors related to demographics, engineering constraints, and 
WASH conditions including use of poor sanitation, stated demand, number of 
beneficiaries, availability of a water piped water supply, location, space, and groundwater 
level. WSUP engineers completed site selection based on the above criteria and were 
charged with determining whether current sanitation conditions in prospective sites were 
considered “poor.” Specifically, engineers assessed the type, functionality, and number of 
latrines. Latrines traditionally classified as “unimproved” (e.g. pit latrines without 
concrete slabs) were designated as poor sanitation, as were technologies typically 
considered “improved” if they had fallen into disrepair or where otherwise not 
functioning as intended (e.g. leaking or clogged pour-flush latrines, cracked slabs or slabs 
covered in dirt or debris). We identified control sites using a subset of WSUP’s 
intervention selection criteria including sharing sanitation in poor condition, number of 
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beneficiaries, access to legal piped water supply, and hypothetical demand for improved 
sanitation. We attempted to identify control compounds with similar numbers of 
members as intervention compounds so that the population distribution of compounds in 
intervention and control compounds would be comparable. Control compounds must also 
have been home to at least one child less than 48 months old.  
We completed enrollment and baseline data collection progressively between February 
2015 and February 2016 as intervention latrines were constructed and scheduled for 
handover. We planned to visit intervention compounds within the two weeks prior to 
intervention handover. Due to unexpected delays in construction, we visited some 
compounds earlier than the scheduled two week window, but visited all compounds prior 
to latrine handover and use. We visited intervention and control compound at 
approximately the same rate during all three study phases to avoid the potential influence 
of seasonality on outcome measures. We scheduled intervention follow-up visits to be 12 
months (±2 weeks) and 24 months (±2 weeks) from the date of intervention use. To 
preserve similarity in visit rates between intervention and control compounds, we 
scheduled a control follow-up visit within two weeks of each intervention follow-up visit. 
Children absent during the baseline visit were eligible for enrollment at the 12-month and 
24-month visit if they resided in an intervention or control compound, if their parents or 
guardians consented to their participation, if they were between 29 days and 60 months 
old at the time of enrollment, and if they had moved into the compound more than six 
months prior to the visit or were born into the compound.  
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Participants and study enumerators were not blinded to intervention status during the 
study given the obvious visual components of the intervention. The WSUP 
implementation team and MapSan field enumerator team functioned independently and 
consisted of different individuals.  
Procedures 
Field data collection procedures have been previously described (Chapter 3). Field teams 
completed consent procedures, and completed survey data and specimen collection 
activities from eligible children at each phase.  Prior to beginning data collection 
activities, enumerators secured verbal assent from the head of the compound or his or her 
spouse. We required the parents or guardians of eligible children to provide written, 
informed consent prior to initial enrollment of the child in the study. At each subsequent 
phase, field enumerators sought verbal assent for continuation in the study.  
We used surveys to collect data on key socio-demographic factors, environmental 
conditions in the household and compound, and WASH practices and behaviors using 
questionnaires and spot-checks (Table 4).  To measure relative household socio-
economic status, we used an asset-based poverty calculator developed for and validated 
in Mozambique (75). Additional survey variables have been described previously 
(Chapter 2, Appendix B, Table B1).  
We tried to collect stool specimens from each enrolled child at each phase regardless of 
reported symptomology. Enumerators provided each caregiver with stool collection 
supplies and returned the next day to collect the specimens. If a child did not have a 
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bowel movement prior to the schedule pickup, caregivers were asked to call the field 
team as soon as the child produced a stool specimen. We provided caregivers with pre-
paid phone credit for this purpose or to request fresh collection supplies. Following 
collection, enumerators stored bulk stool specimens in coolers with cold packs and 
delivered them to the medical parasitology laboratory at the Mozambican Ministry of 
Health (MISAU/INS) within six hours. Laboratory technicians aliquoted the stools into 
up to four sterile tubes, depending on availability of material, and stored aliquots at -80°C 
until shipment. Approximately two times a year, archived stool samples were shipped on 
dry ice to the Georgia Institute of Technology in Atlanta, Georgia, USA where they were 
stored at -80°C until analysis. Each shipment included temperature probes to ensure 
continuity of the cold-chain during shipment. 
We analyzed the concentration of four biomarkers of EED in bulk stool specimens using 
commercially available enzyme-linked immunosorbent assays (ELISAs): alpha-1-
antitrypsin (AAT) (Biovendor, Karasek, Czech Republic), neopterin (NEO) (Genway, 
San Diego, CA, USA), myeloperoxidase (MPO) (ALPCO, Salem, NH, USA), and 
calprotectin (CAL) (ALPCO, Salem, NH, USA). AAT is a serum glycoprotein typically 
released during inflammatory responses (22,160). Because AAT is not synthesized in the 
gut, it is considered a marker of intestinal permeability and is a classic marker of protein-
losing enteropathies (161). Further, AAT concentration has been associated with the 
presence of certain enteric pathogens of importance such as Shigella, Campylobacter, and 
Salmonella (58,162,163) and with poor linear growth outcomes (59). NEO, MPO and 
CAL are considered markers of intestinal (local) inflammation (22). NEO is mostly 
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produced by macrophages and dendritic cells in response to activation of a 
proinflammatory (Th1) immune response (22,59,164). NEO concentration has also been 
associated with growth deficits (59,60). MPO is an enzyme contained in neutrophils (a 
type of white blood cell) and its concentration is considered proportional to the 
concentration of neutrophils in a sample (165). MPO has been proposed as a marker of 
inflammatory bowel disease (IBD) (165), has been associated with the detection of some 
enteric pathogens including Shigella, enteroinvasive E. coli, Campylobacter, and 
adenovirus (58), and has been associated with linear growth deficits in children (58,59). 
Similar to MPO, CAL is a protein associated with neutrophils and its detection in stool 
may be indicative of migration of neutrophils to the intestine as part of an inflammatory 
immune response (22,166). Concentration of fecal CAL has been proposed as a marker of 
IBD, Crohn’s disease, ulcerative colitis, and severity of diarrheal disease (166), however, 
its use may be limited by evidence that its concentration may be associated with 
breastfeeding status (22,66,167).  
All ELISA kits used for biomarker measurement, with the exception of the NEO kit, are 
sandwich ELISAs and specifically tailored for use with stool. The NEO kit uses a 
competitive assay design and is marketed for use with urine, plasma or serum but has 
been used extensively to measure NEO concentrations in stool (58,59,113,159). We 
assayed all samples according to manufacturer instructions, except where noted. Each kit 
included standards and one high concentration and one low concentration control. We 
assayed all standards and controls in duplicate and used the results of the controls to 
validate the standard curve according to the manufacturers’ instructions. We diluted 
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samples to a final dilution of 1:100 – 1:25,000 depending on the target marker. All 
samples we assayed for NEO were run in duplicate and the majority of samples we 
assayed for AAT, MPO, and CAL were run in duplicate. Due to budgetary constraints, 
between 12-16% of samples assayed for AAT, MPO, and CAL could not be tested in 
duplicate. Results from previous analyses indicated a small intra-assay coefficient of 
variation (4.6-6.6%) among sample replicates tested for AAT, MPO, and CAL. Samples 
assayed for NEO were always assayed in duplicate given the comparably higher intra-
assay coefficient of variation of 15.6%. We re-assayed any sample that produced 
duplicate results more than 15% different than their mean. We re-diluted and re-assayed 
any sample with a concentration falling outside of the bounds of the standard curve or 
below the assay limit of detection defined by the manufacturer. 
 Due to an issue with diluent availability, we used 0.9% saline instead of the kit “assay 
buffer” as the sample diluent for approximately 15% of the samples assayed for NEO. 
Previous studies of EED using the same NEO ELISA kit used saline as a sample diluent 
(59,159,168). To correct for any potential discrepancy in results due to choice of diluent, 
we compared the results from 52 stools diluted in saline and assay buffer and assayed in 
parallel. We applied a minor adjustment to the results of samples diluted in saline in 
accordance with the results of the comparison study. 
We were unable to run EED analyses for every stool specimen collected. We prioritized 
enteric pathogen analysis which meant that some samples did not have adequate material 
remaining for all four EED analyses. Similar to previous studies of fecal biomarkers of 
EED (22,58,59), we excluded liquid stools (“diaper samples”) as there is some evidence 
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that diarrheal stools may dilute EED signals resulting in artificially low concentrations 
(169). We also could not assay fecal swabs for EED biomarkers as they were used for 
enteric pathogen analysis. 
Outcomes 
We pre-specified three of the four EED biomarkers as outcomes of the MapSan trial: 
AAT, MPO, and NEO (2). In addition to the pre-specified EED biomarkers, we also 
included CAL as a study outcome. We measured all four EED biomarkers in stool 
collected from children during the baseline, 12-month, and 24-month study phases. We 
combined the results of the AAT, MPO, and NEO assays into a composite EED score 
using the equation developed by Kosek et al (59). The EED score ranges from 0 – 10 
with higher scores representing higher concentrations of the EED biomarkers.  
Statistical analysis 
Sample size calculations for the MapSan trial are described elsewhere (Chapter 3). While 
we attempted to analyze each bulk stool specimen by for all four EED measures, the 
sample size was ultimately limited by the availability of bulk stool material.  
The main analysis included data collected from all children enrolled during the study 
regardless of phase of enrollment. However, if a compound received an intervention 
latrine after the end of the baseline phase (February 2016), only data collected prior to 
handover of the latrine was eligible for inclusion. For example, if a compound received 
an intervention latrine following the 12-month visit, any data collected during the 24-
month visit is excluded from the present analysis. For the main analysis, we examine the 
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effect of the intervention at the 12-month and 24-month phases separately. As an 
exploratory analysis, we assess the effect of the intervention after combining data from 
the 12-month and 24-month visits into a single follow-up phase.  
We also perform several sub-group analyses including an analysis of children with at 
least two phases of data (including baseline), and a comparison of children who were 
born into study sites post-intervention with children of a comparable age group at 
baseline. Our primary analyses and sub-group analyses use complete case data.  
We used t tests and chi-square tests to examine differences in baseline demographic, 
socio-economic, and environmental and WASH characteristics between intervention and 
control sites. We used spearman rank correlation tests to assess pairwise correlations 
between concentrations of EED biomarkers. To evaluate the impact of the intervention on 
the concentrations of biomarkers of EED, we used a difference in difference (DID) 
approach. The DID approach allows us to estimate the effect of the intervention on EED 
while accounting for any secular trends in study population (via measurements of the 
control group) that may impact the outcome. The DID (or ratio of ratio) estimator is 
represented as the interaction of study arm and study phase dummy variables. By design, 
DID estimation accounts for baseline measures of the dependent or outcome variable – 
essentially serving as a form of built-in adjustment for baseline differences between the 
intervention and control arms (138). Prior to regression analysis, we log-transformed the 
concentrations of all four EED biomarkers. We used generalized estimating equations 
(GEE) with robust standard errors to fit linear regression models and account for 
compound level clustering effects. Given the hierarchical nature of the data, we clustered 
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on compound because it was both the unit of intervention allocation and the highest level 
of nested data (126). We based the main outcome assessment on multivariable models but 
also present the results from unadjusted models. While DID models account for baseline 
outcome measures, we refer to them as unadjusted to differentiate between models which 
include additional covariates (adjusted) and those which only include the DID estimator 
and its component variables (phase and study arm). We included covariates we 
determined a priori as potentially important, including child age, sex, breastfeeding 
status, caregiver’s education, and household wealth score. Details on covariate selection 
have been presented previously (Chapter 3). We analyzed data from participants 
according to their exposure to the intervention latrine at each phase (as treated analysis). 
We assessed results of all analyses using traditional statistical hypothesis testing with a 
significance level of α=0.05. We did not adjust for multiple comparisons because the 
main analyses were pre-specified and sub-group analyses were exploratory in nature 
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During the baseline phase (February 2015 – February 2016), field enumerators enrolled 
456 children and collected 362 stool samples in intervention compounds and 537 children 
and 395 stools in control compounds (Figure 2). Enumerators were able to follow up with 
66.4% (303/456) intervention children and 59% (317/537) control children during the 12-
month phase (March 2016 – April 2017) and enroll an additional 155 children in 
intervention compounds and 165 children in control compounds. We collected stools 
from 403 children in intervention compounds and 400 children in control compounds 
over the course of the 12-month phase. Over half (177/320) of new enrollees in 
intervention and control compounds had been born after the baseline visit, one third had 
moved into a study compound (102/320) and approximately 13% were enrolled during 
the 12-month visit for other reasons (absent or traveling during baseline, refused 
enrollment at baseline). During the 24-month phase, we collected data from 500 children 
in intervention compounds including 145 new enrollees, and from 505 children in control 
compounds of which a 159 were new enrollees. The 24-month phase lasted from April 
2017 through May 2018 and we collected stool material from 459 intervention children 
and 464 control children. Of the children present at the 12-month visit, 133 and 167 were 
unavailable for data collection during the 24-month visit in intervention and control 
compounds, respectively. We collected baseline, 12-month, and 24-month data from 
233/456 (51.1%) of intervention children originally enrolled at baseline and 217/537 
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(40.4%) of control children. Over 60% of control children (348/537) and 70% of 
intervention children (333/456) were available during at least one follow-up phase.  
Baseline Population characteristics and balance 
We have previously characterized the demographics, socioeconomic status, and 
environmental and WASH conditions and practices of the study population at baseline 
(Chapters 2 and 3). Briefly, child level demographics such as age, sex, breastfeeding 
status and level of caregiver education were balanced across study arms at baseline 
(Table 4). We observed some imbalance between arms in measures related to compound 
population such as number of households, population density of the immediate compound 
area (measured in persons/m2), and number of water taps within compound boundaries. 
Some features of existing sanitation facilities varied among intervention and control 
compounds including the presence of drophole covers and sturdy latrine walls which 
were more common in intervention compounds than control at baseline. All households 
used a private municipal water tap as their primary drinking water source at baseline, 
though it was more common for the tap to be inside compound boundaries in intervention 
compounds. While intervention households scored slightly lower on our asset based 
wealth index than control compounds, the absolute difference was small.  
The concentration of NEO and CAL, as well as the composite EED score were similar in 
both study arms at baseline (Table 10). The concentration of AAT was higher among 
intervention (-0.43 log10 mg/g) than control (-0.50 log10 mg/g) children at baseline. We 
observed the opposite trend for MPO: control children had higher concentrations of MPO 
(3.69 log10 ng/mL) than intervention children (3.62 log10 ng/mL). The concentrations of 
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all four biomarkers increased with age at baseline, both across arms (pooled intervention 




Table 10: Mean EED score and log concentration of EED biomarkers at baseline and follow-up phases 
Data is presented as mean (SD), n=# of unique children and # of samples included in calculation. The variation in sample sizes for EED assays within a phase is 
due to exhaustion of sample material prior to completion of all 4 analyses. 
 Baseline 12-month 24-month Combined follow-up 



























































































We found positive pairwise correlations between all four of the EED biomarkers pooled 
across arms and in each arm independently at baseline, though the magnitude of 
correlation coefficient, ρ, varied among biomarker pairs (Table 11). Overall, NEO had 
the lowest pairwise correlations with all other biomarkers in pooled analysis, ranging 
from ρ=0.18 between NEO and AAT to ρ=0.39 between NEO and CAL. 
Myeloperoxidase and calprotectin had the highest correlation (ρ=0.76) of any two 




Table 11: Spearman rank correlation coefficients for pairwise comparisons of EED 










(mg/g) 1.00    
log(MPO) 
(ng/mL) 0.35 1.00   
log(NEO) 
(nmol/L) 0.18 0.29 1.00  
log(CAL) 
(ng/mL) 0.41 0.76 0.39 1.00 
Data is pooled across intervention and control arms. All pairwise correlations are significant at α=0.05 and 
have p-values<0.0001 for all pairs. 
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Intervention effect on all children (primary analysis) 
Effect estimates for the main analysis and all sub-group analyses are the average 
expected change in biomarker concentration or EED score due to the intervention and are 
represented by the linear regression coefficient of the DID estimator. Effect point 
estimates and 95% confidence intervals falling below the null value (0) suggest a 
reduction in biomarker concentration or EED score and protective effect of the 
intervention. Confidence intervals which include the null value signify that the 
intervention had no statistically meaningful effect on the specified outcome, and 
estimates with confidence intervals above the null indicate an increase in biomarker 
concentrations (or EED score) due to the intervention.  
At 12-months, we found no effect of the intervention on concentrations of AAT, CAL, or 
on the EED score. The intervention increased the concentration of NEO by 0.17 log10 
nmol/L (95% CI: 0.07 - 0.27) in the 12-month adjusted analysis (Table 12). The 
intervention also had borderline weak effect on the concentration of MPO, which 
increased by 0.09 log10 ng/mL (95% CI: 0.00 - 0.18) in intervention children at the 12-
month time-point. 
The intervention had no effect on the concentration of AAT, MPO, CAL or the EED 
score in adjusted analyses at the 24-month follow-up phase. The concentration of NEO 
increased by 0.10 log10 nmol/L (95% CI: -0.01, 0.21) at 24-months, a smaller effect than 
observed in the 12-month analysis, but the confidence interval of the effect estimate 
included the null value (0). In unadjusted analyses, the intervention was associated with a 
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decrease in the concentration of AAT but the effect was weakened following adjustment 
(Table 12). 
 Results from the combined follow-up analysis were similar to results from the 12-month 
and 24-month individual analyses. The intervention resulted in an increase in the 
concentration of NEO by 0.14 log10 nmol/L (95% CI: 0.05-0.23) in adjusted analyses and 
a decrease in AAT concentration in unadjusted, but not adjusted, analysis (Table 12).  
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Table 12: Effect of intervention on log concentration of EED biomarkers and EED score in all enrolled children at 12-months, and 24-
months and combined follow-up  
 12-month 24-month Combined follow-up 
 Unadjusted Adjusted Unadjusted Adjusted Unadjusted Adjusted 
log(AAT)  
(mg/g) 
-0.07                    
(-0.17, 0.03)  
n=1074 (1421) 
-0.06                   
(-0.16, 0.04)  
n=1024 (1352) 
-0.12                     
(-0.22,-0.02) 
n=1101 (1318) 
-0.08                     
(-0.18, 0.03)  
n=997 (1188) 
-0.09                     
(-0.18,-0.01) 
n= 1308 (2029) 
-0.07                     




0.07                     
(-0.03, 0.16)  
n=1079 (1435) 
0.09                     
(0.00, 0.18)  
n=1028 (1366) 
-0.01                     
(-0.11, 0.10)  
n=1111 (1345) 
0.02                     
(-0.09, 0.13)  
n=1004 (1209) 
0.03                     
(-0.05, 0.12) 
n= 1314 (2063) 
0.06                     




0.14                     
(0.02, 0.26)  
n=1003 (1304) 
0.17                     
(0.07, 0.27)  
n=954 (1240) 
0.03                     
(-0.10, 0.16)  
n=1007 (1169) 
0.10                     
(-0.01, 0.21)  
n=909 (1051) 
0.10                     
(-0.01, 0.20) 
n= 1225 (1805) 
0.14                     




0.00                     
(-0.10, 0.11)  
n=1071 (1427) 
-0.01                     
(-0.11, 0.09)  
n=1021 (1358) 
0.03                     
(-0.08, 0.14)  
n=1097 (1318) 
0.07                     
(-0.04, 0.17)  
n=991 (1185) 
0.01                     
(-0.08, 0.10)  
n=1304 (2030) 





0.18                     
(-0.37, 0.72)  
n=998 (1291) 
0.37                     
(-0.12, 0.86)  
n=950 (1229) 
-0.31                     
(-0.90, 0.28)  
n=991 (1138) 
0.03                     
(-0.54,  0.60)  
n=898 (1028) 
-0.02                     
(-0.51, 0.46) 
n=1213 (1767) 
0.23                     
(-0.21, 0.68) 
n=1122 (1620) 




Sub-group analysis: impact of intervention on EED biomarker concentration in children 
available at 2 (or more) phases 
MapSan was originally designed as a prospective longitudinal cohort study but due to the 
larger than anticipated loss to follow-up, we were only able to follow a subset of all 
enrolled children through time. By analyzing that subset of children who were enrolled at 
baseline and available at one or more follow-up phase, we can simulate the analysis as 
originally planned. Prospective longitudinal cohort studies often have greater statistical 
efficiency than other study designs, such as repeated cross-sectional, assuming similar 
sample sizes (141). 
 The effect of the intervention on NEO concentration we observed in the main analysis of 
all children persisted in the 12-month sub-group analysis and resulted in an increase in 
NEO concentrations of 0.17 log10 nmol/L (95% CI: 0.03, 0.32) in adjusted analysis 
(Table 13). The intervention also had a marginal effect on MPO concentrations which 
increased by 0.12 log10 ng/mL (95% CI: -0.01, 0.26) in adjusted analyses. The 
intervention had no effect on concentrations of AAT or CAL or on the composite EED 
score at 12-months.  
Sample sizes for the 24-month analysis were small due to loss to follow-up, and the 
intervention had no measurable effect on the concentration of the four EED biomarkers 
or the EED score (Table 13). By combining the results from the 12-month and 24-month 
phases, we assessed whether the intervention had any effect on children enrolled at 
baseline and available at one or more follow-up phases. The results were similar to those 
observed in the individual 12-month and 24-month analyses. The intervention resulted in 
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increased concentration of NEO by 0.16 log10 nmol/L (95% CI: 0.03, 0.30) in the 
adjusted analysis. The concentration of AAT was reduced in the adjusted combined 
analysis though the confidence interval just crossed the null (aRR -0.12, 95% CI: -0.25, 
0.01). The effect observed on MPO in the 12-month analysis was attenuated in the 
combined analysis.  
Overall, results from the sub-group analysis were consistent with results from the main 
analysis. The effect on NEO was consistently observed while other effects were less 
stable across analysis type and target.  
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Table 13: Effect of intervention on log concentration of EED biomarkers and EED score in children with stool samples available for 
analysis in two or more phases (including baseline).  
 12-month 24-month Combined follow-up 
 Unadjusted Adjusted Unadjusted Adjusted Unadjusted Adjusted 
log(AAT)  
(mg/g) 
-0.07 (-0.21, 0.07) 
n=347 (694) 
-0.07 (-0.21, 0.07) 
n=328 (656) 
-0.06 (-0.23, 0.11) 
n=217 (434) 
-0.11 (-0.30, 0.07) 
n=191 (382) 
-0.09 (-0.21, 0.03) 
n=409 (973) 




0.1 (-0.03, 0.23)  
n=356 (712) 
0.12 (-0.01, 0.26)  
n=338 (676) 
0 (-0.18, 0.17)  
n=234 (468) 
-0.02 (-0.21, 0.16) 
n=205 (410) 
0.06 (-0.06, 0.17)  
n=421 (1011) 




0.15 (0.00, 0.29)  
n=301 (602) 
0.17 (0.03, 0.32)  
n=286 (572) 
0.09 (-0.11, 0.28)  
n=162 (324) 
0.10 (-0.11, 0.30)  
n=142 (284) 
0.13 (0.00, 0.26)  
n=349 (812) 




0.02 (-0.11, 0.16)  
n=356 (712) 
0 (-0.14, 0.14)  
n=337 (674) 
0.01 (-0.17, 0.19)  
n=221 (442) 
0.01 (-0.18, 0.2)  
n=194 (388) 
0.01 (-0.11, 0.13)  
n=420 (997) 




0.42 (-0.29, 1.14)  
n=293 (586) 
0.52 (-0.19, 1.24)  
n=279 (558) 
-0.39                     
(-1.43, 0.66)  
n=147 (294) 
 -0.44                     
(-1.55, 0.67)  
n=130 (260) 
0.08 (-0.56, 0.72)  
n=334 (774) 
0.17 (-0.50, 0.83)  
n=303 (697) 





Sub-group analysis: impact of the intervention on EED biomarker concentrations in 
children born into the study 
Analysis of children born into the study population post-intervention (or post-baseline 
visit in controls) provides estimates of the effect of the intervention on children who have 
spent their entire lives exposed to intervention. The 12-month sub-group analysis 
compared children less than one year old at the baseline visit with children less than one 
year at the 12-month follow-up visit who were reported as born into the study site. 
Similarly, the 24-month sub-group analysis included children less than two years at 
baseline and children less than two years at the 24-month visit who were recorded as born 
into a study site. The combined follow-up analysis combined observations from the 12- 
and 24-month analyses.  
The intervention had no measurable effect on the concentration of any of the four EED 
biomarkers or the EED score in the 12-month analysis (Table 14). Effect estimates for the 
analyses were based on small sample sizes due to the narrow inclusion criteria. Stool 
material for EED analysis was only available from between 82 and 88 children 
(depending on EED analysis and split approximately evenly between study arms) who 
were born into the study and less than one year old by the 12-month visit. The majority of 
children included in the 12-month analyses were a part of the baseline comparison group 
(children <1 year old).  
More children born into the study after baseline met the inclusion criteria for the 24-
month phase analyses (138 – 164 depending on assay) but the majority of samples 
analyzed came from children in the baseline comparison group (children <2 years old at 
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baseline). Exposure to the intervention resulted in increased concentrations of NEO (0.17 
log10 nmol/L, 95% CI: 0.01-0.33) and CAL (0.18 log10 ng/mL, 95% CI: 0.02-0.35) in 
adjusted analyses (Table 14). The intervention had no impact on AAT or MPO 
concentration or EED score. In the combined analysis, we observed a similar effect on 








Table 14: Effect of intervention on log concentration of EED biomarkers and EED score in children born after baseline (compared to 
children of similar age at baseline) at 12-months, and 24-months and in combined follow-up data. 
 12-month 24-month Combined follow-up 
 Unadjusted Adjusted Unadjusted Adjusted Unadjusted Adjusted 
log(AAT)  
(mg/g) 0.15 (-0.06, 0.37) 
n=265 
0.15 (-0.06, 0.36)  
n= 260 
-0.03                     
(-0.18, 0.12) 
n=556 
0.02 (-0.13, 0.17)  
n=536 
 0.00 (-0.14, 0.13) 
n=602 (642)1 




0.00 (-0.19, 0.2)  
n=270 
-0.01 (-0.20, 0.19) 
n= 265 
0.02 (-0.15, 0.2)  
n=561 
0.04 (-0.14, 0.22)  
n=540 
0.02 (-0.12, 0.16)  
n=608 (649) 




0.16 (0.00, 0.31)  
n= 261 
0.14 (-0.02, 0.30)  
n= 256 
0.08 (-0.10, 0.26)  
n=521 
0.17 (0.01, 0.33)  
n=502 
0.12 (-0.02, 0.26)  
n=571 (606) 




0.12 (-0.11, 0.34)  
n=263 
0.08 (-0.13, 0.30)  
n= 258 
0.15 (-0.01, 0.32)  
n=553 
0.18 (0.02, 0.35)  
n=534 
0.12 (-0.02, 0.25)  
n=598 (635) 




0.91 (-0.24, 2.06)  
n= 256 
0.89 (-0.25, 2.03)  
n= 251 
0.41 (-0.49, 1.31)  
n=513 
0.62 (-0.23, 1.47)  
n=495 
0.49 (-0.28, 1.25)  
n=563 (596) 
0.60 (-0.14, 1.35)  
n=549 (578) 
Effect estimates presented as coefficient of DID estimator (95% CI), n represents # of unique children in analysis unless otherwise specified. 1 n=# of unique 
children (# of samples analyzed).  Children born into the study after baseline but before 12-month were eligible for inclusion in the 24-month follow-up analysis 







The intervention had an inconsistent effect on the concentrations of the EED biomarkers 
after 12 and 24 months of exposure. Unexpectedly, the intervention appeared to increase 
the concentrations of some markers of intestinal inflammation in a subset of the analyses. 
The concentration of NEO, a marker of cellular immune system activation released 
during pro-inflammatory responses, increased in the 12-, 24-month and combined follow-
up analyses, though the effect in the 24-month analysis was smaller and only borderline 
significant. NEO results from the two sub-group analyses were largely consistent with 
results from the main analysis. The intervention also increased the concentration of CAL, 
another marker of intestinal inflammation, among children born into the study before the 
24-month visit, though we did not observe an effect on CAL in any other phase or 
analysis. All other potential effects were either borderline significant or only observed in 
unadjusted analyses, including the observed reductions of AAT, a marker of intestinal 
permeability. 
The concentrations of all four biomarkers decreased in both intervention and control 
children between baseline and the 12-month follow-up. Concentrations of AAT and MPO 
continued to decrease in both arms after the 12-month visit but the concentrations of 
NEO and CAL leveled off in the 24-month measures. These decreases are likely due to 
the aging of the participants over the course of the study given age effect we observed in 
our baseline data. Even with these decreases, the concentration of all markers, with the 
exception of AAT, remained higher than concentrations reported for healthy controls 
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(59,170,171), similar to findings of other studies of EED in children in LMICs 
(59,113,159,172). Concentrations of AAT exceeded the healthy reference level (>0.27 
mg/g) in both intervention and control at baseline, decreased to the healthy reference 
standard by 12-month, and fell below it by the 24-month visits (59,170). The healthy 
reference concentrations used for comparison here, and in many other studies of EED in 
similar settings, are from of adults or children living in high-income countries. These 
reference values may not be representative of what a “healthy” gut looks like in all age 
groups or settings. Future research should focus on establishing healthy reference 
concentrations for these and other biomarkers of EED in a variety of settings and 
populations.  
The onset of EED is hypothesized to be caused by repeated exposure to enteric pathogens 
in fecally contaminated environments. Several observational studies have noted 
associations between increased fecal biomarker concentrations and poor sanitary 
conditions (113,159,168), but to date, few large-scale sanitation intervention trials have 
published results on EED. The WASH-Benefits Bangladesh trial, which measured the 
impacts of nutrition, WASH, and combined WASH+nutrition interventions on markers of 
EED, demonstrated reductions in NEO and lactulose and mannitol (markers of intestinal 
permeability) in children three months of age in all three intervention arms, but those 
reductions were not sustained in the WASH-only arm when the children were remeasured 
at 14 months and 28 months old (159). The NEO effect estimates for the nutrition-only 
and WASH+nutrition arms were similar at age 14 months, suggesting nutrition, and not 
WASH, was driving the reductions. Further, the concentrations of MPO and AAT 
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increased in the WASH-only arm in children aged 28 months. The authors hypothesize 
that the interventions may have delayed the onset of EED in young children but could not 
prevent it. Therefore, “peak deterioration” of the gut may have occurred later in 
intervention children, resulting in the observed increased concentrations of MPO and 
AAT at 28 months and the attenuation of effect on NEO, lactulose, and mannitol 
observed at younger ages. This hypothesis could help explain the increased 
concentrations of NEO and CAL we observed in our sub-group analysis of children born 
into the intervention by the 24-month visit. Unfortunately, we are not able to assess the 
plausibility of this theory because we do not have the statistical power to test whether the 
intervention had an effect on very young children (<3 months or <6 months) born into the 
study.  
Certain enteric pathogen infections have been associated with increases and decreases in 
the concentration of different EED biomarkers (58). For example, infection with 
Campylobacter, Giardia, and Y. pestis have all been associated with decreased 
concentrations of NEO (58). The onset and severity of EED may be driven by exposure 
to fecal contamination generally but also by exposure to and infection with specific 
pathogens. While our cross-sectional measurements of infection cannot provide a full 
accounting of all infections which may have contributed to EED over the course of the 
study, we can examine the potential associations of pathogens measured concurrently 
with EED biomarkers. For example, in contrast with previous findings, we observed that 
Campylobacter infection was associated with increases in NEO concentration in pooled 
analysis. Further, stratification of NEO effect analyses by Campylobacter detection status 
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results in changes in both the magnitude of the effect of the intervention on NEO and the 
strength of the association. Past or present infection with pathogens associated with 
specific EED biomarkers may modify the effect of the intervention on EED. 
Strengths and limitations 
In addition to the strengths and limitations described previously for the MapSan trial in 
general (Chapter 3), there are several specific to this analysis. First, as there is no formal 
case definition for EED (49), we cannot draw conclusions as to whether an individual 
child has EED or not. The lack of a case definition for EED, coupled with the continuing 
examination of its etiology, complicates the interpretation of EED results from health 
impact trials such as MapSan which often seek to understand clinical significance of 
effect estimates or how they translate to changes in exposure. Formalizing a case 
definition for EED has been difficult, in part, because so many candidate markers have 
been proposed and comparison to the current “gold standard” method for assessing EED, 
examining gut histopathology, is difficult given the highly invasive nature of collecting 
specimens. We chose to examine the previously validated fecal markers of EED because 
their widespread use would facilitate comparison across studies. Also, compared with 
other specimen types used in EED analyses, like blood and urine, collection of stool is 
less invasive and logistically simpler to collect. However, the biomarkers we measured, 
which represent a fraction of candidate markers, may not provide a comprehensive 
accounting of a child’s EED status as they only measure two of the five domains of EED 
(Table 1) (22).  
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Second, breastfeeding status likely plays an important role in the development and 
severity of EED. Breast milk can aid in gut maturation (173), impede pathogen adhesion, 
diminish intestinal inflammation (174), and increase concentrations of CAL (175). The 
practice of breastfeeding can modulate a child’s exposures to fecal contamination. For 
these reasons, we measured breastfeeding status and included it as an important covariate 
in our models. However, capturing information about breastfeeding status in a cross-
sectional survey may not provide enough resolution or detail and we cannot dismiss the 
potential for residual confounding by this important variable.    
Third, we had to dilute a subset of samples prepared for the NEO assay with saline in 
place of the diluent provided with the ELISA kit. Saline has been used as the diluent for 
NEO assays in numerous studies (59,159,168). To verify that the short-term change in 
diluent would not affect our results, we assayed samples diluted in both saline and kit 
diluent in parallel, compared the results, and applied a small correction factor based on 
our comparison to our saline results. We ran a similar proportion of stools from 
intervention and control children with the saline diluent at each phase and the use of 
saline should not differentially affect the results.  
Finally, because we excluded diarrheal stools and fecal swabs from our EED analyses 
and prioritized use of bulk stool material for enteric pathogen analysis, our sample sizes 
for EED analyses were lower than for pathogen analysis. This reduced sample size, 
coupled with the noisy nature of the EED measurements, may have limited our ability to 
detect small changes in EED concentrations, especially in sub-group analyses.  
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We found no evidence that the intervention improved indicators of EED in young 
children in this setting. EED’s complex etiology and the numerous interrelated 
pathophysiologic mechanisms (and their representative biomarkers) used to describe it, 
complicate its measurement (22) and our understanding of how to prevent, or at least 
delay, its onset and severity. Our findings emphasize the necessity of filling these 











Figure A1: Original schematic of communal sanitation block design from WSUP. 
Pictured: 2 latrine stalls, 2 pour-flush toilets, septic tank, elevated water storage tank, 
























Table B1.  Definitions and coding schemes for analysis variables. 
Variable Name % Missing Variable definition and format 
Latrine superstructure 1.9 Binary variable that is 1 when there was a wall around the latrine that provided privacy 
and security, 0 otherwise 
Drophole cover present* 1.9 Binary variable that is 1 if the latrine drophole was covered, 0 otherwise. 
Ventpipe present 1.8 Binary variable that is 1 if the latrine pit was vented, 0 otherwise. 
Pedestal or slab present 2.2 Binary variable that is 1 if the latrine had a slab or a concrete/masonry pedestal. 
Composite sanitation score 4.0 Ordinal variable ranging from 0-4. One point each awarded for presence of latrine 
superstructure, drophole cover, ventpipe, or slab/pedestal.  
HHs sharing latrine 4.3 An ordinal variable that was 0 if two or fewer households shared a latrine, 1 if three to 
five households shared a latrine, and 2 if more than five households shared a latrine. 
Disposal of child feces in latrine* 1.3 Binary variable that is 1 if children's feces were disposed of in a latrine, 0 otherwise 
(soiled diapers thrown on the trash heap). 
Standing water in compound 1.9 Binary variable that is 1 if the field team observed standing water in the compound at 
the time of survey, 0 otherwise. 
Wastewater in compound 1.9 Binary variable that is 1 if the field team observed waste water in the compound at the 
time of survey, 0 otherwise. 




Visible feces or used diapers 1.9 Binary variable that is 1 if the field team observed human feces or soiled diapers in the 
compound at the time of survey, 0 otherwise. 
Compound floods when it rains 1.9 Binary variable that is 1 if the head of compound reported that the compound had a 
tendency to flood due to rain, 0 otherwise. 
Compound hygiene score 1.9 Ordinal variable ranging from 0-3. One point each awarded for presence of standing or 
leaking wastewater in compound, presence of visible feces or soiled diapers on 
compound grounds, and reported flooding.  
Drinking water tap on compound grounds 1.8 Binary variable that is 1 if there was a water tap within the compound, 0 otherwise. 
Any animal in compound 0.0 Binary variable that is 1 if the head of compound reported that 1 or more animal lived 
in the compound, 0 otherwise. 
Dogs in compound 0.0 Binary variable that is 1 if the head of compound reported that 1 or more dogs lived in 







Supplemental Information B1  
We used two MI models for this analysis; the first any infection as the dependent 
variable and the second included the outcome measures of any bacterial infection, any 
protozoan infection, and any viral infection. All risk factors and covariates used in the 
analysis model were included in the MI model to ensure consistency and limit 
introduction of bias during imputation. Other than the difference in dependent 
variable, all other components of the MI models were similar. We used MI with 
chained equations (MICE) to create 50 complete datasets (m=50). We used MICE 
given its flexibility in handling binary and categorical variables. Logit distributions 
were used for all binary variables, ordered logistic for categorical, and predictive 
mean matching (knn=10) for any continuous or semi-continuous variables. We used 
an inclusive model with 6 auxiliary variables in the MI models given their observed or 












Table B2: Crude and adjusted risk ratios and 95% confidence intervals for 
associations of caregiver reported diarrhea and enteric infection. Multivariable models 
are adjusted for child age and sex, caregiver education, household wealth, and 
breastfeeding practices. 
  Crude risk ratio, n=652 Adjusted risk ratio, n=635
Any Infection (≥1 infections) 1.11 (0.65 – 1.89) 1.32 (0.75 – 2.31) 
Any Viral Infection 1.37 (0.82 – 2.29) 1.34 (0.79 – 2.27) 
Any Bacterial Infection 1.19 (0.75 – 1.89) 1.35 (0.85 – 2.14) 
Any Protozoan Infection 0.92 (0.63 – 1.34) 1.07 (0.70 – 1.61) 
Bacteria   
Shigella 0.95 (0.65 – 1.37) 1.20 (0.78 – 1.86) 
ETEC LT/ST 0.88 (0.58 – 1.34) 0.88 (0.57 – 1.35) 
Salmonella 0.96 (0.62 – 1.49) 0.90 (0.57  - 1.44) 
Campylobacter 1.07 (0.58 – 1.98) 0.98 (0.52 – 1.86) 
Clostridium difficile, Toxin A/B 1.25 (0.59 – 2.65) 1.11 (0.54 – 2.31) 
Escherichia coli O157 1.13 (0.47 – 2.75) 1.27 (0.51 – 3.15) 
STEC stx1/stx2 0.54 (0.08 – 3.75) 0.58 (0.08 – 3.97) 
Yersinia enterocolitica† - - 
Vibrio cholerae† - - 
Protozoa   
Giardia 0.95 (0.65 – 1.38) 1.11 (0.72 – 1.71) 
Cryptosporidium 1.56 (0.72 – 3.36) 1.46 (0.68 – 3.15) 
Entamoeba histolytica† - - 
Virus   
Norovirus GI/GII 1.74 (1.02 – 2.97)* 1.76 (1.03 – 3.02)* 
Adenovirus 40/41 0.70 (0.20 – 2.41) 0.40 (0.07 – 2.18) 
Rotavirus A 0.79 (0.15 – 4.14) 0.78 (0.15 – 3.96) 





Table B3. Crude and adjusted risk ratios from the multiple imputation risk factor analyses for four measures of enteric infection: any enteric 
infection, any bacterial infection, any protozoan infection, and any viral infection. Multivariable models are adjusted for child age and sex, 
caregiver education, household wealth, and breastfeeding practices.  
Any Infection Any Bacterial Infection Any Protozoan Infection Any Viral Infection 























































































HHs sharing latrine 




























































































Table B3 (continued). 

























































































































































































































































Cumulative rainfall last 30 
days, terciles         



































Child  age         
































































































Table C1: Baseline Compound Questionnaire. This questionnaire has been uploaded 
onto Magpi website and all data is collected electronically through the Magpi android 
mobile application.  
IDs:WSUPID WSUP Compound ID (given by WSUP 
spreadsheet) 
 
bairid Bairros ID (official) |__|__| 
quartid Quarteiro number (official) |__|__| 
 







If intervention compound, what type of latrine will 
the compound receive? 
        Communal Sanitation Block 
        Shared Latrine 
 
compid Compound number (given by study). 4 digits long. 
Intervention start with “2”, control start with “3” 
|__|__|__|__| 
 




complat OBSERVE/ASK Number of latrines/drop holes  
 
|__|__| 
watpoint OBSERVE/ASK Number of water points within 
compound 
|__|__| 




compsize ASK: how many residents, including children, are 
living in this compound right now? 
If>=12 – CONTINUE QUESTIONNAIRE 
If < 12  – STOP HERE 
|__|__|__| 
compstrat 
Tick size category  
11-20  |__| 
21-60  |__| 
61+     |__| 
anychild ASK: is there any child under 4 years (48 month) 
living in this compound right now? 
(1)Yes  
(0) No – STOP HERE 
|__| 
compenr Compound is enrolled 
(1)Yes  





electr OBSERVE/ASK: is there electricity in the 









wastewat OBSERVE: is there open waste water near the 




animal OBSERVE/ASK: what animals are in the 








faeces OBSERVE: Do you see faeces or used diapers on 













Table C2: Baseline household and child questionnaire 
childu5 ASK: is there a under 4 years (48 months) living in this 
household right now? 
(1) yes – CONTINUE QUESTIONNAIRE 
(0) no – STOP HERE 
|__|
read ASK: Have you read him/her the consent form? 
(1) yes – CONTINUE QUESTIONNAIRE 
(0) no-one is available to read it to – STOP HERE 
|__|
cons ASK: Does the respondent agree? 
(1)Yes  
(0) No – STOP HERE 
|__|
resp OBSERVE/ASK: Who is the respondent? 
Note: If possible, the mother or female caregiver should 
be the respondent.  
(1) Female head of household 
(2) Male head of household 
(3) female caregiver 
(4) male caregiver 
(5) other respresentative 
|__|




hhhead Name of HH head ----------------
----------------
---------
hhtel Phone number of HH contact 











Some technical training 
Technical training 
completed 



















hhsize ASK: how many people sleep in your household?  |__|__|
Hhroom ASK: how many bedrooms are in the house?  
Hhbeds ASK: how many beds does this household have 
(single, double, bunkbeds, or for children)?  
(1) One 
(2) Two or more 
(0) none 
 
car ASK: does this HH own a working bicycle, 
motocycle, or car? 
(1) yes, bicycle only 
(2) yes, motocycle or car (regardless of bicycle)  
(0) no 
|__|
Energy ASK: What is the main source of energy for 
lighting in the residence?  
(1) Firewood or batteries 
(2) LGP, oil/paraffin/kerosene, or candles 
(3) other 
(3) Electricity, generator, or solar panel 
 
Iron ASK: Does the household have a non-electric or 
electric clothes iron? 
(1) yes 
(0) no 
fridge ASK: does this HH own a working freezer? 
(1) yes  
(0) no 
|__|
Clock ASK: does the household have a clock (mobile 
phone, wall, wrist, or pocket)?  
(1) yes 
(0) no 
Radio ASK: does the household have a radio, stereo 
system, or cassette player?  
(1) yes, radio only 
(2) yes, stereo system or cassette player (regardless 
of radio) 
(0) no 
sofa ASK/OBSERVE: does this HH own a sofa? 
(1) yes  
(0) no 
kitchen ASK/OBSERVE: where is the kitchen located? 
(1) inside house  
(0) outside house or not connected to the main 
house 
|__|
hhfloor ASK/OBSERVE: What is the main material of the 
floor of the residence (excluding kitchen and 
bathrooms)? 





(2) wood/parquet, marble/granite, cement, or 
mosaic/tile 
  
Hhwalls ASK: What is the main material of the walls of the 
residence?  
(1) Reeds/sticks/bamboo/palm, wood or metal 
sheets, tin/cardboard/paper/sacks or other 
(2) Adobe locks, wattle and daub, cement blocks, or 
bricks 
wingrate ASK/OBSERVE: does the HH have grated 
windows? 
(1) yes  
(0) no 
|__|
doorgrate ASK/OBSERVE: does the house have a grated 
door? 
(1) yes  
(0) no 
|__|
drinkwat Onde é que a sua família 
normalmente busca água 
para beber? 
Se a família busca água 
para beber de fontes 
múltiplas, procura saber 
qual é a fonte mais 
utilizada durante o ano. 
Não permitidas respostas 
múltiplas  
Utilize as folhas com figuras 
para acertar o tipo de fonte. 
1. ..............................................................................
orneira dentro da casa 
2. ..............................................................................
orneira no composto 
3. ..............................................................................





















hhsan ASK and OBSERVE: Qual 
é a latrina ou sistema mais 





Flush/pour flush toilet to piped 
sewer system 
2. ........................................................................ F
lush/pour toilet to onsite, 
underground 
3. ..............................................................................
lush/pour toilet to onsite, 
aboveground 
4. ..............................................................................
it latrine with concrete slab (not 
pour flush) 
5. ..............................................................................



















pen defecation (no facilities) 
8. ..............................................................................
utro 
99. Não querem dizer ou não sabem 
Drophole ASK/OBSERVE: Is the 









 (99) I don’t know 
 
Ventpipe ASK/OBSERVE: Is there a 




Masonry ASK/OBSERVE: Is there a 





Child questions for children under 4 years   - ask every child who is under 4 
years in the household. 
ChildID Child ID #   
respmom Is the respondent the 
child’s mother?  
 
(1) Yes (skip to careeedu question) 
(0) No 
 
mompresent Is the child’s mother 






resprelat If respondmom= no;  
ASK: What is the 
respondent’s relationship 
to the child?  
(1)  father 
(2)  female relative 
(3)  male relative 
(5) other female caregiver 
(6) other male caregiver 
 
careedu ASK: what education did 
caregiver of the child 
under 4 receive? (if 
several caregivers record 
highest education level) 
(0) None 
(1) Some primary 
(2) Primary completed 
(3) Some secondary 
(4) Secondary completed 
(5) Some technical training 
(6)Technical training completed 
(7)Some higher education  
(8) Higher education completed 
(88) Refused question 
(99) Don’t know 
 
childname What is the child’s name?   
birthdate ASK: what is the child’s 
birthdate?  
 





card, postnatal card 
details 
 
Add 01/01/2000 if date 
not available. 
Age IF birthdate not available: 
ASK: in what year and 
month was the child born 
If month not available, 
mark month as 99 
If year not available, 
exclude unless obviously 
under 5 years 
Format:   MM/YYYY  
Breastfed Is the child currently 
breastfeeding?  
 
(1) Yes, exclusively 
(2) Yes, in addition to other foods 
and liquids 
(3) No 
(4) Don’t know 
 
diaper ASK: is this child still in 
diapers? 
 
If the child wears diapers 
sometimes, mark as yes.  
(1) yes, disposable 
(2) yes, cloth 
(0) no  
(99) don’t know 
 
 
diapdisp IF YES, uses disposable 
diapers, ASK: where is 
the diaper disposed when 
child is changed? 
 
(1) Latrine 
(2) Rubbish heap 
(3) Soak pit 
(4) other 
 (99) don’t know 
 
childdef IF NO, does not wear 
diapers, ASK: where 






(99) don’t know 
 
Crèche ASK: how many days per 
week is this child going 
to a crèche? 
 
Enter Number of days 
 
(99)  don’t know 
 
diarrhoea Did this child have 
diarrhoea at any time in 
the last 7 days? 
 
Diarrhea is considered to 
be the passage of >=3 
loose or liquid stools in a 
24 hour period or any 
stool with blood 
(1) Yes  
(0) No 
(99) don’t know 
 
Diabout One the worst day of this 
episode, how many bouts 





of diarrhoea did this child 
have?    
Enter 99 if respondent 
does not know.  
diadays If more than 3 bouts:  
 
For how many days did 
this child have 3 or more 
bouts? 
Enter Number of days 
 
(99)  don’t know 
 
diaeat If diarrhoea= yes 
 
During this time, did this 
child refuse to eat on one 
or more days?  
 
If YES: On how many 
days? 
Enter number of days 
 
(0) No refusal to eat 
(99) don’t know 
 
diafev If diarrhoea= yes 
 
During this time, did this 
child have fever on one 
or more days?  
 
If YES: On how many 
days? 
Enter number of days 
 
(0) No fever 
(99) don’t know 
 
diablood If diarrhoea= yes 
 
During this time, did this 




(99) Don’t know 
 
treat Procurou conselhos ou 




(99) Don’t know 
 
treatsource If treat = yes  
 
Onde procurou conselho 
ou tratamento? Em algum 
outro lugar? Anote todas 
as respostas 
Sector publico 
(1) unidade sanitaria 
(2) brigada movel 





(7) outro privado 
Outra Fonte 
(8) dumba nengue 
(9)medico tradicional 
(10) pessoal de saude do bairro 
(11) outro 





treattime How many days after the 
illness began did you first 
seek advice or treatment? 
(1) mesmo dia 
(2) dia segunte 
(3) after 3 or more days 
(4) don’t know 
 
vomit In the last 7 days, did this 
child vomit on one or 
more days?  
 
If YES: On how many 
days did this child have 
vomiting? 
Enter number of days or:  
 
(0) No vomiting 
(99) don’t know 
 
CHRONIC ABDOMINAL SYMPTOMS AND WEIGHT / HEIGHT 
MEASURES FOR CHILDREN LESS THAN 4 YEARS OLD 
First ask questions, then ask to be allowed to measure weight and height 
chronpain In the last week did this 
child have abdominal 
pain? 
 
If YES: on how many 
days out of the past 
week? 
 
Enter number of days or:  
 
(0) No pain 
(99) don’t know 
 
chronpainloc If abdominal pain: 
 
Was this pain in a 
particular place of the 
belly or everywhere? 
 
(0) local  
(1) everywhere 
(99) don’t know 
 
paineat During this time, did this 
child refuse to eat on one 
or more days because of 
abdominal pain?  
 
If YES: On how many 
days? 
Enter number of days or:  
 
(0) No refusal to eat 
(99) don’t know 
 
weight For children less tan 24 
months, use tared weight. 
For children > 24 months, 
measure child weight 
alone.   
Enter weight in (kg) 
 
height For children less than 24 
months, measure 
recumbent length.  
 
For children older than 
24 months, measure 
standing height. 
 
All measurements should 





be recorded in 





Table C3: 12-month and 24-month Compound survey 
Question text (Eng) Question Text (Port) Answer text 
(Eng) 
Answer text (Port) 
N/A N/A Compound survey 
v.1. 
Compound survey v.1. 
N/A N/A MapSanStudy MapSanStudy 
N/A N/A Final Final 
    Draft Draft 
N/A N/A unique identifier 
for survey 
unique identifier for survey 
N/A N/A MM/DD/YYYY 
H:MM 
MM/DD/YYYY H:MM 
N/A N/A MM/DD/YYYY 
H:MM 
MM/DD/YYYY H:MM 
Enter enumerator ID # ID do inquiridor Isabel Isabel 
  Sergio Sergio 
  Carolina Carolina 
  Maria Celina Maria Celina 
  Olimpio Olimpio 
  Zaida Zaida 






Enter the Bairro ID ID do Bairro (nome oficial) Aeroporto A Aeroporto A 
  Aeroporto B Aeroporto B 
  Chamanculo A Chamanculo A 
  Chamanculo B Chamanculo B 
  Chamanculo C Chamanculo C 
  Malanga Malanga 
  Maxaquene A Maxaquene A 
  Maxaquene B Maxaquene B 
  Maxaquene C Maxaquene C 
  Maxaquene D Maxaquene D 
  Minkadjuine Minkadjuine 
  Munhuana Munhuana 
  Unidade 7 Unidade 7 
  Urbanizacao Urbanizacao 
    Xipamanine Xipamanine 
Enter the Quarteirao 
number 
N° do Quarteirão (oficial) N/A N/A 
Is this an intervention or 
control compound? 
Este é um composto de 
intervenção ou de controlo 
Intervention Intervenção 




What type of latrine did the 
compound receive? 





    shared latrine Latrina partilhada 
Was the compound 
previously part of the 
study? 
O composto foi inscrito 
anteriormente no estudo? 
Yes Written 
consent was 
obtained at one or 
more households 
in the compound 
Sim Consentimento escrito foi obtido em uma ou mais 
casas no composto? 
    No Written was 
NOT obtained 
from any 
households in the 
compound 
Não Consentimento escrito não foi obtido em uma ou 
mais casas no composto 
Who is the survey 
respondent? 
Quem é o entrevistado? Head of the 
compound 
Chefe do Composto 
  Spouse of head of 
compound 
Esposa (o) do (a) Chefe do Composto 
  Other (please 
specify) 
Outro (especifique) 
resp_Other_please_specify_   N/A N/A 






What is the name of the 
current head of the 
compound? 
Qual é o nome do actual chefe do 
composto? 
name name 
What is the phone number 
of the current head of the 
compound? 
Qual é o número de telefone do 
actual chefe do composto? 
8######## 8######## 
    TRUE TRUE 
Has the head of the 
compound changed in the 
past year? 
O chefe do composto foi 
substituído no último ano? 
Yes  Sim 
    No  Nao 
What is the name of the old 
head of the compound? 
Qual é o nome do antigo chefe do 
composto? 
name name 
    TRUE TRUE 
Enter the compound ID 
assigned at baseline. 
Insira o ID do composto atribuído 
no estudo de base 
numeric numeric 
N/A N/A MM/DD/YYYY 
H:MM 
MM/DD/YYYY H:MM 
N/A N/A GPS GPS 
N/A N/A GPS GPS 
N/A N/A GPS GPS 
N/A N/A GPS GPS 
How many households are 
in this compound? 
Quantos agregados familiares 





How many people are living 
in this compound right 
now? 
Quantas pessoas vivem neste 
composto actualmente? 
## ## 
Is there a child less than 5 
years old living in this 
compound right now? 
Existe alguma criança com menos 
de 5 anos (60 meses) que vive 
neste composto actualmente? 
Yes Sim 
    No Nao 
How many children <5 
years old live in this 
compound right now? 
Quantas crianças com menos de 5 
anos (60 meses) vivem neste 
composto actualmente? 
## ## 
Since we last visited, has 
your compound received 
any education or training 
related to hygiene 
promotion or sanitary 
practices? 
Desde a nossa última visita, o 
composto recebeu educação ou 
formação em matéria de higiene 
ou práticas sanitárias? 
Yes Sim 
  No Nao 
    TRUE TRUE 
Who provided the 
education or training? 
Quem facilitou o treinamento? The local CBO Uma organização baseada na comunidade 
  Someone from 
WSUP 
Alguém da WSUP 





  Other (please 
specify) 
Outro (especifique) 
  N/A N/A 
    TRUE TRUE 
Did you compound receive 
deworming medication 
from our study team 
following our first visit last 
year? 
O seu composto receber 
medicação de desparasitação da 
nossa equipa após a nossa 
primeira visita no ano passado? 
Yes Sim 
  No Nao 
    TRUE TRUE 
Other than the medication 
administered by our study 
team, has anyone visited 
your compound to 
administer additional 
deworming medication in 
the past year? 
Para além da medicação 
administrada pelo estudo, uma 
outra pessoas ou instituição 
visitou o composto e deu 
medicação para desparasitação no 
ano passado? 
Yes, someone 
from the Ministry 
of Health 
Sim, alguém do MISAU 
  Yes, someone 
from a different 
organization 




  No, no one has 
visited 
Não, ninguém visitou 
    TRUE TRUE 
About how long ago did 
your compound receive 
deworming medication? 
A quanto tempo o composto 
recebeu a medicação de 
desparasitação? 
within the last 
week (0-7 days) 
Dentro da semana passada (0 -7 dias) 
  within the last 
month (8-30 days) 
Dentro do mês passado (8-30 dias) 
  within the last 3 
months (31 - 90 
days) 
Dentro dos últimos 3 meses (31-90 dias) 
  within the last 6 
months (91 - 180 
days) 
Dentro dos últimos  6 meses (91-180 dias) 
  longer than 6 
months ago (180+ 
days) 
A mais de 6 meses (180+ dias) 
    TRUE TRUE 
Take photos of the 
compound grounds from 
the entrance of the 
compound. 
Tire fotos do composto (espaço 






Stand in the center of the 
compound and click 
"current location" 
Posicione-se no centro do 
composto e clique "localização 
actual" 
GPS GPS 
  GPS GPS 
  GPS GPS 
    GPS GPS 
Is there electricity in the 
compound that normally 
functions? 
O composto tem sempre acesso a 
electricidade? 
Yes Sim 
  No Nao 
OBSERVE: Is there 
standing water in the 
compound? 
OBSERVE: Existe água 
estagnada no composto? 
Yes Sim 
  No Nao 
Take a photo of the 
standing water. 
Tire uma foto da água estagnada N/A N/A 
OBSERVE: Are there feces 
or or used diapers on the 
ground or in a rubbish 
heap? 
OBSERVE:  existem fezes ou 
fraldas usadas no chão ou num 
monte de lixo? 
Yes Sim 
  No Nao 
Take a photo of the feces or 
diapers. 
Tire uma foto das fezes ou fraldas N/A N/A 
Does the compound flood in 
the rainy season? 






  No Nao 
Has the compound flooded 
in the past month? 
O composto ficou inundado no 
último mês? 
Yes Sim 
  No Nao 
If the compound is 
currently flooded, take a 
photo. 
Tire uma foto se o composto 
estiver inundado no momento 
N/A N/A 
How does your compound 
get rid of rubbish (solid 
waste)? 




removido pelo município 
  Bury it enterrado 
  Burn it Queimado 
  Move it outside of 
the compound 
Removido para foram do composto 
  TRUE TRUE 
What animals are regularly 
present in the compound? 
Select all that apply. 
Que animais estão regularmente 
presentes no composto? Selecione 
todas as opções aplicáveis. 
None Nenhum 
  Dog Cão 
  Cat Gato 
  Chicken/duck Galinhas/patos 
  Other (please 
specify) 
Outro (especifique) 




How many dogs are 
regularly present in the 
compound? 
Quantos cães estão normalmente 
presentes no composto? 
# # 
How many cats are 
regularly present in the 
compound? 
Quantos gatos estão normalmente 
presentes no composto? 
# # 
How many chickens or 
ducks are regularly present 
in the compound? 
Quantos patos e/ou galinhas estão 
normalmente presentes no 
composto? 
# # 
How many "other" animals 
are regularly present in the 
compound? 
Quantos 'outros" animais estão 
normalmente presentes no 
composto? 
# # 
Do the animals defecate in 
the compound area? 
Os animais defecam no pátio do 
composto? 




Sim, os animais defecam em qualquer lugar dentro do 
composto 
  Yes, the animals 
defecate in one 
location inside the 
compound (e.g. 
pen) 
Sim, os animais defecam em um local no interior do 
composto (ex. na capoeira) 
  No, the animals 
defecate outside 
of the compound 
Não, os animais defecam fora do composto 
How many water points are 
in the compound? 
Quantas fontes de água existem 
dentro do composto? 
# # 
Take a photo of each 
waterpoint. 






  GPS GPS 
  GPS GPS 
  GPS GPS 
  GPS GPS 
How many 
latrines/dropholes are in 
the compound? 
Quantas latrinas existem no 
composto? 
# # 
In the past 12 months, how 
much money did your 
compound spend on the 
construction and upkeep of 
your current latrine? 
Nos últimos 12 meses, quanto 
dinheiro o composto gastou para 
construção e manutenção da 
actual latrina? 
# # 
    TRUE TRUE 
How much money did your 
compound contribute 
upfront to help pay for the 
construction costs? 
Quanto dinheiro o seu composto 
contribuiu inicialmente para 
ajudar na construção da vossa 
actual latrina? 
# # 
    TRUE TRUE 
How much money does 
your compound pay 
towards the latrine each 
month? 
Quanto dinheiro o seu composto 
contribui mensalmente para 






  TRUE TRUE 
When the latrine pit 
becomes full, how will you 
empty it? 
Quando a latrina ficar cheia, 




Negócio formal grande (ex. Tanque a vácuo) 





Negócio formal pequeno com recurso a equipamento 
manual ou automatizado 




Membros do composto ou esvaziador individual 
informal 
  Will not empty. 
Will cover and dig 
a new pit. 
Não será esvaziado. Irão cobrir a fossa/ buraco e cavar 
um novo. 
  Not yet emptied Ainda nao foi esvaziada 






  N/A N/A 
How will you dispose of the 
latrine contents? 
Como irá desfazer-se dos resíduos 
retirados da latrina? 
Bury it in the 
compound 
Enterrar no composto 
  Put it in the 
rubbish pile 
Colocar no monte lixo no composto 
  Remove it from 
the compound 
Remover do composto 
  Other (please 
specify) 
Outro (especifique) 
  N/A N/A 
Take a photo of the interior 
and exterior of each latrine 
in the compound. 
Tire fotos do interior e exterior de 
cada latrina existente no 
composto 
N/A N/A 
  GPS GPS 
  GPS GPS 
  GPS GPS 




Stand outside of the latrine 
and click "current 
location" to record GPS 
points of the latrine. 
Posicione-se fora da latrina e 
clique "localização actual" para 
gravar as coordenadas de GPS da 
latrina. 
GPS GPS 
  GPS GPS 
  GPS GPS 
    GPS GPS 
OBSERVE: Is the latrine 
inside the compound or 
outside of the compound? 
Existe uma latrina dentro do 
composto ou fora do composto? 
Inside Dentro 
  Outside Fora 
    Not Applicable Não aplicável 
OBSERVE: Is the latrine 
located on higher ground 
than the rest of the 
compound? 
OBSERVE: a latrina está 
localizada em um ponto superior 
em relação as demais 
infraestruturas existentes no 
composto? 
Yes Sim 




    Not Applicable Não aplicável 
OBSERVE: Does the 
latrine have stone walls? 
OBSERVE:  a latrina têm paredes 
de pedra/blocos de cimento? 
Yes, on all cabins Sim, em todas as cabines 
  Yes, on some 
cabins 
Sim, em algumas cabines 
  No Nao 
    Not Applicable Não aplicável 
OBSERVE: Is the drophole 
covered? 
OBSERVE: o latrina/ buraco esta 
coberto? 
Yes Sim 
  No Nao 
    Not Applicable Não aplicável 
OBSERVE: Is the drophole 
clogged? 
OBSERVE: a latrina/buraco está 
obstruído? 
Yes Sim 
  No Nao 
    Not Applicable Não aplicável 
OBSERVE: Does the 
latrine have a ventilation 
pipe? 
OBSERVE: a latrina possui um 





  No Nao 
    Not Applicable Não aplicável 
Is the ventilation pipe 
covered? 
O tubo de ventilação está coberto? Yes Sim 
  No Nao 
OBSERVE: Is the 
underground tank/hole 
sealed? 
OBSERVE : O tanque 
subterrâneo / buraco está selado ? 
Yes Sim 
  No Nao 
  Not Applicable Não aplicável 
OBSERVE: Is there a 
masonry or tile  slab, or 
pedestal? 
OBSERVE: Existe uma laje de 
alvenaria, azuleijo ou pedestral? 
Yes Sim 
  No Nao 




OBSERVE: Is the pedestal 
intact? 
OBSERVE: o pedestral está 
intacto? 
Yes Sim 
  No Nao 
  Not Applicable Não aplicável 
ASK: Is the pit full? (Is the 
compound still using the pit 
for defecation or is it no 
longer in use?) 
Pergunte: a fossa esta cheia? (O 
composto ainda usa a latrina para 
defecar ou a latrina não esta em 
uso?) 
Yes Sim 
  No Nao 
  Not Applicable Não aplicável 
  Don't Know Não sabe 
Measurement 1 - pit 
opening to sludge (Measure 
the distance from the pit 
opening to the sludge using 
the laser tape measure.) 
Medição 1 - buraco da latrina 
(Medir a distância do buraco da 
latrina e o nível das fezes, usando 
a fita métrica a laser .) 
### ### 
Measurement #2 for pit 
fullness. Top of 
pedestal/tire/etc to ground. 
(If no second measurement 
is needed, enter 0) 
Medição 2 - medição da distância 
do topo do pedestal/pneu para o 
solo (início do buraco da latrina). 
(Se não for necessária uma 
segunda medida, digite 0) 
### ### 




OBSERVE: Is there open 
wastewater near the 
latrines or leaking from the 
latrines? 
OBSERVE: Existem águas 
residuais próximo ou a vasar da 
latrina? 
Yes Sim 
  No Nao 
Take a photo of the 
standing or leaking 
wastewater. 
Tire uma foto das água residuais 
próximas a latrina ou a vazar da 
mesma 
N/A N/A 
OBSERVE: Is there a door 
on the latrine that 
functions? (Can the door be 
opened and closed easily) 
OBSERVE: existe uma porta em 
funcionamento na latrina? (A 
porta pode ser aberta e fechada 
com facilidade?) 
Yes Sim 
  No Nao 
  Not Applicable Não aplicável 
During the day, is the 
latrine usually locked on 
the outside? 
Durante o dia, a latrina fica 
normalmente tracada por fora? 
Yes Sim 
  No Nao 
  Not Applicable Não aplicável 
At night, is the latrine 
usually locked on the 
outside? 
Durante a noite, a latrina fica 





  No Nao 
  Not Applicable Não aplicável 
OBSERVE: Was the latrine 
locked when you entered 
the compound? 
OBSERVE:  A latrina estava 
trancada quando iniciou a visita 
ao composto? 
Yes Sim 
  No Nao 
  Not Applicable Não aplicável 
Do all of the households in 
this compound have a key 
to the latrine? 
Todos os agregados familiares do 
composto possuem as chaves da 
latrina? 
Yes Sim 
  No Nao 
  Not Applicable Não aplicável 
OBSERVE: Is there a lock 
on the inside of the cabin 
that the user can use for 
privacy? 
OBSERVE: existe uma tranca por 
dentro do compartimento da 
latrina que possa ser usada para 
garantir privacidade? 
Yes on all cabins Sim, em todas as cabines 
  Yes on some 
cabins 
Sim, em algumas cabines 




  Not Applicable Não aplicável 
OBSERVE: Is there a 
handwashing station at or 
near the latrine? 
OBSERVE: existe uma estação 
para a lavagem das mãos dentro 
ou próximo ao espaço da latrina? 
Yes, built into the 
latrine 
Sim, construído junto ao espaço da latrina 
  Yes, near the 
latrine 
Sim, próximo a latrina 
  No Nao 
OBSERVE: Is there access 
to water at the 
handwashing station? 
OBSERVE: existe acesso a água 
na estação de lavagem das mãos? 





Sim, existe uma conexão de água canalizada na 
estação de lavagem das mãos 
  Yes, water bucket 
or container near 
station with water 
present 
Sim, existe um balde/recipiente com água próximo a 
estação de lavagem das mãos 
  No. Não 
OBSERVE: Is there soap 
present at the handwashing 
station? 
OBSERVE: Existe sabão na 
estação de lavagem das mãos? 
Yes Sim 
  No Nao 
OBSERVE: Does the 
latrine appear to be in use? 
OBSERVE: a latrina aparenta 





  No Nao 
  Not Applicable Não aplicável 
OBSERVE: Is the floor of 
the latrine wet? 
OBSERVE: o chão da latrina está 
molhando? 
Yes Sim 
  No Nao 
  Not Applicable Não aplicável 
Is the latrine seat dusty? OBSERVE: acento da latrina está 
empoeirado? 
Yes Sim 
  No Nao 
  Not Applicable Não aplicável 
OBSERVE: Does the 
latrine appear clean? 
OBSERVE: a latrina aparenta 
estar limpa? 
Yes Sim 
  No Nao 
  Not Applicable Não aplicável 
Does anyone who does not 
live in the compound 
regularly use the latrine in 
the compound? 
Alguém que não vive no 
composto usa regularmente a 
latrina? 
Yes Sim 




How many people from 
outside the compound 
regularly use the latrine? 
Quantas pessoas de fora do 
composto normalmente usam a 
latrina? 
## ## 
Are there any latrines not 
built by WSUP on the 
compound grounds? 
Existe alguma latrina não 
construída pela WSUP dentro 
composto? 
Yes Sim 
  No Nao 
Is the non-WSUP latrine(s) 
in use? 
A latrina não construída pela 
WSUP está em uso? 
Yes Sim 
  No Nao 
Do all families in the 
compound use all of the 
latrines? 
Todas as famílias no composto 
usam todas as latrinas? 
Yes Sim 
  No Nao 






Table C4: 12- and 24-month Household level survey 
Question text (Eng) Question Text (Port) Answer text (Eng) Answer text (Port) 
N/A N/A Compound survey v.1. Compound survey v.1. 
N/A N/A MapSanStudy MapSanStudy 
N/A N/A Final Final 
    Draft Draft 
N/A N/A unique identifier for 
survey 
unique identifier for survey 
N/A N/A MM/DD/YYYY 
H:MM 
MM/DD/YYYY H:MM 
N/A N/A MM/DD/YYYY 
H:MM 
MM/DD/YYYY H:MM 
Field worker ID ID do Inquiridor Isabel Isabel 
  Sergio Sergio 
  Carolina Carolina 
  Olimpio Olimpio 
  Zaida Zaida 




N/A N/A MM/DD/YYYY 
H:MM 
MM/DD/YYYY H:MM 
Bairros ID (official) ID do Bairro (oficial) Aeroporto A Aeroporto A 
  Aeroporto B Aeroporto B 
  Chamanculo A Chamanculo A 
  Chamanculo B Chamanculo B 
  Chamanculo C Chamanculo C 
  Malanga Malanga 
  Maxaquene A Maxaquene A 
  Maxaquene B Maxaquene B 
  Maxaquene C Maxaquene C 
  Maxaquene D Maxaquene D 
  Minkadjuine Minkadjuine 
  Munhuana Munhuana 
  Unidade 7 Unidade 7 
  Urbanizacao Urbanizacao 




Quarteirao ID (official) Número do Quarteirão (oficial) N/A N/A 
Compound number (given by study) Número do composto (atribuído pelo 
Estudo) 
#### #### 
Is this an intervention or control 
compound? 
Este é um composto de intervenção ou 
de controlo 
Intervention Intervenção 
    Control Controlo 
How many people live in this household 
right now? 
Quantas pessoas vivem actualmente 
neste agregado familiar? 
## ## 
Was this household previously part of the 
study? 
Este agregado familiar fez parte do 
estudo de base? 




Sim (Consentimento escrito 
do agregado familiar) 
    No (Did not receive 
written consent from 
household at baseline) 
Não (Não foi obtido 
consentimento escrito do 
agregado) 
Is there a child less than 5 years old living 
in this household right now? 
Existe alguma criança menor de 5 anos 
(60 meses) a viver actualmente neste 
agregado familiar? 
Yes Sim 
    No. Stop survey here. Não (TERMINE AQUI) 
What was the HH ID assigned at 
baseline?  




Enter the household ID assigned at 
baseline. 
Insira o ID do AF atribuído no estudo de 
base. 
## ## 
Enter a new HH ID. If the To 
differentiate the newly enrolled HHs from 
HHs enrolled at baseline, HH IDs for 
newly enrolled HHs will start at 50 and go 
up sequentially within a compound. 
Insira um novo ID do AF. Para 
diferenciar um novo AF do AF visitado 
no estudo de base, o novo AF deve 
iniciar pelo número 50 e aumentar 
sequencialmente dentro do composto. 
## ## 
Assign the household a HH ID Atribua um ID ao agregado familiar ## ## 
Have you gone over the verbal consent 
information sheet with the respondent 
and answered any study related 
questions? (QUESTION TEXT FOR 
PREVIOUSLY ENROLLED 
HOUSEHOLDS) 
Percorreu o formulário do 
consentimento informado verbal com o 
entrevistado (a) e respondeu a qualquer 
dúvida que o mesmo tenha apresentado? 
Yes Sim 
Have you gone over the participant 
information sheet and consent form with 
the respondent and answered any 
questions? (QUESTION TEXT FOR 
NEWLY ENROLLED HOUSEHOLDS) 
Verificou o formulário de informação do 
participante e o consentimento 
juntamente com o mesmo. Respondeu 
qualquer dúvida ou questão relacionada 
com o estudo? 
No. Do not continue 
with survey until this 
is complete. 
Não. Não continue com o 





Does the household agree to remain in the 
study? 
O agregado familiar concorda em 
continuar no estudo? 
Yes Sim 
Has the respondent filled out the consent 
form? 
O entrevistado (a) preencheu o 
formulário de consentimento? 
No. Stop here. Não (TERMINE AQUI) 
What is the respondent's name? Qual é o nome do entrevistado? Respondent's name Respondent's name 
What is the respondent's telephone 
number? 
Qual é o número de contacto do 
entrevistado? 
8######## 8######## 
    N/A N/A 
What is the head of household's name? Qual é o nome do chefe do agregado 
familiar? 
name name 
What is the head of the household's 
telephone number? 
Qual é o número de telefone do chefe do 
agregado? 
8######## 8######## 
  TRUE TRUE 
    TRUE TRUE 
Stand at the front door of the household 
and record GPS points by pressing 
"current location" 
Posicione-se na porta de entrada do 
agregado e grave as coordenadas de 
GPS ao clicar em "localização actual" 
GPS GPS 




  GPS GPS 
    GPS GPS 
Take a photo of the interior and exterior 
of the household. 
Tire foto do interior e do exterior da 
casa do AF 
N/A N/A 
Who is the respondent? (If possible, the 
mother or female caregiver should be the 
respondent) 
Quem é o(a) entrevistado(a)? (Se 
possível, entreviste a mãe ou mulher 
cuidadora da criança.) 
Male head of 
household 
Homem chefe do agregado 
  Female head of 
household 
Mulher chefe do agregado 
  female caregiver Mulher cuidadora 
  male caregiver Homem cuidador 
  Other representative 
(please specify) 
Outro (especifique) 
    role of respondent role of respondent 
What religion is practiced in this 
household? 




Cristianismo (Católica ou 
protestante) 
  Islam Islão 
  Prefer not to answer Prefere não responder 
  Other (please specify) Outro (especifique) 
    N/A N/A 
What education did the head of the 
household receive? 
Qual é o nível de escolaridade do chefe 
do agregado? 




  primary completed Ensino primário completo 
  some secondary Ensino secundário 
incompleto 
  secondary completed Ensino secundário completo 
  some technical 
training 
Ensino técnico incompleto 
  technical training 
completed 
Ensino técnico completo 
  some higher education Ensino superior incompleto 
  higher education 
completed 
Ensino superior completo 
    TRUE TRUE 
What is the household's relationship with 
the other members or households of the 
compound? 
Qual é a relação do AF com os demais 
membros ou agregados do composto? 
Family Família 
  Friends Amigos 
  Other established 
relationship 




  No relationship Nenhuma relação 
    N/A N/A 
Do you own or rent your property? A casa é arrendada ou é propriedade do 
agregado? 
Own Própria 
    Rent Arrendada 
In the month, how much did your 
household spend on food including things 
such as rice/xima, meat, fruits, vegetales, 
and cooking oils. Include the value of any 
food that produced and consumed by the 
household and exclude alcohol, tobacco, 
and restaurant meals. 
Num mês quanto é que o seu agregado 
familiar gastou em comida, incluindo 
itens como arroz/xima, carne, frutas, 
vegetais e óleo de cozinha. Incluí o 
valor de qualquer produto alimentar 
produzido e consumido pelo agregado e 
excluí álcool, Tabaco e refeições 
compradas em restaurantes/barracas 
### ### 
How much money do you spend just on 
rent each month? 
Quanto gasta mensalmente com a renda 
de casa? 
### ### 
In the past month, how much did your 
household spend on housing, gas, 
electricity, water, telephone, and heating 
fuel? 
No último mês quanto é que o seu 
agregado familiar gastou em dispesas de 
renda da casa, gás, electricidade, carvão, 
água, telefone 
### ### 
How much money does your household 
spend on education fees and supplies in a 
typical month? 
Num mês típico quanto é que o seu 
agregado familiar gastou em materiais e 
propinas escolares 
### ### 
In the past month, how much money did 
your household spend on healthcare costs, 
No último mês quanto é que o seu 





excluding any insurance reimbursements? de saúde 
In the past month, how much money did 
your household spend on all other goods 
and services? (E.g. restaurant meals, 
transportation costs, events (wedding, 
funerals) 
No último mês quanto é que o seu 
agregado familiar gastou em todos 
outros bens e serviços  (Por exemplo. 
refeições em restaurantes, os custos de 
transporte , eventos (casamento, 
funerais) 
### ### 
In the past month, how much money did 
your household spend in total? (Ask 
respondents to consider all costs (e.g. 
food, rent, utilities, cell phones, etc). 
Respondent can estimate.) 
No último mês quanto é que o seu 
agregado gastou no total? (Peça ao 
entrevistado(a) para considerar todos os 
custos (ex. Alimentação, renda, crédito, 
etc). O entrevistado (a) pode estimar) 
### ### 
How many children less than 5 years old 
live in your household? 
Quantas crianças menores de 5 anos 
vivem no agregado? 
### ### 
How many bedrooms are in your house? Quantos quartos existem no agregado? ### ### 
How many beds does this household have 
(single, double, bunkbeds, or for 
children)? 
Quantas camas existem no agregado 
(solteira, dupla, beliche, ou berço)? 
None Nenhuma 
  One Uma 
    Two or more Duas ou mais 
Does the household own a working 
bicycle, motorcycle, or car? 
O agregado possuí uma bicicleta, 





  Motorcycle motocicleta 
  Car Carro 
    None Nenhuma 
What is the main source of energy for 
lighting in the residence? 
Qual é a principal fonte de energia para 
iluminação da residência? 
Firewood or batteries Lenha ou baterias/pilha 






  Electricity, generator, 
or solar panel 
Electricidade, gerador, ou 
painel solar 
  Other (please specify) Outro (especifique) 
    N/A N/A 
Does the household have a non-electric or 
electric clothes iron? 
Existe  no agregado um ferro de 
engomar eléctrico ou não eléctrico? 
Yes Sim 
    No Não 
Does the household own a working 
freezer? 
O agregado possuí uma geleira em 
funcionamento? 
Yes Sim 
    No Não 
Does the household own a working clock? 
(E.g. mobile phone, wall clock, wrist 
watch, or pocket watch) 
O agregado possuí relógio em 
funcionamento? (Ex. do telemóvel, de 





    No Não 
Does the household own a working radio, 
stereo, or cassette player? 
O agregado possuí rádio, leitor de 
CD/DVD, leitor de cassete em 
funcionamento? 
Radio Rádio 
  Stereo Leitor de CD/DVD 
  Cassette player Leitor de cassete 
    None Nenhuma 
Does the household own a sofa? O agregado possuí um sofá? Yes Sim 
    No Não 
Is the kitchen located indoors (covered) or 
outdoors? 
A cozinha encontra-se localizada no 
interior (coberta) ou no exterior? 
Indoors Interior 
    Outdoors Exterior 
Is the kitchen attached to the house or is it 
in a communal area in the compound? 
A cozinha está localizada dentro do 
espaço da residência ou encontra-se em 
uma área comum dentro do composto? 
Attached to household Parte do agregado 
    In communal area Na área comum 
What is the main material of the floor of 
hte residence? 
Qual é o principal material do piso da 
residência? (excluindo cozinha e casas 
de banho)? 
uncovered Descoberto 








  Other (please specify) Outro (especifique) 
    N/A N/A 
What is the main material of the wall of 
the house? 










  Adobe locks Adobe 
  wattle and daub Pau a pique 
  cement blocks or 
bricks 
Blocos de cimento ou tijolo 
  Other (please specify) Outro (especifique) 
    N/A N/A 
Does the household have grated windows O agregado tem as janelas gradeadas? Yes Sim 
    No Não 
Does the house have a grated door? O agregado tem as portas gradeadas? Yes Sim 




Where does your household normally 
collect water to drink? (If more than one 
source is used, choose the source most 
often used during the year.) 
Onde normalmente o agregado busca 
água para beber? (Caso mais de uma 
fonte seja usada, escolha a mais usada 
durante o ano.) 
Tap inside the house Torneira dentro de casa 
  Tap in the compound Torneira dentro do composto 
  Public tap or fountain Fonte de água pública ou 
fontanário 
  protected spring Nascente protegida 
  unprotected spring Nascente desprotegida 
  collected rainwater Água da chuva 
  borehole Furo 
  Other (please specify) Outro (especifique) 
    N/A N/A 
How many hours a day is water available 
from your water source? 
Quantas horas por dia tem acesso a água 





When we visited your Household one year 
ago, what type of sanitation system did 
you use? (If intervention compound, make 
sure respondent understands that we are 
asking about sanitation BEFORE WSUP 
built the new latrine.) 
Quando visitamos a sua casa no ano 
passado, que tipo de latrina ou sistema 
de saneamento os membros do seu 
agregado usava? (Se for um composto 
de intervenção, certifique que o 
entrevistado entenda que a pergunta é 
sobre a latrina ou sistema de saneamento 
que usava antes da latrina ou bloco 
construido pela WSUP) 
Flush/pour flush toilet 
to piped sewer system 
Sistema com água corrente 
ligado ao esgoto 
What type of sanitation system did you 
use one year ago?  (If intervention 
compound, make sure respondent 
understands that we are asking about 
sanitation BEFORE WSUP built the new 
latrine.) QUESTION TEXT 
MODIFCATION FOR NEWLY 
ENROLLED COMPOUNDS 
A um ano atrás, que tipo de latrina ou 
sistema de saneamento os membros do 
seu agregado usava? (Se for um 
composto de intervenção, certifique que 
o entrevistado entenda que a pergunta é 
sobre a latrina ou sistema de saneamento 
que usava antes da latrina ou bloco 
construido pela WSUP) QUESTION 
TEXT MODIFICATION FOR NEWLY 
ENROLLED COMPOUNDS 
Flush/pour flush toilet 
to underground 
pit/tank 
Sistema com água corrente 
ligado a fossa séptica 
  Flush/pour flush toilet 
to onsite, above 
ground, open pit 
Sistema com água corrente 
para o local ou na superfície 
  Pit latrine with 
concrete slab (not 
pour flush) 
Latrina com laje de concreto 




  Pit latrine without slab 
(not pour flush) 
Latrina tradicional sem laje 
  Bucket Balde 
  Bag Plástico 
  Open defecation (no 
facilities) 
Fecalismo a céu aberto (sem 
instalações) 
  Other (please specify) Outro (especifique) 
    N/A N/A 
Presently, what type of latrine or 
sanitation system do members of your 
family use most often? 
Actualmente, que tipo de latrina ou 
sistema de saneamento os membros do 
seu agregado usam com mais 
frequência? 
WSUP-built latrine Latrina construída pela 
WSUP 
  Flush/pour flush toilet 
to piped sewer system 
Sistema com água corrente 
ligado ao esgoto 
  Flush/pour flush toilet 
to underground 
pit/tank 
Sistema com água corrente 




  Flush/pour flush toilet 
to onsite, above 
ground, open pit 
Sistema com água corrente 
para o local ou na superfície 
  Pit latrine with 
concrete slab (not 
pour flush) 
Latrina com laje de concreto 
(sistema sem descarga) 
  Pit latrine without slab 
(not pour flush) 
Latrina tradicional sem laje 
  Bucket Balde 
  Bag Plástico 
  Open defecation (no 
facilities) 
Fecalismo a céu aberto (sem 
instalações) 
  Other (please specify) Outro (especifique) 
    N/A N/A 
Does your facility have  container to 
dispose of menstrual hygiene items? 
No local onde esta instalada a latrina 






    No Não 
Are the latrine cabins usually locked on 
the outside? 
O compartimento da latrina encontra-se 
normalmente fechado por fora? 
Yes Sim 
  No Não 
    TRUE TRUE 
Do you(or your family) have a key to the 
latrine? 
O (a) entrevistado (a) (e outros membros 
do agregado) tem acesso a chave da 
latrina? 
Yes Sim 
    No Não 
Are there times when you want to use the 
latrine but do not have a key? 
Houve/há vezes que deseja usar a latrina 
mas não o faz porque não tem acesso as 
chaves? 
Yes Sim 




Which, if any, of the following categories 
of people do not regularly use the latrine? 
Qual, se alguma, das categorias de 
pessoas não usa regularmente a latrina? 
Women and girls Mulheres e raparigas 
  infants Crianças 
  People with 
disabilities 
Pessoas com deficiência 
  people with 
HIV/AIDS 
Pessoas com HIV/SIDA 
  Other (please specify) Outro (especifique) 
  None of the above (all 
groups of people have 
access) 
Nenhuma das alternativas 
acima (todos os grupos de 
pessoas usam a latrina) 
    N/A N/A 
On average, how many minutes do you 
usually wait to use the latrine? 
Em média, quantos minutos 
normalmente espera para usar a latrina? 
## ## 
Does the latrine pit overflow when it 
rains? 






  No Não 
    TRUE TRUE 
Last time the pit was emptied, who paid 
for the service? 
Quem pagou para a latrina ser esvaziada 
da última vez que esta esteve cheia? 
Only my household só o meu agregado familiar 
  All households that 
share the toilet 
Todas as famílias que 
partilham a casa de banho 
  Some of the 
households that share 
the toilet 
Algumas as famílias que 
partilham a casa de banho 
  landlord Senhorio/ dono da casa 
  Free service provided 
by municipality, 
NGO, etc 
Serviço gratuito oferecido 
pelo município , ONG , etc 
  Other (please specify) Outro (especifique) 
    N/A N/A 
Since the last time we visited your 
household, has anyone (unrelated to the 
study) come to speak with you about 
hygiene practices or sanitary behavior? 
Alguém aproximou-se a si para falar 
sobre práticas de higiene ou saneamento 
desde a nossa última visita 





In the past year, has anyone come to 
speak with you about hygiene practices or 
sanitary behavior? QUESTION TEXT 
MODIFICATION FOR NEWLY 
ENROLLED HOUSEHOLDS 
Alguém aproximou-se a si para falar 
sobre práticas de higiene ou saneamento 
no ano passado, ? QUESTION TEXT 
MODIFICATION FOR NEWLY 
ENROLLED HOUSEHOLDS 
Yes, someone from 
WSUP 
Sim, alguém da WSUP 
  Yes, someone from 
MISAU/INS 
Sim, alguém do MISAU/INS 
  Yes, someone from a 
different organization 
Sim, alguém de uma 
organização diferente 
    No Não 
Ask the respondent to confirm whether 
members of the household received 
deworming medication from a member of 
the MapSan team following the baseline 
visit? (OIimpio Zavale and a 
representative from MISAU administered 
deworming medication) 
Peça ao entrevistado para confirmar se 
membros do seu agregado receberam 
medicação para a desparasitação de um 
membro da equipa Mapsan depois da 
visita do estudo de base. (OIimpio 
Zavale e um representante do MISAU 






    Unconfirmed Não confirmado 
Since the last time we visited, has anyone 
not involved with the MapSan trial come 
to the compound and administered 
deworming medication to household 
members? 
Desde a nossa última visita (um ano), 
alguém fora da equipa Mapsan veio ao 
composto e administrou medicação de 
desparasitação aos membros do 
agregado? 
Yes, someone from 
MISAU 
Sim, alguém do MISAU 
In the past year, has anyone not involved 
with the MapSan trial come to the 
compound and administered deworming 
medication to household members? 
QUESTION TEXT MODIFICATION 
FOR NEWLY ENROLLED 
HOUSEHOLDS 
Desde a nossa última visita (um ano), 
alguém fora da equipa Mapsan veio ao 
composto e administrou medicação de 
desparasitação aos membros do 
agregado? QUESTION TEXT 
MODIFICATION FOR NEWLY 
ENROLLED COMPOUNDS 
Yes, someone from a 
different organization 
Sim, alguém de uma 
organização diferente 
    No Não 
Was deworming medication given 
household members older than 5 years? 
A medicação de desparasitação foi dada 
a membros do agregado maiores de 5 
anos? 
Yes Sim 
    No Não 
Was deworming medication given to 
children less than 5 years old? 
A medicação de desparasitação foi dada 






    No Não 
About how long ago did your compound 
receive deworming medication? 
A quanto tempo o seu composto recebeu 
a medicação para a desparasitação? 
within the past week 
(0-7 days) 
Dentro da semana passada (0 
-7 dias) 
  within the past month 
(8-30 days) 
Dentro do mês passado (8-30 
dias) 
  within the past 3 
months (31 - 90 days) 
Dentro dos últimos 3 meses 
(31-90 dias) 
  within the past 6 
months (90- 180 days) 
Dentro dos últimos  6 meses 
(91-180 dias) 
    Longer than 6 months 
ago (180+ days) 
A mais de 6 meses (180+ 
dias) 
Was the medicine given in a tablet or 
liquid form? 
O medicamento foi dado em forma de 
comprimido ou em forma líquida? 
Liquid Líquido 




    TRUE TRUE 
How much money did your household 
initially contribute to the construction of 
the latrine in your compound? 
Quanto dinheiro o seu agregado 
contribuiu inicialmente para a 
construção da latrina existente no 
composto? 
## ## 
Does your household contribute money 
each month to help pay for the latrine? 
O seu agregado contribui um valor 
monetário mensalmente para pagar para 
qualquer dispesa relacionada com a 
latrina? 
Yes Sim 
  No Não 
    TRUE TRUE 
How much money does your household 
contribute each month? 
Quanto dinheiro o seu agregado 
contribui mensalmente? 
## ## 
Is the latrine functioning right now? A latrina está em funcionamento? Yes Sim 
  No Não 
    TRUE TRUE 
Is there a committee assigned to cleaning 
and maintaining the latrine for the 
compound? 
Existe um comité para a limpesa e 





  No Não 
    TRUE TRUE 
How often is the latrine cleaned? (Do not 
read the answers to the respondent. Ask 
the question and select the appropriate 
response.) 
 Com que regularidade a latrina é limpa? 
(Não leia as respostas. Faça a pergunta e 
seleccione a opção apropriada.) 
1 time per day or 
more 
1 ou mais vezes por dia 
  1 time per week or 
more 
1 ou mais vezes por semana 
  1 time per month or 
more 
1 ou mais vezes por mês 
  less than 1 time per 
month 
Menos de uma ves por mês 
  Never Nunca 
  TRUE TRUE 
    TRUE TRUE 
When defecating at home, how often do 
do you use the WSUP-built latrine? 
Quando defeca em casa, com que 
frequência usa uma latrina construída 
pela WSUP? 
Always Sempre 




  Sometimes As vezes 
    Rarely Raramente 
During the last 2 days, what was your 
primary place of defecation? 
Durante os dois últimos dias, qual foi o 
seu principal local para defecação? 
Private latrine in my 
house 
Latrina privada dentro de 
casa 
  Latrine in my 
compound (WSUP 
latrine) 
Latrina no composto (latrina 
construída pela WSUP) 
  Latrine in my 
compound (NOT 
WSUP latrine) 
Latrina dentro do composto 
(não construída pela WSUP) 
  Latrine outside of my 
compound 
Latrina fora do composto 
  Bag or bucket Plástico ou pinico/balde 
  Open defecation in the 
compound 
Fecalismo ao céu aberto no 
composto 
    Open defecation 
outside of the 
compound 





What type of latrine was it? Que tipo de latrina foi? Pour flush to 
underground pit/tank 
Sistema com água corrente 
ligado a fossa séptica 
  Pour flush to sewer 
system 
Sistema com água corrente 
ligado ao esgoto 
  Pour flush to 
elsewhere (above 
ground, open) 
Sistema com água corrente 
para o local ou na superfície 
  Pit latrine with 
concrete slab (not 
pour flush) 
Latrina com laje de concreto 
(sistema sem descarga) 
    Pit latrine without 
concrete slab (not 
pour flush) 
Latrina tradicional sem laje 
What type of latrine did you use outside 
of your compound? 
Que tipo de latrina usa fora do seu 
composto? 
WSUP buit latrine Latrina construída pela 
WSUP 
  Pour flush to 
underground pit/tank 
Sistema com água corrente 




  Pour flush to sewer 
system 
Sistema com água corrente 
ligado ao esgoto 
  Pour flush to 
elsewhere (above 
ground, open) 
Sistema com água corrente 
para o local ou na superfície 
  Pit latrine with 
concrete slab (not 
pour flush) 
Latrina com laje de concreto 
(sistema sem descarga) 
    Pit latrine without 
concrete slab (not 
pour flush) 
Latrina tradicional sem laje 
Was the latrine outside of the compound 
private, shared, or public? 
A latrina fora do composto era privada, 
partilhada, ou pública 
Private (in a private 
home or business) 
Privada (Em uma casa ou 
estabelecimento) 
  Shared (shared by a 
known group of 
people) 
Partilhada (Partilhada por um 
grupo de pessoas conhecidas) 
    Public (used by a 
large group of 
unknown people) 
Público (Usada por um grupo 
grande de pessoas 
desconhecidas) 
During the last 2 days, did you defecate 
anywhere else? 
Durante os últimos 2 dias, defecou em 
algum outro local? 
Private latrine in my 
house 
Latrina privada dentro de 
casa 
  Latrine in my 
compound (WSUP 
latrine) 
Latrina no composto (latrina 




  Latrine in my 
compound (not WSUP 
latrine) 
Latrina dentro do composto 
(não construída pela WSUP) 
  Latrine outside of my 
compound 
Latrina fora do composto 
  Into bag or bucket Plástico ou penico/balde 
  Open defecation in the 
compound 
Fecalismo ao céu aberto no 
composto 
  Open defecation 
outside of the 
compound 
Fecalismo ao céu aberto fora 
do composto 
    No Não 
What type of latrine was it? Que tipo de latrina foi? Pour flush to 
undeground pit/tank 
Com descarga para uma 
fossa ou tanque séptico 
  Pour flush to 
underground sewer 
system 
Com descarga para o Sistema 
de esgoto 
  Pour flush to 
elsewhere (above 
Com descarga para um outro 





  Pit latrine with 
concrete slab (not 
pour flush) 
Latrina com laje de concreto 
(sistema sem descarga) 
    Pit latrine without 
concrete slab (not 
pour flush) 
Latrina tradicional sem laje 
What type of latrine did you use outside 
of your compound? 
Que tipo de latrina usa fora do seu 
composto? 
WSUP buit latrine Latrina construída pela 
WSUP 
  Pour flush to 
underground pit/tank 
Sistema com água corrente 
ligado a fossa séptica 
  Pour flush to sewer 
system 
Sistema com água corrente 
ligado ao esgoto 
  Pour flush to 
elsewhere (above 
ground, open) 
Sistema com água corrente 
para o local ou na superfície 
  Pit latrine with 
concrete slab (not 
pour flush) 
Latrina com laje de concreto 




    Pit latrine without 
concrete slab (not 
pour flush) 
Latrina tradicional sem laje 
Was the latrine outside of the compound 
private, shared, or public? 
A latrina fora do composto era privada, 
partilhada, ou pública 
Private (in a private 
home or business) 
Privada (Em uma casa ou 
estabelecimento) 
  Shared (shared by a 
known group of 
people) 
Partilhada (Partilhada por um 
grupo de pessoas conhecidas) 
    Public (used by a 
large group of 
unknown people) 
Público (Usada por um grupo 
grande de pessoas 
desconhecidas) 
During the last 2 days, what was the 
primary place of defecation for all other 
household members older than 5 years? 
Durante os últimos 2 dias, qual foi o 
principal local de defecação de todos os 
membros do agregado maires de 5 anos? 
Private latrine in my 
house 
Latrina privada dentro de 
casa 
  Latrine in my 
compound (WSUP 
latrine) 
Latrina no composto (latrina 
construída pela WSUP) 
  Latrine in my 
compound (not WSUP 
latrine) 
Latrina dentro do composto 
(não construída pela WSUP) 
  Latrine outside of my 
compound 




  Into bag or bucket Plástico ou penico/balde 
  Open defecation in the 
compound 
Fecalismo ao céu aberto no 
composto 
    Open defecation 
outside of the 
compound 
Fecalismo ao céu aberto fora 
do composto 
Do you and members of your household 
ALWAYS use the WSUP latrine for 
defecation (not just when you're at 
home)? 
Você e membros do seu agregado 
SEMPRE usam as latrinas da WSUP 
para defecarem (mesmo estando fora de 
casa)? 
Yes, we always use it Sim, usamos sempre 
    No, sometimes we do 
not use it 
Não, por vezes não usamos 
What is the main reason you (or others in 
your household) do not ALWAYS use the 
shared compound latrine built by WSUP? 
Qual é a principal razão para que o 
entrevistado (ou outro membro do 
agregado) não use a latrina construída 
pela WSUP? 
We do use it Nós usamos 
  It is dirty/smells É suja/mal cheirosa 
  It is always busy Está sempre ocupada 




  It is not private 
enough 
Não é privada o suficiente 
  It is not safe to use Não é seguro usar 
  Prefer other latrine Prefere outra latrina 
  Water to flush is 
expensive 
A água para descarga é cara 
  The pit is full A fossa esta cheia 
  Often use facilities 
outside of the 
compound 
Usam muitas vezes 
instalações fora do composto 
  Other (please specify) Outro (especifique) 
    N/A N/A 
Do you ever use the latrine for any of the 
following activities? 
Usa a latrina para alguma das seguintes 
actividades? 
defecation Defecar 
  urination Urinar 




  menstrual hygiene Higiene menstrual 
    changing clothes Mudar de roupa 
How do you cleanse yourself after 
defecating? 
Como é que se limpa depois de defecar? Wash with water Lava com água 
  Use toilet paper Usa papel higiénico 
  Other (please specify) Outro (especifique) 
    N/A N/A 
Where do you dispose of the toilet paper 
after use? (Do not read options to 
respondent. Let respondent answer and 
then select correct answer.) 
Onde deita o papel higiénico depois de 
usa-lo? (Não leia as respostas. Deixe o 
entrevistado responder e seleccione a 
opção mencionada.) 
latrine pit Na latrina 
  rubbish heap No monte de lixo 
  soak pit Na fossa 
  on the compound 
ground 




  Other (please specify) Outro (especifique) 
  N/A N/A 








Table C5: 12- and 24-month child level surveys 











N/A N/A Final Final 
    Draft Draft 















What is the compound ID? N/A #### #### 




What is the child's common name? Qual é o nome comum da criança?   





What is the child's sex? Qual é o sexo da criança? Female Feminino 
    Male Masculino 
Was the child previously enrolled in the study? Esta criança fez parte do estudo de base? Yes Sim 
    No Não 
Enter the child ID listed at baseline Registe o ID atribuído no estudo de base ## ## 
Assign the child a child ID number. (Assign the 
child an ID number. Since the child was not 
previously enrolled in the study, assign child Ids 
starting at 50 and going up sequentially for each 
new child enrolled in that HH.) (QUESTION 
TEXT FOR NEWLY ENROLLED 
CHILDREN) 
Atribua um número ID a criança. (Atribua um número 
ID a criança. Caso a criança não tenha feito parte do 
estudo de base, atribua um ID iniciando pelo número 50 
de maneira crescente para cada criança dentro do 
composto ao agregado.) (QUESTION TEXT FOR 
NEWLY ENROLLED CHILDREN) 
    
Is the child currently living in the household? Esta criança vive actualmente no agregado? Yes Sim 




Why doesn't the child live in your household any 
longer? 











  Other 
(please 
specify) 
Outro (registe a 
resposta do 
entrevistado) 
    N/A N/A 
Did the child move to another house in this 
compound or bairro? 
A criança mudou-se para uma outra casa neste 
composto? 
Yes Sim 
  No Não 
    N/A N/A 
Is the respondent the child's mother? (If 
possible, the respondent should be the child's 
mother or female caregiver) 
A entrevistada é mãe da criança? (Se possível,  
entrevistada deve ser a mãe ou cuidadora da criança) 
Yes Sim 
    No Não 
What is the respondent's relationship to the 
child? 




  Female 
relative 
Familiar mulher 
  Male 
relative 
Familiar homem 









What education did the caregiver of the child 
receive? (If there are several caregivers, record 
the highest education level.) 
Qual é o nível de escolaridade do cuidador da criança? 
(Se existir mais de um cuidador, registe o nível de 
escolaridade mais elevado) 
None Nenhum 












































    TRUE TRUE 
Is the child's birth certificate and vaccination 
card available? If available, ask the respondent 
to see them. 
A certidão de nascimento e/ ou de vacinação da criança 
































What is the child's birthdate? (Ask to see the 
chid's birth certificate or vaccination card and 
verify the birthdate. Once you type the date into 
the survey, show it to the respondent for 
confirmation.) 
Qual é a data de nascimento da criança? (Peça ao 
entrevistado para mostrar-lhe a certidão de nascimento 
da criança ou o cartão de vacinação e verifique a data 
de nascimento da criança. Assim que inserir a data no 





    TRUE TRUE 
If birthdate is not available, ask the respondent 
for the month and year of the child's birth. 
Se a data de nascimento não estiver disponível, 
pergunte ao entrevistado pelo mês e ano de nascimento 
MM/YYYY MM/YYYY 
    TRUE TRUE 
If the month and year is not available, ask for 
the year of the child's birth. 
Se o mês não for sabido, pergunte ao entrevistado pelo 
ano de nascimento 
YYYY YYYY 
    TRUE TRUE 
What type of facility was the child born in? Em que tipo de unidade sanitária a criança nasceu? Posto de 
saude 
Posto de saúde 
  Centro de 
saude 
Centro de saúde 









  hospital 
geral 
Hospital geral 
  hospital 
central 
Hospital central 
    TRUE TRUE 
What is the name of the facility/hospital the 
child was born in? (Enter the information 
provided on the birth certificate, e.g. Facility 
name) 
Qual é o nome da unidade sanitária onde a criança 
nasceu? (Insira a informação disponível na certidão de 
nascimento, ex. Nome da unidade sanitária/hospital ou 




  TRUE TRUE 
    TRUE TRUE 
In what province was the child born? Em que província a criança nasceu? Maputo 
Cidade 
Maputo Cidade 




  Gaza Gaza 
  Inhambane Inhambane 
  Manica Manica 




  Zambézia Zambézia 
  Tete Tete 
  Nampula Nampula 
  Cabo 
Delgado 
Cabo Delgado 
  Niassa Niassa 
  Other 
(please 
specify) 
Outro (registe a 
resposta do 
entrevistado) 
    N/A N/A 
Did this child receive a rotavirus vaccination? 
(Enumerator should check the vaccination card 
if available.) 
Esta criança recebeu a vacinação contra o rotavirus? 
(Inquiridor deve verificar o cartão de vacinação se 
disponível.) 
Yes Sim 
  No Não 
    TRUE TRUE 
What was the date of the child's first rotavirus 
vaccination? (Check the child's vaccination 
card) 
Qual é a data da primeira vacinação contra o rotavirus? 








What was the month and year of the child's first 
rotavirus vaccination? 
Qual foi o mês e ano da primeira vacinação contra 
rotavirus? 
MM/YYYY MM/YYYY 
    TRUE TRUE 
What was the year of the child's first rotavirus 
vaccination? 
Qual foi o ano da primeira vacinação contra rotavirus? YYYY YYYY 
    TRUE TRUE 
In what type of facility did the child receive the 
first rotavirus vaccine? 
Em que tipo de unidade sanitária a criança receber a 
primeira vacina contra o rotavírus ? 
Posto de 
saude 
Posto de saúde 
  Centro de 
saude 
Centro de saúde 
  hospital 
distrital 
Hospital distrital 










  hospital 
central 
Hospital central 
  Other 
(please 
specify) 
Outro (registe a 
resposta do 
entrevistado) 
  N/A N/A 
    TRUE TRUE 
What is the name of the facility in which the 
child received the first rotavirus vaccine? (Enter 
the information provided on the vaccination 
card, e.g. Facility name and location) 
Qual é o nome da unidade sanitária onde a criança 
recebeu a primeira vacinação contra rotavirus (Insira a 
informação disponível no  cartão de vacinação, ex. 




    TRUE TRUE 
In what province did the child receive the first 
rotavirus vaccination? 












  Gaza Gaza 
  Inhambane Inhambane 
  Manica Manica 
  Sofala Sofala 
  Zambézia Zambézia 
  Tete Tete 
  Nampula Nampula 
  Cabo 
Delgado 
Cabo Delgado 
  Niassa Niassa 
  TRUE TRUE 
    TRUE TRUE 
What was the date of the child's second 
rotavirus vaccination? 








    TRUE TRUE 
What was the month and year of the child's 
second rotavirus vaccination? 
Qual foi o mês e ano da segunda vacinação contra 
rotavirus? 
MM/YYYY MM/YYYY 
    TRUE TRUE 
What was the year of the child's second 
rotavirus vaccination? 
Qual foi o ano da segunda vacinação contra rotavirus? YYYY YYYY 
    TRUE TRUE 
In what type of facility did the child receive the 
second rotavirus vaccine? 
Em que tipo de unidade sanitária a criança receber a 
segunda vacina contra o rotavírus ? 
Posto de 
saude 
Posto de saúde 
  Centro de 
saude 
Centro de saúde 










  hospital 
geral 
Hospital geral 
  hospital 
central 
Hospital central 
  Other 
(please 
specify) 
Outro (registe a 
resposta do 
entrevistado) 
  N/A N/A 
    TRUE TRUE 
What is the name of the facility in which the 
child received the second rotavirus vaccine? 
Qual é o nome da unidade sanitária onde a criança 




    TRUE TRUE 
In what province did the child receive the second 
rotavirus vaccination? 












  Gaza Gaza 
  Inhambane Inhambane 
  Manica Manica 
  Sofala Sofala 
  Zambézia Zambézia 
  Tete Tete 
  Nampula Nampula 
  Cabo 
Delgado 
Cabo Delgado 












Sim, além de 
outros alimentos 
e líquidos. 
  No Não 
    TRUE TRUE 
About how long ago did the child start eating 
and drinking other foods and liquids?  
A cerca de quanto tempo a criança começou a comer e 






(0 -7 dias) 
  within the 
past month 
(8-30 days) 
Dentro do mês 
passado (8-30 
dias) 





últimos 3 meses 
(31-90 dias) 





últimos  6 meses 
(91-180 dias) 










Where does the child normally defecate? (Do not 
read answers. Let the respondent reply and then 
select the correct answer.) 
Onde a criança normalmente defeca? (Não leia as 
respostas. Deixe o entrevistado responder e depois 
insira a resposta dada.) 
In a diaper Na fralda 
  on the 
ground 
No chão 
  Potty No penico 
  In the 
latrine 
Na latrina 
  in a bag No plástico 
  Other 
(please 
specify) 
Outro (registe a 
resposta do 
entrevistado) 
    N/A N/A 
Where is the diaper disposed of when the child is 
changed? 
Onde é deitada a fralda usada pela criança? Latrine Latrina 
  Rubbish 
pile 
Monte de lixo 
  soak pit Fossa 
  it is washed É lavada (fralda 
de pano) 
  Other 
(please 
specify) 






  N/A N/A 
    TRUE TRUE 
After the child has defecated on the ground, 
what is done with the feces? 
Depois da criança defecar no chão, o que é feito com as 
fezes? 
It is left on 
the ground 
São deixadas no 
chão 








no monte de lixo 
  It is put into 
a soak pit 
São descartadas 
na fossa 
  Other 
(please 
specify) 
Outro (registe a 
resposta do 
entrevistado) 
  N/A N/A 




After the child has defecated into the potty, how 
are the feces disposed of? 







dentro da latrina 
  It is 
emptied 
into a soak 
pit 
É esvaziado na 
fossa 





É descartado no 
monte de lixo 







  Other 
(please 
specify) 
Outro (registe a 
resposta do 
entrevistado) 
  N/A N/A 




After the child has defecated into the bag, how is 
the bag disposed of? 






Monte do lixo 
dentro do 
composto 





Monte de lixo 
fora do composto 
  soak pit Fossa 
  latrine latrina 
  Other 
(please 
specify) 
Outro (registe a 
resposta do 
entrevistado) 
  N/A N/A 
    TRUE TRUE 
Did this child have diarrhea at any time in the 
last 7 days? (Diarrhea is considered to be the 
passage of 3 or more loose or liquid stools per 
day (or more frequent passage than normal) or 
any stool with blood) 
Esta criança teve diarreia em algum momento nos 
últimos 7 dias? (Considera-se diarreia a ocorrência de 3 
ou mais fezes líquidas durante um dia (ou ocorrência 






  No Não 
    TRUE TRUE 
On the worst day of this episode, how many 
bouts of diarrhea did this child have? 
No pior dia do episódio, quantas vezes a criança fez 
diarreia? 
## ## 
    TRUE TRUE 
How many days did the child have 3 or more 
bouts of diarrhea? 
Se mais de 3 vezes, por quantos dias a criança fez 
diarreia 3 ou mais vezes por dia? 
## ## 
During this time, did the child refuse to eat on 
one or more days? 
Durante este período, a criança recusou-se a comer em 
um ou mais dias? 
Yes Sim 
  No Não 
    TRUE TRUE 




    TRUE TRUE 
During this time, did the child have a fever on 
one or more days? 
Durante este período, a criança teve febres em um ou 
mais dias? 
Yes Sim 
  No Não 
    TRUE TRUE 
For how many days did the child have a fever? Por quantos dias a criança teve febres? ## ## 
    TRUE TRUE 
During this time did the child ever have blood in 
the stool? 
Durante este período, as fezes da criança vinham 
acompanhadas de sangue? 
Yes Sim 
  No Não 




Did you ever seek treatment or advice for the 
diarrhea? 
Procurou conselho ou tratamento para a diarreia? Yes Sim 
  No Não 
    TRUE TRUE 
How many days after the illness began did you 
first seek treatment? 
Quantos dias depois do início da doença procurou por 
conselho ou tratamento? 
The same 
day 
No mesmo dia 
  The 
following 
day 
No dia seguinte 
  After 3 or 
more days 
Depois de 3 ou 
mais dias 
    TRUE TRUE 
In the last 7 days, did this child vomit on one or 
more days? 
Nos últimos 7 dias, a criança vomitou em um ou mais 
dias? 
Yes Sim 
  No Não 




On how many days did the child vomit? Por quantos dias a criança vomitou? ## ## 
    TRUE TRUE 
In the last week, did the child have abdominal 
pain? 
Na última semana, esta criança teve dores abdominais? Yes Sim 
  No Não 
    TRUE TRUE 
On how many days did the child have pain? Por quantos dias a criança queixou-se da dor? ## ## 
    TRUE TRUE 
During this time, did the child refuse to eat on 
one or more days because of the abdominal 
pain? 
Durante esta altura, a criança recusou-se a comer em 
um ou mais dias por causa de dores abdominais? 
Yes Sim 




    TRUE TRUE 
On how many days did the child refuse to eat 
because of the pain? 
Por quantos dias a criança recusou-se a comer por 
causa da dor? 
## ## 
    TRUE TRUE 
Was the pain in a particular place of the belly or 
everywhere? 
A dor era em uma área específica da barriga ou em todo 
lado? 
local local 
  everywhere Todo o lado 
    TRUE TRUE 
Please confirm whether this child was dewormed 
by a member of our study team following the 
baseline visit. 
Pode por favor confirmar, se esta criança foi 
desparasitada por um membro do nosso estudo depois 
da visita do estudo de base? 









Was the child dewormed by someone outside of 
our study team since we last visited? 
Esta criança foi desparasitada por alguém fora do nosso 





Sim, por alguém 
do MISAU 










  No Não 
    TRUE TRUE 





(0 -7 dias) 
  Within the 
past month 
(8-30 days) 
Dentro do mês 
passado (8-30 
dias) 
  within the 
past 3 
months (31 
- 90 days) 
Dentro dos 





  within the 
past 6 
months (91 
- 180 days) 
Dentro dos 
últimos  6 meses 
(91-180 dias) 
    More than 6 
months ago 
(180+ days) 
A mais de 6 
meses (180+ 
dias) 
OBSERVE: is the child wearing shoes? OBSERVE: a criança calçava sapatos no momento da 
entrevista? 
Yes Sim 
    No Não 
Measure the child's weight. (For children less 
than 24 months, use tared weight. For children 
older than 24 months, measure child weight 
alone.) 
Registe o peso em Kg (Para crianças com menos de 24 
meses, meça-as acompanhadas. Para crianças> 24 
meses, meça-as sozinhas.) 
## ## 
    N/A N/A 
Measure the child's height or length in cm (For 
children less than 24 months, measure 
recumbent length. For children older than 24 
months, measure standing height.) 
Meça a altura ou comprimento em cm (Para crianças 
menores de 24 meses, use a esteira de medição. Para as 
crianças maiores de 24 meses, use o altimetro.) 
## ## 
    N/A N/A 
Is the child currently less than 5 years of age and 
living in the household? 
Esta criança tem actualmente menos de 5 anos e vive 
no agregado? 
Yes Sim 
    No. Stop 
here. Move 
Não termine aqui 








Why wasn't the child previously enrolled in the 
study? 






da última visita 
da equipa do 
Mapsan 





Mudou-se para o 
composto depois 
da última visita 
da equipa do 
Mapsan 




parte do estudo 
anterior 
  Other 
(please 
specify) 
Outro (registe a 
resposta do 
entrevistado) 
    N/A N/A 
How long ago did the child move into the 
household? 





(0 -7 dias) 
  Within the 
past month 
(8-30 days) 
Dentro do mês 
passado (8-30 
dias) 








  Within the 
past 6 
months (91 
- 180 days) 
N/A 
    More than 6 
months ago 
(180+ days) 











Table D1: Baseline characteristics of children available at 12-month visit and children lost to follow-up by 12-month visit pooled 
across all children and stratified by study arm. 
 
All children 
– lost to 
follow-up by 
12-month 








– available at 
12-month  



































n (%) | 
Mean 
(SD) p 
Baseline outcome measures 



































































































(1.4%) 0.41 111 
4 



















Yersinia 268 ND 489 
1 
(0.2%) 1.00 111 ND 251 
1 















































































40/411 268 8 (3%) 489 
14 












Table D1 (continued). 
Rotavirus A  268 
5 









































































































EED score 227 5 (2.6) 435 
5.1 










































Table D1 (continued). 
Child is 
































disposal in latrine 

















































































(3.5) 0.10 218 
5.2 
(2.1) 317 6 (3) 0.00 
Household wealth 
score, 1 (poorer) - 














































































Latrine used by 
household                
































population 373 19 (14) 620 21 (15) 0.01 153 24 (20) 251 26 (18) 0.27 220 
15 






(4.5) 0.09 153 6 (6.4) 251 
6.1 









Table D1 (continued). 
Number of water 
taps inside the 
compound 364 1.2 (1) 609 
1.5 




(2.8) 0.01 215 
0.97 
(0.83) 310 1 (1.1) 0.66 
Number of 


















(3.2) 0.03 150 
4.5 






















































































Table D1 (continued). 









































Data are n (%) or mean (SD) and collected by questionnaire unless otherwise noted. ^ p-values calculated using t tests or chi-square tests (Fisher’s exact used in 
place of chi-square test when cell counts <5). ND = not detected. ♦ p-value could not be calculated due to non-detects †Assessed using Simple Poverty Scorecard 
for Mozambique, ‡Data collected by direct observation, *Calculated as # of people living in the compound divided by the area of the compound in square meters. 





Table D2: Baseline characteristics of children available at 24-month visit and children lost to follow-up by 24-month visit  
 
All children 
– lost to 
follow-up 











































n (%) | 
Mean 
(SD) p 
Baseline outcome measures 































































































(1.3%) 0.40 152 6 (4%) 210 
3 


























%) 396 ND 1.00 152 
1 
(0.66































(5.1%) 0.05 152 3 (2%) 210 
13 





















































































































Table D2 (continued). 
























































(2.5) 0.40 182 5 (2.6) 161 
5.3 
(2.6) 0.37 






























Child is breastfed, 






























disposal in latrine 
















Table D2 (continued). 



































































(3.6) 0.00 287 
5.2 
(2.2) 248 6.3 (3) 0.00 
Household wealth 
score, 1 (poorer) - 














































































Table D2 (continued). 
Latrine used by 
household                
Has a ceramic or 


































(15) 0.00 193 
23 



















Number of water 









(2.8) 0.00 282 
0.98 
(0.91) 243 1 (1.1) 0.69 
Number of latrines 




(0.62) 0.96 186 1.3 (1) 210 
1.2 








(3.4) 0.00 189 
4.4 





Latrine walls made 
of brick, concrete 




































Table D2 (continued). 
Compound has 
electricity that 


















































































Data are n (%) or mean (SD) and collected by questionnaire unless otherwise noted. ^ p-values calculated using t tests or chi-square tests (Fisher’s exact used in 
place of chi-square test when cell counts <5). ND = not detected. ♦ p-value could not be calculated due to non-detects †Assessed using Simple Poverty Scorecard 
for Mozambique, ‡Data collected by direct observation, *Calculated as # of people living in the compound divided by the area of the compound in square meters. 







Table D3: Characteristics of children enrolled at baseline and children newly enrolled at 12-month follow-up (measurements at 12-
month).  





– Enrolled At 
Baseline 





– Enrolled At 
Baseline 











































































































Table D3 (continued). 
Household 
Wealth Score, 
















































































0.54 155 7 (7.4) 270 6.3 
(5.9) 













































































































Observed‡ (77%) (77%) (81%) (83%) (72%) (71%)
Data are n (%) or mean (SD) and collected by questionnaire unless otherwise noted. Tot n represents denominator for given variable. p-values calculated using t 
tests or chi-square tests. †Assessed using Simple Poverty Scorecard for Mozambique, ‡Data collected by direct observation, *Calculated as # of people living in 




Table D4: Characteristics of children enrolled at baseline and children newly enrolled at 24-month follow-up (measurements at 24-
month). 














































































































0.00 248 6.6 
(3.8) 
248 6.5 (3) 0.61 
Household 
wealth score, 1 







































































              
Compound 
population 











0.46 237 6.7 (7) 239 6.2 
(6.1) 

























































































































Data are n (%) or mean (SD) and collected by questionnaire unless otherwise noted. New enrollees at 24-month includes children enrolled at 12-month. Tot n 
represents denominator for given variable. p-values calculated using t tests or chi-square tests. †Assessed using Simple Poverty Scorecard for Mozambique, ‡Data 
collected by direct observation, *Calculated as # of people living in the compound divided by the area of the compound in square meters. Area measurement 
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